<SEC-DOCUMENT>0001193125-24-228997.txt : 20240930
<SEC-HEADER>0001193125-24-228997.hdr.sgml : 20240930
<ACCEPTANCE-DATETIME>20240930160554
ACCESSION NUMBER:		0001193125-24-228997
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240925
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240930
DATE AS OF CHANGE:		20240930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Guardian Pharmacy Services, Inc.
		CENTRAL INDEX KEY:			0001802255
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				200100834
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42284
		FILM NUMBER:		241339588

	BUSINESS ADDRESS:	
		STREET 1:		300 GALLERIA PARKWAY SE
		STREET 2:		SUITE 800
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339
		BUSINESS PHONE:		(404) 810-0089

	MAIL ADDRESS:	
		STREET 1:		300 GALLERIA PARKWAY SE
		STREET 2:		SUITE 800
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Guardian Pharmacy, LLC
		DATE OF NAME CHANGE:	20200204
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d894834d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:grdn="http://imetrix.edgar-online.com/20240925" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-472">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-09-25_to_2024-09-25">0001802255</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-09-25_to_2024-09-25" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2024-09-25_to_2024-09-25">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="grdn-20240925.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-09-25_to_2024-09-25"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001802255</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-25</xbrli:startDate> <xbrli:endDate>2024-09-25</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-484">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt:datemonthdayyearen" id="ixv-485">September&#160;25, 2024</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-486">Guardian Pharmacy Services, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:stateprovnameen" id="ixv-487">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-488">001-42284</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-489">87-3627139</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:49%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-490">300 Galleria Parkway SE</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-491">Suite 800</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-492">Atlanta</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:stateprovnameen" id="ixv-493">Georgia</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-494">30339</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-495">(404)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-496">810-0089</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:boolballotbox" id="ixv-497">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:boolballotbox" id="ixv-498">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:boolballotbox" id="ixv-499">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:boolballotbox" id="ixv-500">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title&#160;of&#160;each&#160;class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;each&#160;exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-501">Class&#160;A Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-502">GRDN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:exchnameen" id="ixv-503">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:boolballotbox" id="ixv-504">&#9746;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2024-09-25_to_2024-09-25" format="ixt-sec:boolballotbox" id="ixv-505">&#9744;</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INTRODUCTORY NOTE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;27, 2024, Guardian Pharmacy Services, Inc. (the &#8220;Company&#8221;) consummated its previously announced initial public offering (the &#8220;IPO&#8221;) of 8,000,000 shares of its Class&#160;A common stock, par value $0.001 per share (&#8220;Class&#160;A common stock&#8221;), described in the Company&#8217;s prospectus dated September&#160;25, 2024 (the &#8220;Prospectus&#8221;), as filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on September&#160;26, 2024 pursuant to Rule&#160;424(b) under the Securities Act of 1933 (the &#8220;Securities Act&#8221;). Also on September&#160;27, 2024, the underwriters for the IPO exercised in full their option to purchase an additional 1,200,000 shares of Class&#160;A common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to the consummation of the IPO, the Company completed a series of internal reorganization transactions (the &#8220;Corporate Reorganization&#8221;) pursuant to which, among other things, Guardian Pharmacy, LLC became a wholly owned subsidiary of the Company and the members of Guardian Pharmacy, LLC immediately prior to the consummation of the IPO (other than Guardian Investor, Inc.) became holders of the Company&#8217;s Class&#160;B common stock, par value $0.001 per share (&#8220;Class&#160;B common stock&#8221;). </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholders&#8217; Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the IPO, on September&#160;25, 2024, the Company entered into a Stockholders&#8217; Agreement (the &#8220;Stockholders&#8217; Agreement&#8221;) with Bindley Capital Partners I, LLC (&#8220;Bindley Capital&#8221;), Pharmacy Investors, LLC (&#8220;Pharmacy Investors&#8221;), Cardinal Equity Fund LP (&#8220;Cardinal&#8221; and, together with Pharmacy Investors, the &#8220;Cardinal Stockholders&#8221;), Fred P. Burke, David K. Morris and G. Kendall Forbes (collectively, the &#8220;Guardian Founders&#8221;). The Stockholders&#8217; Agreement provides for, among other things, certain director nomination rights with respect to the Company&#8217;s board of directors (the &#8220;Board&#8221;) and certain voting agreements among the Guardian Founders. Pursuant to the terms and conditions of the Stockholders&#8217; Agreement, Bindley Capital has the right to designate up to two nominees for election to the Board (the &#8220;Bindley Capital Nominees&#8221;), the Cardinal Stockholders have the right to designate one nominee for election to the Board (the &#8220;Cardinal Stockholders Nominee&#8221;), and each of Mr.&#160;Burke and Mr.&#160;Morris will be nominees for election to the Board. The three remaining nominees for election to Board will be selected by our board of directors, each of whom must qualify as independent pursuant to New York Stock Exchange (&#8220;NYSE&#8221;) listing standards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Stockholders&#8217; Agreement are further described in the Prospectus in the section titled &#8220;<span style="font-style:italic">Management&#8212;Stockholders&#8217; Agreement and Controlled Company Exemption</span>,&#8221; which description is incorporated herein by reference. The foregoing description of the Stockholders&#8217; Agreement does not purport to be complete and is qualified in its entirety by the full text of the Stockholders&#8217; Agreement, a copy of which is attached hereto as Exhibit 4.1 and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Bindley Capital is an affiliate of William Bindley and Thomas Salentine, Jr., and the Cardinal Stockholders are affiliates of John Ackerman. Messrs. Bindley, Salentine, Jr., Ackerman, Burke and Morris are members of the Board, and Messrs. Burke, Morris and Forbes are executive officers of the Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Merger Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Corporate Reorganization, the Company entered into an Agreement and Plan of Merger dated as of September&#160;27, 2024 (the &#8220;Merger Agreement&#8221;), by and among the Company, Guardian Merger Corp., a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC, with Guardian Pharmacy, LLC as the surviving entity (the &#8220;Merger&#8221;). As a result of the Merger, which was consummated on September&#160;27, 2024, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into the right to receive one share of Class&#160;B common stock and the right to receive $1.02 in cash (the &#8220;Merger Consideration&#8221;). The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by the full text of the Merger Agreement, a copy of which is attached hereto as Exhibit 2.1 and is incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon consummation of the Corporate Reorganization and the Merger on September&#160;27, 2024, the Company issued 54,094,132 shares of Class&#160;B common stock to former members of Guardian Pharmacy, LLC as part of the Merger Consideration under the Merger Agreement. The foregoing issuances were made pursuant to an exemption from registration under Section&#160;4(a)(2) of the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights of the holders of Class&#160;A common stock and Class&#160;B common stock are identical, except for certain transfer restrictions and conversion terms applicable to Class&#160;B common stock, which terms are described in the Prospectus in the section titled &#8220;<span style="font-style:italic">Description of Capital Stock&#8212;Common Stock&#8212;Transfer Restrictions and Conversion of Class</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;B Common Stock</span>,&#8221; which description is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Material Modification to Rights of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information set forth under Item 5.03 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">2024 Equity and Incentive Compensation Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the consummation of the IPO and the Corporate Reorganization, the Company adopted the Guardian Pharmacy Services, Inc. 2024 Equity and Incentive Compensation Plan (the &#8220;2024 Plan&#8221;). The 2024 Plan became effective on September&#160;27, 2024 upon consummation of the IPO, in accordance with its terms. The terms of the 2024 Plan are described in the Prospectus in the section titled &#8220;<span style="font-style:italic">Executive Compensation&#8212;2024 Equity and Incentive Compensation Plan</span>,&#8221; which description is incorporated herein by reference. The foregoing description of the 2024 Plan does not purport to be complete and is qualified in its entirety by the full text of the 2024 Plan, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Board of Directors Changes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;25, 2024 and upon the effectiveness of the Restated Certificate (as defined below), the size of the Board was increased to eight members and William Bindley, John Ackerman, Steve Cosler, Randall Lewis, Mary Sue Patchett and Thomas Salentine, Jr. were elected to the Board. Mr.&#160;Bindley and Mr.&#160;Salentine were elected to the Board as the Bindley Capital Nominees, Mr.&#160;Ackerman was elected as the Cardinal Stockholders Nominee, and Mr.&#160;Burke and Mr.&#160;Morris continue to serve on the Board in furtherance of their nomination rights, in each case pursuant to the Stockholders&#8217; Agreement. The Board affirmatively determined that each of Mr.&#160;Cosler, Mr.&#160;Lewis and Ms.&#160;Patchett are independent within the meaning of NYSE listing standards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Cosler, Mr, Lewis and Ms.&#160;Patchett will be entitled to compensation consistent with the Company&#8217;s previously disclosed standard compensatory arrangements for <span style="white-space:nowrap">non-affiliated</span> directors, which are described in the Prospectus in the section titled &#8220;<span style="font-style:italic">Director Compensation&#8212;Anticipated Compensation of Our <span style="white-space:nowrap">Non-Affiliated</span> Directors Following this Offering</span>.&#8221; Such compensation for 2024 will be prorated to reflect the commencement date of such directors&#8217; Board service. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also upon the effectiveness of the Restated Certificate and in accordance with the terms thereof, the Board was classified into three classes, designated as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Messrs. Morris and Salentine and Ms.&#160;Patchett were designated as Class&#160;I directors, to serve for initial terms expiring at the Company&#8217;s annual meeting of stockholders to be held in 2025; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Messrs. Ackerman and Lewis were designated as Class&#160;II directors, to serve for initial terms expiring at the Company&#8217;s annual meeting of stockholders to be held in 2026; and </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Messrs. Bindley, Burke and Cosler were designated as Class&#160;III directors, to serve for initial terms expiring at the Company&#8217;s annual meeting of stockholders to be held in 2027. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Restated Certificate, only one class of directors will be elected at each annual meeting of stockholders. At each annual meeting of stockholders, the successors to the class of directors whose term expires at that meeting will be elected to serve for a term expiring at the annual meeting of stockholders held in the third year following the year of their election and until their respective successors are elected and qualified. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Board established two standing committees of the Board, consisting of the Audit Committee and the Compensation Committee, and appointed the directors to serve on each committee as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:50%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Audit&#160;Committee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Compensation&#160;Committee</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Randall Lewis (Chair)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">Steve Cosler (Chair)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Steve Cosler</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">Randall Lewis</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Mary Sue Patchett</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">Mary Sue Patchett</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective September&#160;27, 2024, the Company&#8217;s wholly owned subsidiary, Guardian Pharmacy Services Management, LLC entered into employment agreements with each of (i)&#160;Mr.&#160;Burke, relating to his service as the Company&#8217;s President and Chief Executive Officer; (ii)&#160;Mr.&#160;Morris, relating to his service as the Company&#8217;s Executive Vice President and Chief Financial Officer; and (iii)&#160;Mr.&#160;Forbes, relating to his service as the Company&#8217;s Executive Vice President, Sales&#160;&amp; Operations (collectively, the &#8220;Employment Agreements&#8221;). The terms of the Employment Agreements are described in the Prospectus in the sections titled &#8220;<span style="font-style:italic">Executive Compensation&#8212;Employment Agreements</span>&#8221; and &#8220;<span style="font-style:italic">Executive Compensation&#8212;Severance and Change in Control Compensation</span>,&#8221; which descriptions are incorporated herein by reference. The foregoing descriptions of the Employment Agreements do not purport to be complete and are qualified in their entirety by the full text of the Employment Agreements, copies of which are attached hereto as Exhibit 10.2, Exhibit 10.3 and Exhibit 10.4, respectively. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;25, 2024, the Company filed an Amended and Restated Certificate of Incorporation (the &#8220;Restated Certificate&#8221;) with the Secretary of State of the State of Delaware. Also on September&#160;25, 2024, the Company adopted Amended and Restated Bylaws (the &#8220;Restated Bylaws&#8221;). A description of the Restated Certificate and the Restated Bylaws is set forth in the Prospectus in the section titled &#8220;<span style="font-style:italic">Description of Capital Stock</span>,&#8221; which description is incorporated herein by reference. The foregoing description of the Restated Certificate and the Restated Bylaws does not purport to be complete and is qualified in its entirety by the full text of the Restated Certificate and the Restated Bylaws, copies of which are attached hereto as Exhibit 3.1 and Exhibit 3.2, respectively, and are incorporate herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d894834dex21.htm">Agreement and Plan of Merger, dated as of September&#160;27, 2024, by and among Guardian Merger Corp., Guardian Pharmacy, LLC and Guardian Pharmacy Services, Inc.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d894834dex31.htm">Amended and Restated Certificate of Incorporation of Guardian Pharmacy Services, Inc.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d894834dex32.htm">Amended and Restated Bylaws of Guardian Pharmacy Services, Inc.</a></td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:94%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d894834dex41.htm">Stockholders&#8217; Agreement, dated as of September&#160;25,&#160;2024, by and among Guardian Pharmacy Services, Inc., Bindley Capital Partners I, LLC, Pharmacy Investors, LLC, Cardinal Equity Fund LP, Fred Burke, David Morris and Kendall Forbes.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1802255/000119312524219239/d856029dex105.htm">Guardian Pharmacy Services, Inc. 2024 Equity and Incentive Compensation Plan (incorporated by reference to Exhibit&#160;10.5. to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1/A</span> (Registration <span style="white-space:nowrap">No.&#160;333-274847),</span> filed with the SEC on September&#160;16, 2024).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d894834dex102.htm">Employment Agreement by and between Guardian Pharmacy Services Management, LLC and Fred Burke.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d894834dex103.htm">Employment Agreement by and between Guardian Pharmacy Services Management, LLC and David Morris.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d894834dex104.htm">Employment Agreement by and between Guardian Pharmacy Services Management, LLC and Kendall Forbes.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Management contract or compensatory plan, contract or arrangement. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">GUARDIAN&#160;PHARMACY&#160;SERVICES&#160;INC.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: September&#160;30, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David K. Morris</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">David K. Morris</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President and Chief Financial</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Officer</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d894834dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AGREEMENT AND PLAN OF MERGER (this &#147;<B><I>Agreement</I></B>&#148;) is entered into this 27th day of September, 2024 among Guardian
Merger Corp., an Indiana corporation (&#147;<B><I>Merger Sub</I></B>&#148;), Guardian Pharmacy, LLC, an Indiana limited liability company (&#147;<B><I>Guardian Pharmacy</I></B>&#148;), and Guardian Pharmacy Services, Inc., a Delaware corporation
(&#147;<B><I>Guardian Services</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RECITALS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Merger Sub and Guardian Pharmacy desire to merge into a single limited liability company (the &#147;<B><I>Merger</I></B>&#148;)
pursuant to Chapter 2 of the Indiana Uniform Business Organization Transactions Act (the &#147;<B><I>IN Act</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
board of directors of Merger Sub and the sole stockholder of Merger Sub have duly adopted and approved the execution and performance of this Agreement in accordance with the IN Act; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors of Guardian Services and the sole stockholder of Guardian Services have duly adopted and approved the
execution and performance of this Agreement in accordance with the IN Act; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of managers of Guardian Pharmacy and a
supermajority in interest of the preferred members of Guardian Pharmacy have duly adopted and approved the execution and performance of this Agreement in accordance with the IN Act and the Amended and Restated Operating Agreement of Guardian
Pharmacy, dated May&nbsp;1, 2018, as amended (the &#147;<B><I>Operating Agreement</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, both parties to this
Agreement, in consideration of the mutual covenants, agreements and provisions hereinafter contained, do hereby prescribe the terms and conditions of the Merger and mode of carrying the same into effect as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AGREEMENT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>Merger</U>. On the terms and subject to the conditions set forth in this Agreement, and in accordance with the applicable provisions of the IN Act, at the Effective Time, Merger Sub will be merged with and into Guardian Pharmacy, the separate
corporate existence of Merger Sub will cease, and Guardian Pharmacy will continue as the surviving limited liability company in the Merger (the &#147;<B><I>Surviving Entity</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Filings; Effective Time</U>. As soon as practicable following the execution hereof, the parties will cause articles of merger with
respect to the Merger to be executed and filed with the Secretary of State of the State of Indiana. The Merger will become effective upon the filing of such documents or at such later time as indicated therein (such time, the &#147;<B><I>Effective
Time</I></B>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Articles of Organization and Operating Agreement</U>. As of the Effective Time,
(a)&nbsp;the articles of organization of Guardian Pharmacy in effect immediately prior to the Effective Time will continue as the articles of organization of the Surviving Entity, and (b)&nbsp;the Operating Agreement in effect immediately prior to
the Effective Time will continue as the operating agreement of the Surviving Entity, until amended or amended and restated in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Managers of the Surviving Entity</U>. The managers of Guardian Pharmacy immediately prior to the Effective Time will be the managers of
the Surviving Entity until the earlier of the death, resignation or removal of any such person or until their respective successors are duly elected or appointed, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Effects Generally</U>. The Merger will have the effects set forth in the IN Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Effects on Equity Interests</U>. At the Effective Time, by virtue of the Merger and without any action on the part of the parties hereto
or any other person or entity, (a)&nbsp;each issued and outstanding share of capital stock of Merger Sub will be converted into one thousand (1,000) Common Units of Guardian Pharmacy, (b)&nbsp;each issued and outstanding Common Unit of Guardian
Pharmacy as of immediately prior to the Effective Time (other than Common Units held by Guardian Investor, Inc.) will be converted into the right to receive one fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> share of
Class&nbsp;B Common Stock, par value $0.001 per share, of Guardian Services, plus the right to receive $1.02 in cash, without interest, and (c)&nbsp;each issued and outstanding Common Unit of Guardian Pharmacy held by Guardian Investor, Inc. as of
immediately prior to the Effective Time will be unaffected by the Merger and will remain outstanding immediately following the Merger as a Common Unit of the Surviving Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Miscellaneous</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a.
<U>Amendments</U>. This Agreement may only be amended by a written instrument executed by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Counterparts</U>.
This Agreement may be executed in multiple original or .pdf counterparts (including by electronic signature and/or transmission), each of which will be deemed an original, and all of which taken together will be considered one and the same
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Governing Law</U>. This Agreement shall in all respects be construed, interpreted and enforced in accordance with and
governed by the laws of the State of Indiana without regard to the conflict of laws principles thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>]
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first set
forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUARDIAN PHARMACY, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David K. Morris</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: David K. Morris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUARDIAN MERGER CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fred P. Burke</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUARDIAN PHARMACY SERVICES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fred P. Burke</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Agreement and Plan of Merger</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>d894834dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GUARDIAN PHARMACY
SERVICES, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Guardian Pharmacy Services, Inc., a corporation organized and existing under the laws of the State of Delaware (the
&#147;<B><I>Company</I></B>&#148;), hereby certifies as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The original Certificate of Incorporation of the Company was filed
with the Office of the Secretary of State of the State of Delaware on November&nbsp;16, 2021 (the &#147;<B><I>Original Certificate</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The Company is filing this Amended and Restated Certificate of Incorporation of the Company, which amends and restates the Original
Certificate, and which was duly adopted by all necessary action of the board of directors of the Company and the stockholders of the Company in accordance with the provisions of Sections 242, 245 and 228 of the General Corporation Law of the State
of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The text of the Original Certificate is hereby amended and restated in its entirety by this Amended and Restated
Certificate of Incorporation to read as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the corporation is Guardian Pharmacy Services, Inc. (the &#147;<B><I>Company</I></B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address
of the Company&#146;s registered office in the State of Delaware is 9 E. Loockerman Street, Suite 311, Dover, Kent County, Delaware 19901. The name of the Company&#146;s registered agent at such address is Registered Agent Solutions, Inc. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose
of the Company is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware, as amended (the &#147;<B><I>DGCL</I></B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Authorized Capital Stock</U>. The total number of shares of capital stock that the Company shall have authority to issue is
850,000,000, consisting of 700,000,000 shares of Class&nbsp;A Common Stock, par value $0.001 per share (&#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;A Common Stock</I></B>&#148;), 100,000,000 shares of Class&nbsp;B Common Stock, par value
$0.001 per share (&#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;B Common Stock</I></B>&#148;), and 50,000,000 shares of Preferred Stock, par value $0.001 per share (&#147;<B><I>Preferred Stock</I></B>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the effectiveness of the filing of this Amended and Restated Certificate of
Incorporation of the Company with the Secretary of State of the State of Delaware (the &#147;<B><I>Effective Time</I></B>&#148;), each share of Common Stock (as defined in the Original Certificate) issued and outstanding immediately prior to the
Effective Time shall be reclassified as and converted into one fully-paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> share of Class&nbsp;B Common Stock (the &#147;<B><I>Reclassification</I></B>&#148;). The Reclassification shall
occur automatically as of the Effective Time without any further action by the Company or the holders of the shares affected thereby and whether or not any certificates representing such shares are surrendered to the Company. Upon the Effective
Time, each certificate that as of immediately prior to the Effective Time represented shares of Common Stock shall be deemed to represent an equivalent number of shares of Class&nbsp;B Common Stock. The Reclassification shall also apply to any
outstanding securities or rights convertible into, or exchangeable or exercisable for, Common Stock and all references to the Common Stock in agreements, arrangements, documents and plans relating thereto or any option or right to purchase or
acquire shares of Common Stock shall be deemed to be references to the Class&nbsp;B Common Stock or options or rights to purchase or acquire shares of Class&nbsp;B Common Stock, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Preferred Stock</U>. The Preferred Stock may be issued in one or more series. The Board of Directors of the Company (the
&#147;<B><I>Board</I></B>&#148;) is hereby authorized to issue the shares of Preferred Stock in one or more series and to fix from time to time before issuance the number of shares to be included in any such series and the designation, powers,
preferences and relative participating, optional or other rights, if any, and the qualifications, limitations or restrictions thereof. The authority of the Board with respect to each such series will include, without limiting the generality of the
foregoing, the determination of any or all of the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the number of shares of any series, which number the Board may (except
where otherwise provided in the Preferred Stock Designation (as defined below)) increase or decrease, and the designation to distinguish the shares of such series from the shares of all other series, which may be by distinguishing number, letter or
title; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the voting powers, if any, and whether such voting powers are full or limited in such series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the redemption provisions, if any, applicable to such series, including the redemption price or prices to be paid; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) whether dividends, if any, will be cumulative or noncumulative, the dividend rate of such series, and the dates and preferences of
dividends on such series; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the rights of such series upon the voluntary or involuntary dissolution of, or upon any distribution of the
assets of, the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable
for, shares of any other class or classes or of any other series of the same or any other class or classes of stock, or any other security, of the Company or any other corporation or other entity, and the rates or other determinants of conversion or
exchange applicable thereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) the right, if any, to subscribe for or to purchase any securities of the Company or any other
corporation or other entity; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) the provisions, if any, of a sinking fund applicable to such series; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any other relative, participating, optional, or other special powers, preferences or rights and qualifications, limitations, or
restrictions thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">all as may be determined from time to time by the Board and stated or expressed in the resolution or resolutions providing for the
issuance of such Preferred Stock (collectively, a &#147;<B><I>Preferred Stock Designation</I></B>&#148;). Subject to the rights of the holders of any series of Preferred Stock, the number of authorized shares of Preferred Stock may be increased or
decreased (but not below the number of shares thereof then outstanding) by the approval of the Board of Directors and by the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the Company
entitled to vote generally in an election of directors, without the separate vote of the holders of the Preferred Stock as a class, irrespective of the provisions of Section&nbsp;242(b)(2) of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Rights of Class</U><U></U><U>&nbsp;A Common Stock and Class</U><U></U><U>&nbsp;B Common Stock</U>. The relative powers,
rights, qualifications, limitations and restrictions granted to or imposed on the shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock are as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Voting Rights</U>. Except as otherwise expressly provided herein or required by applicable law, the holders of Class&nbsp;A Common Stock
and Class&nbsp;B Common Stock shall vote together as one class on all matters submitted to a vote of the stockholders, and each share of Class&nbsp;A Common Stock and each share of Class&nbsp;B Common Stock shall entitle the holder thereof to one
vote per share on any matter submitted to a vote of the stockholders. The number of authorized shares of Class&nbsp;A Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the approval of the
Board of Directors and by the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the Corporation entitled to vote generally in an election of directors, without the separate vote of the
holders of the Class&nbsp;A Common Stock as a class, irrespective of the provisions of Section&nbsp;242(b)(2) of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Identical Rights</U>. Except as otherwise expressly provided herein or required by applicable law, shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock shall have the same rights and privileges and rank equally, share ratably and be
identical in all respects as to all matters, including, without limitation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) <U>Dividends</U>. Subject to the terms of any series of
Preferred Stock, shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock shall be treated equally, identically and ratably, on a per share basis, with respect to any dividend paid by the Company, unless different treatment of the shares of
each such class is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;B Common Stock,
each voting separately as a class; provided, however, that in the event a dividend is paid in the form of Class&nbsp;A Common Stock or Class&nbsp;B Common Stock (or rights to acquire such stock), then holders of Class&nbsp;A Common Stock shall
receive Class&nbsp;A Common Stock (or rights to acquire such stock, as the case may be) and holders of Class&nbsp;B Common Stock shall receive Class&nbsp;B Common Stock (or rights to acquire such stock, as the case may be). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) <U>Subdivision, Combination or Reclassification</U>. If the Company in any manner
subdivides, combines or reclassified the outstanding shares of Class&nbsp;A Common Stock or Class&nbsp;B Common Stock, the outstanding shares of the other such class will be subdivided, combined or reclassified in the same proportion and manner,
unless different treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and by the affirmative vote of the holders of a majority of the
outstanding shares of Class&nbsp;B Common Stock, each voting separately as a class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) <U>Liquidation, Dissolution or Winding Up</U>.
Subject to the terms of any series of Preferred Stock, upon the dissolution, distribution of assets, liquidation or winding up of the Corporation, whether voluntary or involuntary, holders of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock
will be entitled to receive ratably all assets of the Company available for distribution to its stockholders unless different treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the
outstanding shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, each voting separately as a class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(4) <U>Merger or
Consolidation</U>. In the case of any distribution or payment in respect of the shares of Class&nbsp;A Common Stock or Class&nbsp;B Common Stock, or any consideration into which such shares are converted, upon the consolidation or merger of the
Company with or into any other entity, such distribution, payment or consideration that the holders of shares of Class&nbsp;A Common Stock or Class&nbsp;B Common Stock have the right to receive, or the right to elect to receive, shall be made
ratably on a per share basis among the holders of the Class&nbsp;A Common Stock and Class&nbsp;B Common Stock as a single class; provided, however, that shares of such classes may receive, or have the right to elect to receive, different or
disproportionate consideration in connection with such consolidation, merger or other transaction if such different treatment is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and
Class&nbsp;B Common Stock, each voting separately as a class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Transfer Restriction</U>. Shares of Class&nbsp;B Common Stock may
not be Transferred by the holder thereof, unless such Transfer is a Permitted Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Automatic Conversion of
Class</U><U></U><U>&nbsp;B Common Stock</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) On the 182<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP> day following any
Class&nbsp;B Issuance Date (&#147;<B><I>First Conversion Date</I></B>&#148;), <FONT STYLE="white-space:nowrap">one-fourth</FONT> (1/4) of each Qualified Stockholder&#146;s then outstanding shares of Class&nbsp;B Common Stock issued on such
Class&nbsp;B Issuance Date shall automatically convert into an equal number of shares of Class&nbsp;A Common Stock, without any further action by the holder thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) On the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of any Class&nbsp;B Issuance Date (&#147;<B><I>Second Conversion
Date</I></B>&#148;), <FONT STYLE="white-space:nowrap">one-third</FONT> (1/3) of each Qualified Stockholder&#146;s then outstanding shares of Class&nbsp;B Common Stock relating to such First Conversion Date shall automatically convert into an equal
number of shares of Class&nbsp;A Common Stock, without any further action by the holder thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii) On the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the First
Conversion Date, <FONT STYLE="white-space:nowrap">one-half</FONT> (1/2) of each Qualified Stockholder&#146;s then outstanding shares of Class&nbsp;B Common Stock issued on such Class&nbsp;B Issuance Date shall automatically convert into an equal
number of shares of Class&nbsp;A Common Stock, without any further action by the holder thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv) On the <FONT
STYLE="white-space:nowrap">two-year</FONT> anniversary of any Class&nbsp;B Issuance Date, all of each Qualified Stockholder&#146;s then outstanding shares of Class&nbsp;B Common Stock issued on such Class&nbsp;B Issuance Date shall automatically
convert into an equal number of shares of Class&nbsp;A Common Stock, without any further action by the holder thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v) If the
conversion of any shares of Class&nbsp;B Common Stock pursuant to the foregoing provisions of this <U>Article IV</U>, <U>Section</U><U></U><U>&nbsp;4(d)(1)</U> would result in the conversion of any fractional share of Class&nbsp;B Common Stock, the
number of shares so converted shall be rounded down to the nearest whole number. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Conversion by Action of the Board</U>. All or any
portion of the issued and outstanding shares of Class&nbsp;B Common Stock shall be converted into an equal number of shares of Class&nbsp;A Common Stock pursuant to an action of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Procedures</U>. The Company may, from time to time, establish such policies and procedures relating to the conversion of Class&nbsp;B
Common Stock to Class&nbsp;A Common Stock and the general administration of this dual class stock structure, including the issuance of stock certificates (or the establishment of book-entry positions) with respect thereto, as it may deem reasonably
necessary or advisable, and may from time to time request that holders of shares of Class&nbsp;B Common Stock furnish to the Company such certifications, affidavits or other evidence as the Company deems necessary to verify the ownership of
Class&nbsp;B Common Stock or to assess other related administrative matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Effects of Conversion</U>. Upon the effectiveness of
any conversion of Class&nbsp;B Common Stock to Class&nbsp;A Common Stock, all rights of any holder of shares of Class&nbsp;B Common Stock so converted shall cease and such holder shall be treated for all purposes as having become the record holder
or holders of such shares of Class&nbsp;A Common Stock into which such shares of Class&nbsp;B Common Stock were converted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)
<U>Reservation of Stock</U>. The Company shall at all times reserve and keep available out of its authorized but unissued shares of Class&nbsp;A Common Stock, solely for the purpose of effecting the conversion of the shares of Class&nbsp;B Common
Stock, such number of its shares of Class&nbsp;A Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of Class&nbsp;B Common Stock into shares of Class&nbsp;A Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Treatment of Class</U><U></U><U>&nbsp;B Stock Upon Conversion</U>. Each share of Class&nbsp;B Common Stock that is converted pursuant
to this <U>Article IV</U> shall be retired by the Company and returned to the authorized but unissued shares of Class&nbsp;B Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Defined Terms</U>: For purposes of this <U>Article IV</U>, the following terms have the meanings set forth below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) <B><I>&#147;Class</I></B><B><I></I></B><B><I>&nbsp;B Issuance Date&#148;</I></B> means the date of initial issuance of such share of
Class&nbsp;B Common Stock, as recorded in the stock records of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) &#147;<B><I>Distribution</I></B>&#148; means (i)&nbsp;any dividend of cash, property or
shares of the Company&#146;s capital stock, and (ii)&nbsp;any distribution following or in connection with any liquidation, dissolution or winding up of the Company, either voluntary or involuntary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) &#147;<B><I>Family Member</I></B>&#148; means with respect to any natural person who is a Qualified Stockholder, the spouse, domestic
partner, parents, grandparents, lineal descendants, siblings and lineal descendants of siblings of such Qualified Stockholder. Lineal descendants shall include adopted persons, but only so long as they are adopted while a minor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(4) &#147;<B><I>Permitted Entity</I></B>&#148; means with respect to a Qualified Stockholder: (i)&nbsp;a Permitted Trust solely for the
benefit of (A)&nbsp;such Qualified Stockholder, (B)&nbsp;one or more Family Members of such Qualified Stockholder, or (C)&nbsp;any other Permitted Entity of such Qualified Stockholder; or (ii)&nbsp;any general partnership, limited partnership,
limited liability company, corporation or other entity exclusively owned by (A)&nbsp;such Qualified Stockholder, (B)&nbsp;one or more Family Members of such Qualified Stockholder, or (C)&nbsp;any other Permitted Entity of such Qualified Stockholder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(5) &#147;<B><I>Permitted Transfer</I></B>&#148; means, and be restricted to, any Transfer of a share of Class&nbsp;B Common Stock: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) approved in advance by the Board, in its discretion; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) by a Qualified Stockholder (A)&nbsp;to one or more Family Members of such Qualified Stockholder, (B)&nbsp;to any Permitted Entity of
such Qualified Stockholder, (C)&nbsp;to such Qualified Stockholder&#146;s revocable living trust, which revocable living trust is a Permitted Trust, or (D) upon such Qualified Stockholder&#146;s death by will, intestate succession or operation of
law; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii) by a Permitted Entity of a Qualified Stockholder to (A)&nbsp;such Qualified Stockholder or one or more Family Members of
such Qualified Stockholder, or (B)&nbsp;any other Permitted Entity of such Qualified Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(6) &#147;<B><I>Permitted
Transferee</I></B>&#148; means a transferee of shares of Class&nbsp;B Common Stock received in a Permitted Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(7)
&#147;<B><I>Permitted Trust</I></B>&#148; means a bona fide trust where each trustee is (i)&nbsp;a Qualified Stockholder, (ii)&nbsp;a Family Member, or (iii)&nbsp;a professional in the business of providing trustee services, including private
professional fiduciaries, trust companies and bank trust departments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(8) <B><I>&#147;Qualified Stockholder&#148; </I></B>means
(i)&nbsp;the record holder of a share of Class&nbsp;B Common Stock upon the initial issuance thereof, and<B><I> </I></B>(ii) a Permitted Transferee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(9) &#147;<B><I>Transfer</I></B>&#148; of a share of Class&nbsp;B Common Stock means any sale, assignment, transfer, conveyance,
hypothecation or other transfer or disposition of such share or any legal or beneficial interest in such share, whether or not for value and whether voluntary or involuntary or by operation of law. The term &#147;<B><I>Transferred</I></B>&#148;
shall have a correlative meaning. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Board may make, amend, and repeal the Bylaws of the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Action by Written Consent of Stockholders</U>. Subject to the rights of the holders of any series of Preferred Stock, from
and after the time the Company ceases to be a &#147;controlled company&#148; (within the meaning of Nasdaq rules), any action required or permitted to be taken by the stockholders of the Company may only be taken at a duly called annual or special
meeting of stockholders of the Company and may not be taken without a meeting by means of any consent in writing of such stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Special Meetings of Stockholders</U>. Subject to the rights of the holders of any series of Preferred Stock, special
meetings of stockholders of the Company may be called only (i)&nbsp;by the Chairman of the Board (the &#147;<B><I>Chairman</I></B>&#148;) or (ii)&nbsp;by the Secretary of the Company (the &#147;<B><I>Secretary</I></B>&#148;) acting at the request of
the Chairman or a majority of the total number of directors of the Company (the &#147;<B><I>Directors</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.
<U>Business Conducted at Meetings of Stockholders</U>. At any annual meeting or special meeting of stockholders of the Company, only such business will be conducted or considered as has been brought before such meeting in the manner provided in the
Bylaws of the Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Number, Election and Terms of Directors</U>. Subject to the rights, if any, of the holders of any series of Preferred Stock
to elect additional Directors under circumstances specified in any Preferred Stock Designation, the number of Directors of the Company will not be less than 5 nor more than 9 and will be fixed from time to time in the manner provided in the Bylaws
of the Company. The Directors, other than those who may be elected by the holders of any series of Preferred Stock, will be classified with respect to the time for which they severally hold office into three classes, as nearly equal in number as
possible, designated Class&nbsp;I, Class&nbsp;II, and Class&nbsp;III. At any meeting of stockholders at which Directors are to be elected, the number of Directors elected may not exceed the greatest number of Directors then in office in any class of
Directors. The Board shall assign members of the Board already in office to Class&nbsp;I, Class&nbsp;II or Class&nbsp;III. The Directors first appointed to Class&nbsp;I will hold office for a term expiring at the annual meeting of stockholders to be
held in 2025; the Directors first appointed to Class&nbsp;II will hold office for a term expiring at the annual meeting of stockholders to be held in 2026; and the Directors first appointed to Class&nbsp;III will hold office for a term expiring at
the annual meeting of stockholders to be held in 2027, with the members of each class to hold office until their successors are elected and qualified. At each succeeding annual meeting of the stockholders of the Company, the successors to the class
of Directors whose term expires at that meeting will be elected by plurality vote of all votes cast at such meeting to hold office for a term expiring at the annual meeting of stockholders held in the third year following the year of their election
and until their successors are elected and qualified. Subject to the rights, if any, of the holders of any series of Preferred Stock to elect additional Directors under circumstances specified in a Preferred Stock Designation. Election of Directors
need not be by written ballot. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Nomination of Director Candidates</U>. Advance notice of stockholder
nominations for the election of Directors must be given in the manner provided in the Bylaws of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Newly
Created Directorships and Vacancies</U>. Subject to the rights, if any, of the holders of any series of Preferred Stock to elect additional Directors under circumstances specified in a Preferred Stock Designation, newly created directorships
resulting from any increase in the number of Directors and any vacancies on the Board resulting from death, resignation, disqualification, removal, or other cause will be filled solely by the affirmative vote of a majority of the remaining Directors
then in office, even though less than a quorum of the Board, or by a sole remaining Director. Any Director elected in accordance with the preceding sentence will hold office for the remainder of the full term of the class of directors in which the
new directorship was created or the vacancy occurred and until such Director&#146;s successor has been elected and qualified. No decrease in the authorized number of Directors constituting the Board may shorten the term of any incumbent Director.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. <U>Removal</U>. Subject to the rights, if any, of the holders of any series of Preferred Stock to elect additional
Directors under circumstances specified in a Preferred Stock Designation, so long as the Board is divided into classes, any Director may be removed from office by the stockholders only for cause. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the
fullest extent permitted by the DGCL and any other applicable law currently or hereafter in effect, no Director or officer of the Company will be personally liable to the Company or its stockholders for monetary damages for or with respect to any
breach of fiduciary duty or other act or omission as a Director or officer of the Company. No repeal or modification of this <U>Article VIII</U> will adversely affect the protection of any Director or officer of the Company provided hereby in
relation to any breach of fiduciary duty or other act or omission as a Director or officer of the Company occurring prior to the effectiveness of such repeal or modification. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Forum Generally</U>. Unless the Company consents in writing to the selection of an alternative forum, the sole and
exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the
Company&#146;s stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the DGCL, this Certificate of Incorporation or the Bylaws of the Company (as either may be amended from time to time), or (iv)&nbsp;any action
asserting a claim governed by the internal affairs doctrine, shall be the Court of Chancery in the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Securities Act Matters</U>. Notwithstanding
<U>Section</U><U></U><U>&nbsp;1</U> of this <U>Article IX</U>, unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any
complaint asserting a cause of action arising under the Securities Act of 1933, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Deemed Notice</U>. Any
person or entity purchasing or otherwise acquiring any interest in any security of the Company shall be deemed to have notice of and consented to the provisions of this <U>Article IX</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Amended and Restated Certificate of
Incorporation to be signed on this 25th day of September, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUARDIAN PHARMACY SERVICES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fred P. Burke</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Amended and Restated Certificate of Incorporation</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>4
<FILENAME>d894834dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GUARDIAN PHARMACY SERVICES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED BYLAWS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">As Adopted and Effective </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">on
<B></B><B></B>September&nbsp;25, 2024 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">STOCKHOLDERS MEETINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time and Place of Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Meetings; Adjournment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;5.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inspectors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;6.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Quorum</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;7.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting; Proxies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;8.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Organization; Conduct of Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#8199;9.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Stockholder Proposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">10.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Director Nominations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">11.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Provisions Relating to the Notice of Stockholder Business and Director
Nominations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">12.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Record Dates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">13.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">List of Stockholders Entitled to Vote</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">14.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">15.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number, Election and Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">16.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Newly Created Directorships and Vacancies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">17.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">18.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Resignation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">19.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regular Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">20.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">21.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Quorum</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">22.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Participation in Meetings by Remote Communications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">23.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Committees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">24.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">25.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rules</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">26.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">27.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Action by Unanimous Consent of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(i) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(continued) </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">NOTICES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">28.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Generally</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;&#8195;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">29.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waivers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">OFFICERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">30.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Generally</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">31.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">32.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Succession</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">33.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authority and Duties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">STOCK</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">34.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">35.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">36.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lost, Stolen or Destroyed Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">INDEMNIFICATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">37.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right to Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">38.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right to Advancement of Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">39.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">40.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of Indemnitee to Bring Suit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">41.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">42.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">43.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Duplication of Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">GENERAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">44.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fiscal Year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">45.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reliance Upon Books, Reports and Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">46.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(ii) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STOCKHOLDERS MEETINGS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Time and Place of Meetings</U>. All meetings of stockholders will be held at such time and place, within or without the State of
Delaware, as may be designated by resolution of the Board of Directors (the &#147;<B><I>Board</I></B>&#148;) of Guardian Pharmacy Services, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), from time to time or, in the absence of
a designation by the Board, by the Chairman of the Board (the &#147;<B><I>Chairman</I></B>&#148;) or Secretary of the Company (the &#147;<B><I>Secretary</I></B>&#148;), and stated in the notice of the meeting. Notwithstanding the foregoing, the
Board may, in its sole discretion, determine that a meeting of stockholders will not be held at any place, but may instead be held by means of remote communications in accordance with Section&nbsp;211(a) of the General Corporation Law of the State
of Delaware (the &#147;<B><I>DGCL</I></B>&#148;), subject to such guidelines and procedures as the Board may adopt from time to time. The Board may cancel, postpone or reschedule to an earlier or later date any previously scheduled annual or special
meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Annual Meetings</U>. An annual meeting of stockholders shall be held at such date and time as may be
designated by resolution of the Board from time to time. At each annual meeting of stockholders, the stockholders will elect the directors and transact such other business as may properly be brought before the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Special Meetings</U>. A special meeting of stockholders for any purpose or purposes may be called only (i)&nbsp;by the Chairman or
(ii)&nbsp;by the Secretary acting at the request of the Chairman or a majority of the Board, and may not be called by any other person or persons. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in
the notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Notice of Meetings; Adjournment</U>. Notice of every meeting of stockholders, stating the place, if any, date and time
thereof, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is
called, will be given, not less than ten nor more than 60 calendar days before the date of the meeting to each stockholder of record entitled to vote at such meeting as of the record date for determining stockholders entitled to notice of the
meeting, except as otherwise provided by law, the certificate of incorporation (as may amended and/or restated from time to time, the &#147;<B><I>Certificate of</I></B> <B><I>Incorporation</I></B>&#148;) or these Bylaws. When a meeting is adjourned
to another place, if any, date, or time, notice need not be given of the adjourned meeting<B><I> </I></B>if the place, if any, date and time thereof, and the means of remote communications, if any, by which stockholders and proxy holders may be
deemed to be present in person and vote at such recessed or adjourned meeting, are announced at the meeting at which the recess or adjournment is taken or are provided in any other matter permitted by the DGCL; <I><U>provided</U></I><I>,</I>
<I><U>however</U></I>, that if the adjournment is for more than 30 calendar days, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the place, if any, date and time thereof, and the means of remote
communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting, must be given in conformity herewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Inspectors</U>. The Board may, and shall if required by law, in advance of any meeting
of stockholders, appoint one or more inspectors to act at the meeting and make a written report thereof. The Board may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is
able to act at a meeting of stockholders, the presiding officer of the meeting will appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath to execute
faithfully the duties of inspector with strict impartiality and according to the best of his or her ability. The inspectors shall have such duties as provided by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Quorum</U>. Except as otherwise provided by law, the Certificate of Incorporation or these Bylaws, the holders of a majority in voting
power of the shares of stock issued and outstanding and entitled to vote at the meeting, present in person or represented by proxy, will constitute a quorum at a meeting of stockholders for the transaction of business thereat. A quorum, once
established, will not be broken by the subsequent withdrawal of enough votes to leave less than a quorum. If, however, such a quorum shall not be present or represented at any meeting of the stockholders, the presiding officer of the meeting or the
stockholders so present, by the affirmative vote of the holders of a majority in voting power of the shares of the corporation which are present in person or by proxy and entitled to vote thereon, may adjourn the meeting from time to time, in the
manner provided in <U>Bylaw 4</U>, until a quorum is present or represented. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Voting; Proxies</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>General</U>. Except as otherwise provided by law or the Certificate of Incorporation, each stockholder will be entitled at every
meeting of the stockholders to one vote for each share of stock having voting power standing in the name of such stockholder on the books of the Company on the record date for the meeting. Such votes may be cast either in person or by another person
or persons who have been authorized by the stockholder to act for such stockholder by proxy. No proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. Every proxy must be authorized in a
manner permitted by Section&nbsp;212 of the DGCL (or any successor provision). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Vote Required for Stockholder Action</U>. At all
meetings of stockholders for the election of directors at which a quorum is present a plurality of the votes cast shall be sufficient to elect. All other matters presented to the stockholders at a meeting at which a quorum is present, shall, unless
a different or minimum vote is required by the Certificate of Incorporation, these Bylaws, the rules or regulations of any stock exchange applicable to the Company, or any law or regulation applicable to the Company or its securities, in which case
such different or minimum vote shall be the applicable vote on the matter, be decided by the affirmative vote of a majority of the votes properly cast on the matter (excluding any abstentions or broker
<FONT STYLE="white-space:nowrap">non-votes).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Organization; Conduct of Meetings</U>. The Chairman, or an officer of the
Company designated from time to time by the Board, will call meetings of stockholders to order and will act as presiding officer thereof. The date and time of the opening and the closing of the polls for each matter upon which the stockholders will
vote at a meeting shall be announced at the meeting by the person officer of the meeting. The Board may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. Except to the extent
inconsistent with such rules and regulations adopted by the Board, the presiding officer of any meeting of stockholders shall have the right and authority to convene and (for any or no reason) to recess and/or adjourn the meeting, to prescribe such
rules, regulations and procedures and to do all such acts as, in the judgment of such presiding officer, are appropriate for the proper conduct </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">of the meeting. Such rules and regulations or procedures, whether adopted by the Board or prescribed by the
presiding officer of the meeting, may include without limitation: (a)&nbsp;the establishment of an agenda or order of business for the meeting; (b)&nbsp;rules and procedures for maintaining order at the meeting and the safety of those present;
(c)&nbsp;limitations on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies or such other persons as the presiding officer of the meeting shall determine;
(d)&nbsp;restrictions on entry to the meeting after the time fixed for the commencement thereof; and (e)&nbsp;limitations on the time allotted to questions or comments by participants. The presiding officer at any meeting of stockholders, in
addition to making any other determinations that may be appropriate to the conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that a matter or business was not properly brought before the meeting and if such
presiding officer should so determine, such presiding officer shall so declare to the meeting and any such matter or business not properly brought before the meeting shall not be transacted or considered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">9. <U>Notice of Stockholder Proposals</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Business to Be Conducted at Annual Meeting</U>. At an annual meeting of stockholders, only such business may be conducted as has been
properly brought before the meeting. To be properly brought before an annual meeting, business (other than the nomination of a person for election as a director, which is governed by <U>Bylaw 10</U>, and, to the extent applicable, <U>Bylaw 11</U>),
must be brought before the meeting only (i)&nbsp;pursuant to the Company&#146;s notice of meeting, (ii)&nbsp;by or at the direction of the Board or (iii)&nbsp;by a stockholder who (A)&nbsp;has complied with all applicable requirements of this
<U>Bylaw 9</U> and <U>Bylaw 11</U> in relation to such business, (B)&nbsp;was a stockholder of record of the Company at the time of giving the notice required by this <U>Bylaw 9</U> and is a stockholder of record of the Company at the time of the
annual meeting, and (C)&nbsp;is entitled to vote at the annual meeting. For the avoidance of doubt, the foregoing clause (iii)&nbsp;will be the exclusive means for a stockholder to submit business before an annual meeting of stockholders (other than
proposals properly made in accordance with Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Securities Exchange Act of 1934, as amended (such act, and the rules and regulations promulgated thereunder, the &#147;<B><I>Exchange
Act</I></B>&#148;) and included in the notice of meeting given by or at the direction of the Board). For business to be properly brought before an annual meeting by a stockholder pursuant to clause (iii)&nbsp;of <U>Bylaw 9(a)</U>, the stockholder
must have given timely notice thereof in writing to the Secretary of the Company in accordance with this <U>Bylaw 9</U> and <U>Bylaw 11</U> and any such proposed business must constitute a proper matter for stockholder action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Required Form for Stockholder Proposals</U>. To be in proper form, a stockholder&#146;s notice to the Secretary must set forth in
writing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Information Regarding the Proposing Person</U>. As to each Proposing Person (as such term is defined in <U>Bylaw
11(e)(ii))</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(A) the name and address of such stockholder, as they appear on the Company&#146;s books and the name and address of any
other Proposing Person; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(B) the class, series and number of shares of the Company&#146;s stock directly or
indirectly beneficially owned or held of record by such Proposing Person (including any shares of any class or series of the Company as to which such Proposing Person has a right to acquire beneficial ownership, whether such right is exercisable
immediately or only after the passage of time); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(C) a representation (1)&nbsp;that the stockholder giving the notice is a holder of
record of stock of the Company entitled to vote at the annual meeting and intends to appear in person or by proxy at the annual meeting to bring such business before the annual meeting and (2)&nbsp;as to whether any Proposing Person intends or is
part of a group which intends to (x)&nbsp;deliver a proxy statement and form of proxy to holders of at least the percentage of shares of the Company entitled to vote and required to approve the proposal, (y)&nbsp;otherwise to solicit proxies or
votes from stockholders in support of such proposal and (z)&nbsp;solely with respect to nominations pursuant to <U>Bylaw 10</U>, to solicit proxies in support of any proposed nominee in accordance with Rule
<FONT STYLE="white-space:nowrap">14a-19</FONT> promulgated under the Exchange Act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(D) a description of any (1)&nbsp;option, warrant,
convertible security, stock appreciation right or similar right or interest (including any derivative securities, as defined under Rule <FONT STYLE="white-space:nowrap">16a-1</FONT> under the Exchange Act), whether or not presently exercisable, with
an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of securities of the Company or with a value derived in whole or in part from the value of any class or series of securities of the
Company, whether or not such instrument or right is subject to settlement in whole or in part in the underlying class or series of securities of the Company or otherwise, directly or indirectly held of record or owned beneficially by such Proposing
Person and (2)&nbsp;each other direct or indirect right or interest that may enable such Proposing Person to profit or share in any profit derived from, or to manage the risk or benefit from, any increase or decrease in the value of the
Company&#146;s securities, in each case regardless of whether (x) such right or interest conveys any voting rights in such security to such Proposing Person, (y)&nbsp;such right or interest is required to be, or is capable of being, settled through
delivery of such security, or (z)&nbsp;such Proposing Person may have entered into other transactions that hedge the economic effect of any such right or interest (any such right or interest referred to in this clause (D)&nbsp;being a
&#147;<B><I>Derivative Interest</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(E) any proxy, contract, arrangement, understanding or relationship pursuant to which
the Proposing Person has a right to vote any shares of the Company or which has the effect of increasing or decreasing the voting power of such Proposing Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(F) any rights directly or indirectly held of record or beneficially by the Proposing Person to dividends on the shares of the Company that
are separated or separable from the underlying shares of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(G) any performance-related fees (other than an asset-based fee)
to which the Proposing Person may be entitled as a result of any increase or decrease in the value of shares of the Company or Derivative Interests; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(H) any other information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing
required pursuant to Section&nbsp;14(a) of the Exchange Act to be made in connection with a general solicitation of proxies or consents by such Proposing Person in support of the business proposed to be brought before the meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Information Regarding the Proposal</U>: As to each item of business that the
stockholder giving the notice proposes to bring before the annual meeting: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(A) a description in reasonable detail of the business desired
to be brought before the annual meeting and the reasons why such stockholder or any other Proposing Person believes that the taking of the action or actions proposed to be taken would be in the best interests of the Company and its stockholders;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(B) a description in reasonable detail of any material interest of any Proposing Person in such business and a description in reasonable
detail of all agreements, arrangements and understandings among the Proposing Persons or between any Proposing Person and any other person or entity in connection with the proposal; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(C) the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such
business includes a proposal to amend the Bylaws, the language of the proposed amendment). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>No Right to Have Proposal Included</U>.
A stockholder is not entitled to have its proposal included in the Company&#146;s proxy statement and form of proxy solely as a result of such stockholder&#146;s compliance with the foregoing provisions of this <U>Bylaw 9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Requirement to Attend Annual Meeting</U>. Notwithstanding the foregoing provisions of this <U>Bylaw 9</U>, if a stockholder (or a
qualified representative of the stockholder) does not appear at the annual meeting to present its proposal, such proposal will be disregarded and not transacted (notwithstanding that such proposal is set forth in the notice of meeting and
notwithstanding that proxies in respect of such proposal may have been solicited, obtained or delivered). For purposes of this <U>Bylaw 9</U> and <U>Bylaw 10</U>, to be considered a qualified representative of the stockholder, a person must be a
duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of
stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Notice of Director Nominations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Nomination of Directors</U>. Subject to the rights, if any, of any series of Preferred Stock to nominate or elect directors under
circumstances specified in a Preferred Stock Designation, only persons who are nominated in accordance with the procedures set forth in this <U>Bylaw 10</U> will be eligible to elected or serve as directors. Nominations of persons for election as
directors of the Company may be made at an annual meeting of stockholders only (i) by or at the direction of the Board or (ii)&nbsp;by a stockholder who (A)&nbsp;has complied with all applicable requirements of this <U>Bylaw 10</U> and <U>Bylaw
11</U> in relation to such nomination, (B)&nbsp;was a stockholder of record of the Company at the time of giving the notice required by this <U>Bylaw 10</U> and is a stockholder of record of the Company at the time of the annual meeting, and
(C)&nbsp;is entitled to vote at the annual meeting. For a nomination to be properly made at an annual meeting by a stockholder pursuant to clause (ii)&nbsp;of this <U>Bylaw 10(a)</U>, the stockholder must have given timely notice thereof in writing
to the Secretary of the Company in accordance with this <U>Bylaw 10</U> and <U>Bylaw 11</U>. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">number of nominees a stockholder may nominate for election at the annual meeting (or in the case of one or
more stockholders giving the notice on behalf of a beneficial owner, the number of nominees such stockholders may collectively nominate for election at the annual meeting on behalf of such beneficial owner) shall not exceed the number of directors
to be elected at such annual meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Required Form for Director Nominations</U>. To be in proper form, a stockholder&#146;s
notice to the Secretary must set forth in writing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Information Regarding the Proposing Person</U>. As to each Nominating Person (as
such term is defined in <U>Bylaw 11(d)(iii))</U>, the information set forth in <U>Bylaw 9(b)(i)</U> (except that for purposes of this <U>Bylaw 10</U>, the term &#147;<B><I>Nominating Person</I></B>&#148; will be substituted for the term
&#147;<B><I>Proposing Person</I></B>&#148; in all places where it appears in <U>Bylaw 9(b)(i)</U> and any reference to &#147;<B><I>business</I></B>&#148; or &#147;<B><I>proposal</I></B>&#148; therein will be deemed to be a reference to the
&#147;<B><I>nomination</I></B>&#148; contemplated by this <U>Bylaw 10</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Information Regarding the Nominee</U>: As to each
person whom the stockholder giving notice proposes to nominate for election as a director: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(A) all information with respect to such
proposed nominee that would be required to be set forth in a stockholder&#146;s notice pursuant to <U>Bylaw 9(b)(i)</U> if such proposed nominee were a Proposing Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(B) all information relating to such proposed nominee that would be required to be disclosed in a proxy statement or other filing required
pursuant to Section&nbsp;14(a) under the Exchange Act to be made in connection with a general solicitation of proxies for an election of directors in a contested election (including such proposed nominee&#146;s written consent to be named in the
proxy statement as a nominee and to serve as a director if elected); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(C) all information that would be required to be disclosed pursuant
to Items 403 and 404 under Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> if the stockholder giving the notice or any other Nominating Person were the &#147;registrant&#148; for purposes of such rule and the proposed nominee were a director
or executive officer of such registrant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(D) a completed questionnaire (in the form provided by the Secretary upon written request) with
respect to the identity, background and qualification of the proposed nominee and the background of any other person or entity on whose behalf the nomination is being made; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(E) a written representation and agreement (in the form provided by the Secretary upon written request) that the proposed nominee (1) is not
and will not become a party to (x)&nbsp;any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how the proposed nominee, if elected as a director of the Company, will act or
vote on any issue or question (a &#147;<B><I>Voting</I></B> <B><I>Commitment</I></B>&#148;) that has not been disclosed to the Company or (y)&nbsp;any Voting Commitment that could limit or interfere with the proposed nominee&#146;s<B><I>
</I></B>ability to comply, if elected as a director of the Company, with the proposed nominee&#146;s fiduciary duties under applicable law, (2)&nbsp;is not and will not become a party to any agreement, arrangement or understanding with any person or
entity other than the Company with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">respect to any direct or indirect compensation, reimbursement or indemnification in connection with service
or action as a director that has not been disclosed therein, and (3)&nbsp;if elected as a director of the Company, the proposed nominee would be in compliance and will comply, with all applicable publicly disclosed corporate governance, ethics,
conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may require any proposed
nominee to furnish such other information as may be reasonably required by the Company to determine the qualifications and eligibility of such proposed nominee to serve as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Special Meetings of Stockholders</U>. Only such business shall be conducted at a special meeting of stockholders as shall have been
brought before the meeting pursuant to the Company&#146;s notice of meeting. Nominations of persons for election to the Board may be made at a special meeting of stockholders at which directors are to be elected pursuant to the Company&#146;s notice
of meeting (i)&nbsp;by or at the direction of the Board (ii)&nbsp;provided that the Board has determined that directors shall be elected at such meeting, by any stockholder who (A)&nbsp;has complied with all applicable requirements of this <U>Bylaw
10</U> and <U>Bylaw 11</U> in relation to such nomination, (B)&nbsp;was a stockholder of record of the Company at the time of giving the notice required by this <U>Bylaw 10</U> and is a stockholder of record of the Company at the time of the special
meeting, and (C)&nbsp;is entitled to vote at the special meeting. The number of nominees a stockholder may nominate for election at the special meeting at which directors are to be elected (or in the case of one or more stockholders giving the
notice on behalf of a beneficial owner, the number of nominees such stockholders may collectively nominate for election at the special meeting on behalf of such beneficial owner) shall not exceed the number of directors to be elected at such special
meeting. In the event a special meeting of stockholders is duly called for the purpose of electing one or more directors to the Board of Directors, any such stockholder entitled to vote in such election of directors may nominate a person or persons
(as the case may be) for election to such position(s) as specified in the Corporation&#146;s notice of meeting, if the stockholder&#146;s notice required by this <U>Bylaw 10</U> shall be delivered to the Secretary in accordance with <U>Bylaw 11</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Right to Have Nominees Included</U>. A stockholder is not entitled to have its nominees included in the Company&#146;s proxy
statement solely as a result of such stockholder&#146;s compliance with the foregoing provisions of this <U>Bylaw 10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<U>Requirement to Attend Annual Meeting; Compliance with Rule <FONT STYLE="white-space:nowrap">14a-19</FONT></U>. If a stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting to present its nomination,
such nomination will be disregarded (notwithstanding that such nomination is set forth in the notice of meeting and notwithstanding that that proxies in respect of such nomination may have been solicited, obtained or delivered). Notwithstanding
anything to the contrary in these Bylaws, unless otherwise required by law, if any stockholder or Nominating Person (i)&nbsp;provides notice pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the Exchange Act with
respect to any proposed nominee and (ii)&nbsp;subsequently fails to comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14a-19(a)(2)</FONT> or Rule <FONT STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the Exchange
Act (or fails to timely provide reasonable evidence sufficient to satisfy the Corporation that such stockholder has met the requirements of Rule <FONT STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the Exchange Act in accordance
with the following sentence), then the nomination of each such proposed nominee shall be disregarded, notwithstanding that the nominee is included as a nominee in the Company&#146;s proxy statement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">notice of meeting or other proxy materials for any annual meeting (or any supplement thereto) and
notwithstanding that proxies or votes in respect of the election of such proposed nominees may have been received by the Company (which proxies and votes shall be disregarded). Upon request by the Corporation, if any stockholder or Nominating Person
provides notice pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the Exchange Act, such stockholder shall deliver to the Corporation, no later than five (5)&nbsp;business days prior to the applicable meeting,
reasonable evidence that it or such Nominating Person has met the requirements of Rule <FONT STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Additional Provisions Relating to the Notice of Stockholder Business and Director Nominations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Timely Notice</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
To be timely, a stockholder&#146;s notice required by <U>Bylaw 9(a)(iii)</U> or <U>Bylaw 10(a)(ii)</U> must be delivered to or mailed and received by the Secretary at the principal executive offices of the Company not less than 90 nor more than 120
calendar days prior to the first anniversary of the date on which the Company held the preceding year&#146;s annual meeting of stockholders (which preceding year&#146;s annual meeting shall, for purposes of the Company&#146;s first annual meeting
after the Company&#146;s shares are first publicly traded, be deemed to have occurred on <B>[ ]</B>); <I><U>provided</U></I><I>,</I> <I><U>however</U></I>, that if the date of the annual meeting is scheduled for a date more than 30 calendar days
prior to or more than 30 calendar days after the anniversary of the preceding year&#146;s annual meeting, notice by the stockholder to be timely must be so delivered not earlier than 120 calendar days prior to such annual meeting and not later than
the close of business on the later of the 90th calendar day prior to such annual meeting and the 10th calendar day following the day on which public disclosure of the date of such meeting is first made. In no event will a recess or adjournment of an
annual meeting (or any announcement of any such recess or adjournment) commence a new time period (or extend any time period) for the giving of a stockholder&#146;s notice as described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything in this <U>Bylaw 11(a)</U> to the contrary, in the event that the number of directors to be elected to the Board
at the annual meeting is increased effective after the time period for which nominations would otherwise be due under this <U>Bylaw 11(a)</U> and there is no public announcement by the Company naming the nominees for the additional directorships at
least 100 days prior to the first anniversary of the preceding year&#146;s annual meeting, a stockholder&#146;s notice required by this this <U>Bylaw 11(a)</U> shall also be considered timely, but only with respect to nominees for the additional
directorships, if it shall be delivered to the Secretary at the principal executive offices of the Company not later than the close of business on the 10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day following the day on which such
public announcement is first made by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) In the event a special meeting of stockholders is duly called for the purpose of
electing one or more directors to the Board, stockholder&#146;s notice required by <U>Bylaw 10(c)</U> must be delivered to or mailed and received by Secretary at the principal executive offices of the Company not earlier than 120 calendar day prior
to such special meeting and not less than the later of 90 calendar days prior to such special meeting or the 10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day following the day on which the Company first makes a public announcement of
the date of the special meeting at which directors are to be elected. In no event will a recess or adjournment of an annual meeting (or any announcement of any such recess or adjournment) commence a new time period (or extend any time period) for
the giving of a stockholder&#146;s notice as described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Updating Information in Notice</U>. A stockholder providing notice of business
proposed to be brought before an annual meeting pursuant to <U>Bylaw 9</U> or notice of any nomination to be made at an annual meeting pursuant to <U>Bylaw 10</U> must further update and supplement such notice, if necessary, so that the information
provided or required to be provided in such notice pursuant to <U>Bylaw 9</U> or <U>Bylaw 10</U>, as applicable, is true and correct (x) as of the record date for notice and voting at the meeting and (y)&nbsp;as of the date that is fifteen
(15)&nbsp;days prior to the meeting or any adjournment or postponement thereof. Any such update and supplement must be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Company (i)&nbsp;in the case of
any update and supplement required to be made as of any record date for the meeting that is at least ten (10)&nbsp;days prior to the meeting, not later than five (5)&nbsp;days after such record date for the meeting and (ii)&nbsp;in the case of any
update or supplement required to be made as of fifteen (15)&nbsp;days prior to the meeting or adjournment or postponement thereof, not later than ten (10)&nbsp;days prior to the date for the meeting or any adjournment or postponement thereof. For
the avoidance of doubt, the obligation to update and supplement as set forth in this <U>Bylaw 11(b)</U> or any other section of these Bylaws shall not limit the Company&#146;s rights with respect to any deficiencies in any stockholder&#146;s notice,
including, without limitation, any representation required herein, extend any applicable deadlines under these Bylaws or enable or be deemed to permit a stockholder who has previously submitted a stockholder&#146;s notice under these Bylaws to amend
or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business and/or resolutions proposed to be brought before a meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Determinations Regarding Compliance.</U> The presiding officer of any annual meeting will, if the facts warrant, determine that a
proposal was not made in accordance with the procedures prescribed by <U>Bylaw 9</U> and this <U>Bylaw 11</U> or that a nomination was not made in accordance with the procedures prescribed by <U>Bylaw 10</U> and this <U>Bylaw 11</U>, and if he or
she should so determine, he or she will so declare to the meeting and the defective proposal or nomination, as applicable, will be disregarded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Compliance with the Exchange Act. Notwithstanding the foregoing provisions of <U>Bylaws 9</U>, <U>10</U>, and <U>11</U>, a stockholder
shall also comply with all applicable requirements of the Exchange Act and the rules and regulations promulgated thereunder with respect to the matters set forth in <U>Bylaws 9</U>, <U>10</U>, and <U>11</U>; provided however, that any references in
these Bylaws to the Exchange Act or the rules and regulations promulgated thereunder are not intended to and shall not limit any requirements applicable to nominations or proposals as to any other business to be considered pursuant to <U>Bylaws
9</U>, <U>10</U>, and <U>11</U>, and compliance with <U>Bylaws 9</U>, <U>10</U>, and <U>11</U> shall be the exclusive means for a stockholder to make nominations or submit other business (other than, as provided in the penultimate sentence of
<U>Bylaw 9(a)</U>, business other than nominations brought properly under and in compliance with Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act, as may be amended from time to time). Nothing in <U>Bylaws 9</U>, <U>10</U>, and
<U>11</U> shall be deemed to affect any rights (i)&nbsp;of stockholders to request inclusion of proposals other than nominations in the Company&#146;s proxy statement pursuant to applicable rules and regulations promulgated under the Exchange Act or
(ii)&nbsp;of the holders of any series of Preferred Stock to elect directors pursuant to any applicable provisions of a Preferred Stock Designation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Certain Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) For purposes of <U>Bylaw 9</U> and <U>Bylaw 10</U> and this <U>Bylaw 11</U>, &#147;<B><I>public disclosure</I></B>&#148; means disclosure
in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document filed by the Company with the Securities and Exchange Commission pursuant to Exchange Act or furnished by the Company to
stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) For purposes of <U>Bylaw 9</U> and this <U>Bylaw 11</U>, &#147;<B><I>Proposing Person</I></B>&#148; means (A)&nbsp;the
stockholder providing the notice of business proposed to be brought before an annual meeting, (B)&nbsp;the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to be brought before the annual
meeting is given, and (C)&nbsp;any Affiliate or Associate (each within the meaning of Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act) of such stockholder or beneficial owner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) For purposes of <U>Bylaw 10</U> and this <U>Bylaw 11</U>, &#147;<B><I>Nominating Person</I></B>&#148; means (A)&nbsp;the stockholder
providing the notice of the nomination proposed made to be at an annual meeting, (B)&nbsp;the beneficial owner or beneficial owners, if different, on whose behalf the notice of nomination proposed to be made at the annual meeting is given, and
(C)&nbsp;any Affiliate or Associate (each within the meaning of Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act) of such stockholder or beneficial owner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Record Dates</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<U>Voting Record Dates</U>. In order that the Company may determine the stockholders entitled to notice of any meeting of stockholders, the Board may fix a record date, which will not precede the date upon which the Board resolution fixing the same
is adopted and will not be more than 60 nor less than 10 calendar days before the date of such meeting. If the Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless
the Board determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the Board, the record date for determining
stockholders entitled to notice of or to vote at a meeting of stockholders will be at the close of business on the calendar day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the calendar day
next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of the stockholders will apply to any adjournment of the meeting; <I><U>provided</U></I><I>,</I>
<I><U>however</U></I>, that the Board may fix a new record date for the determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to such notice of such
adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the foregoing provisions of this <U>Bylaw 12(a)</U> at the adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Payment Record Dates</U>. In order that the Company may determine the stockholders entitled to receive payment of any dividend or other
distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board may fix a record date, which record date
will not be more than 60 calendar days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose will be at the close of business on the calendar day on which the Board adopts the resolution
relating thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Identity of Registered Holder</U>. The Company will be entitled to treat the person
in whose name any share of its stock is registered as the owner thereof for all purposes, and will not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other person, whether or not the Company has
notice thereof, except as expressly provided by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>List of Stockholders Entitled to Vote</U>. The corporation shall
prepare, no later than the tenth day before each meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting (<I><U>provided</U></I>, <I><U>however</U></I>, if the record date for determining the stockholders
entitled to vote is less than 10 days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date), arranged in alphabetical order, and showing the address of each stockholder
and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder for any purpose germane to the meeting for a period of 10 days ending on the day before the meeting date (i)&nbsp;on a
reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of meeting or (ii)&nbsp;during ordinary business hours at the principal place of business of the corporation.
Except as otherwise provided by law, the stock ledger shall be the only evidence as to who are the stockholders entitled to examine the list of stockholders required by this <U>Bylaw 13</U> or to vote in person or by proxy at any meeting of
stockholders. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DIRECTORS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Authority</U>. The business and affairs of the Company will be managed by and under the direction of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Number, Election and Terms</U>. Subject to the rights, if any, of any series of Preferred Stock to elect additional directors under
circumstances specified in the Certificate of Incorporation including any Preferred Stock Designation, and to the minimum and maximum number of authorized directors provided in the Certificate of Incorporation, the authorized number of directors may
be fixed from time to time only by a resolution adopted by a majority of the Board. The terms of directors shall be as set forth in the Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Newly Created Directorships and Vacancies</U>. Subject to the rights, if any, of the holders of any series of Preferred Stock to elect
additional directors under circumstances specified in the Certificate of Incorporation including any Preferred Stock Designation, newly created directorships resulting from any increase in the authorized number of directors and any vacancies on the
Board resulting from death, resignation, disqualification, removal or other cause may be filled solely by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board, or by a sole remaining
director. Any director elected in accordance with the preceding sentence will hold office for the remainder of the full term of the class of directors in which the new directorship was created or the vacancy occurred and until such director&#146;s
successor is elected and qualified. No decrease in the authorized number of directors will shorten the term of any incumbent director. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Removal</U>. Subject to the rights, if any, of the holders of any series of Preferred
Stock to elect additional directors under circumstances specified in the Certificate of Incorporation including any Preferred Stock Designation, any director may be removed from office by the stockholders only in the manner provided in the
Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Resignation</U>. Any director may resign at any time upon notice given in writing or by electronic
transmission to the Chairman or the Secretary. Any resignation is effective when the resignation is delivered to the Company unless the resignation specifies a later effective date or an effective date that is contingent upon the occurrence or <FONT
STYLE="white-space:nowrap">non-occurrence</FONT> of one or more specified events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Regular Meetings</U>. Regular meetings of the
Board may be held at such places either within or without the State of Delaware and at such times as may from time to time be determined by the Board. Notice of regular meetings of the Board need not be given. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Special Meetings</U>. Special meetings of the Board may be called by the Chairman on at least 24 hours&#146; notice to each director
and will be called by the Chairman, in like manner and on like notice, upon the request of a majority of the Board. The time and place, if any, of any such special meeting shall be as specified in the notice of such meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Quorum</U>. At all meetings of the Board, a majority of the Board will constitute a quorum for the transaction of business. Except for
actions required by these Bylaws or the Certificate of Incorporation to be taken by a majority of the Board, the act of a majority of the directors present at any meeting at which there is a quorum will be the act of the Board. If a quorum is not
present at any meeting of the Board, the directors present thereat may adjourn the meeting from time to time to another place, if any, time, or date, without notice other than announcement at the meeting, until a quorum is present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Participation in Meetings by Remote Communications</U>. Members of the Board or any committee designated by the Board may participate
in a meeting of the Board or any such committee, as the case may be, by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a
meeting will constitute presence in person at the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Committees</U>. The Board may designate one or more committees, each
committee to consist of one or more of the directors. The Board may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or
disqualification of a member of a committee, the member or members present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act at the
meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the Board, or in these Bylaws, will have and may exercise all the powers and authority of the Board in the management of
the business and affairs of the Company, and may authorize the seal of the Company to be affixed to all papers which may require it; but no such committee will have the power or authority in reference to the following matters: (a)&nbsp;approving or
adopting, or recommending to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">stockholders for approval or (b)&nbsp;making, adopting, amending or repealing any provision of these Bylaws.
Unless the Board provides otherwise, each committee designated by the Board may make, alter and repeal rules and procedures for the conduct of its business. In the absence of such rules and procedures, each committee shall conduct its business in
the same manner as the Board conducts its business. Any resolution of the Board establishing or directing any committee of the Board or establishing or amending the charter of any such committee may establish requirements or procedures relating to
the governance and/or operation of such committee that are different from, or in addition to, those set forth in these Bylaws and, to the extent that there is any inconsistency between these Bylaws and any such resolution or charter, the terms of
such resolution or charter shall be controlling. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Compensation</U>. The Board may establish the compensation of directors,
including without limitation compensation for membership on the Board and on committees of the Board, attendance at meetings of the Board or committees of the Board, and for other services provided to the Company or at the request of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>Rules</U>. The Board may adopt rules and regulations for the conduct of meetings and the oversight of the management of the affairs of
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. <U>Chairman of the Board</U>. The Board, by a majority vote of the Board, shall elect a Chairman from among the members
of the Board. The Chairman shall not be considered an officer of the Company in his or her capacity as such. The Chairman may be removed from that capacity by a majority vote of the Board. The Chairman shall preside at meetings of the Board and of
the stockholders of the Company and exercise and perform such other powers and duties as may from time to time be assigned to him or her by the Board or as may be prescribed by these Bylaws. In the absence of the Chairman, such other director of the
Company designated by the Chairman or by the Board shall act as chairman of any meeting of the Board. The Chairman or the Board may appoint a Vice Chairman of the Board to exercise and perform such other powers and duties as may from time to time be
assigned to him or her by the Chairman or by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27. <U>Action by Unanimous Consent of Directors</U>. Unless otherwise restricted
by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board, or of any committee thereof, may be taken without a meeting if all members of the Board or such committee, as the case may
be, consent thereto in writing or by electronic transmission. After an action is taken, the consent or consents relating thereto shall be filed with the minutes of proceedings of the board or committee in the same paper or electronic form as the
minutes are maintained. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NOTICES</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">28. <U>Generally</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<U>Form of Notices</U>. Except as otherwise provided by law, these Bylaws, or the Certificate of Incorporation, whenever by law or under the provisions of the Certificate of Incorporation or these Bylaws notice is required to be given to any
director or stockholder, it will not be construed to require personal notice, but such notice may be given in writing, by mail or courier service or, to the extent permitted by the DGCL, by electronic transmission, addressed to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">such director or stockholder. Any notice sent to stockholders by mail or courier service shall be sent to
the address of such stockholder as it appears on the records of the Company, with postage thereon prepaid, and such notice will be deemed to be given, if mailed, at the time when the same is deposited in the United States mail, postage prepaid, or,
if delivered by courier service, at the earlier of when the notice is received or left at such stockholders&#146; address. Notices sent by electronic transmission shall be deemed given as set forth in Section&nbsp;232 of the DGCL. For purposes of
this <U>Bylaw 28</U>, &#147;<B><I>electronic transmission</I></B>&#148; shall be defined as set forth in Section&nbsp;232 of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Notices to Directors</U>. Notices to directors may be given by mail or courier service, telephone, electronic transmission or as
otherwise may be permitted by these Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29. <U>Waivers</U>. Whenever any notice is required to be given by law or under the
provisions of the Certificate of Incorporation or these Bylaws, a waiver thereof in writing, signed by the person entitled to such notice, or a waiver by electronic transmission by the person entitled to such notice, whether before or after the time
of the event for which notice is to be given, will be deemed equivalent to such notice. Attendance of a person at a meeting will constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of
objecting at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OFFICERS</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.
<U>Generally</U>. The officers of the Company will be elected annually by the Board and will consist of a Chief Executive Officer, a Secretary and a Treasurer. The Board may also choose any or all of the following: a President, one or more Vice
Presidents (who may be given particular designations with respect to authority, function, or seniority), one or more Assistant Secretaries, one or more Assistant Treasurers and such other officers as the Board may from time to time determine.
Notwithstanding the foregoing, the Board may authorize the Chief Executive Officer to appoint any person to any office other than the Secretary or Treasurer. Any number of offices may be held by the same person. Any of the offices may be left vacant
from time to time as the Board may determine. In the case of the absence or disability of any officer of the Company or for any other reason deemed sufficient by the Board, the Board may delegate the absent or disabled officer&#146;s powers or
duties to any other officer or to any director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">31. <U>Compensation</U>. The compensation of all directors who are also officers and
agents of the Company and the executive officers of the Company will be fixed by the Board or by a committee of the Board. The Board may fix or delegate the power to fix, the compensation of other officers and agents of the Company to an officer of
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">32. <U>Succession</U>. The officers of the Company will hold office until their successors are elected and qualified or
until such officer&#146;s earlier death, resignation or removal. Any officer may be removed at any time by the affirmative vote of a majority of the Board. Any vacancy occurring in any office of the Company may be filled by the Board or by the Chief
Executive Officer as provided in <U>Bylaw 30</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">33. <U>Authority and Duties</U>. Each of the officers of the Company will have such
authority and will perform such duties as are customarily incidental to their respective offices or as may be specified from time to time by the Board. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STOCK</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">34.
<U>Certificates</U>. The shares of the Company shall be represented by certificates, provided that the Board may provide by resolution or resolutions that some or all of any or all classes or series of the stock of the Company shall be
uncertificated shares. Every holder of stock represented by certificates shall be entitled to have a certificate signed by, or in the name of the Company by, any two authorized officers of the Company (it being understood that each of the Chairman,
Chief Executive Officer, Chief Financial Officer, Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary shall be an authorized officer for such purpose). Any or all of the signatures on a certificate may be a facsimile
signature. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be
issued by the Company with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">35.
<U>Transfer</U>. Transfers of shares shall be made upon the books of the Company (a)&nbsp;only by the holder of record thereof, or by a duly authorized agent, transferee or legal representative and (b)&nbsp;in the case of certificated shares, upon
the surrender to the Company of the certificate or certificates for such shares. No transfer shall be made that is inconsistent with the provisions of applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">36. <U>Lost, Stolen or Destroyed Certificates</U>. The Secretary may direct a new certificate or certificates or uncertificated shares to be
issued in place of any certificate or certificates theretofore issued by the Company alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact, satisfactory to the Secretary, by the person claiming the certificate
of stock to be lost, stolen or destroyed. As a condition precedent to the issuance of a new certificate or certificates, the Company may require the owners of such lost, stolen or destroyed certificate or certificates to give the Company a bond in
such sum and with such surety or sureties as the Secretary may direct as indemnity against any claims that may be made against the Company with respect to the certificate alleged to have been lost, stolen or destroyed or the issuance of the new
certificate or uncertificated shares. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>INDEMNIFICATION</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">37. <U>Right to Indemnification</U>. Each person who was or is made a party or is threatened to be made a party to or is otherwise subject to
or involved in any claim, demand, action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#147;<B><I>Proceeding</I></B>&#148;), by reason of the fact that he or she is or was a director or an officer of the Company
or is or was serving at the request of the Company as a director, officer, employee or agent of another company or of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan (an
&#147;<B><I>Indemnitee</I></B>&#148;), whether the basis of such Proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall
be indemnified by the Company to the fullest extent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">permitted or required by the DGCL and any other applicable law, as the same exists or may hereafter be
amended against all expense, liability and loss (including attorneys&#146; fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such Indemnitee in connection therewith
(&#147;<B><I>Indemnifiable Losses</I></B>&#148;); <I><U>provided</U></I>, <I><U>however</U></I>, that, except as provided in <U>Bylaw 40</U> with respect to Proceedings to enforce rights to indemnification, the Company shall indemnify any such
Indemnitee pursuant to this <U>Bylaw 37</U> in connection with a Proceeding (or part thereof) initiated by such Indemnitee only if such Proceeding (or part thereof) was authorized by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">38. <U>Right to Advancement of Expenses</U>. The right to indemnification conferred in <U>Bylaw 37</U> shall include the right to advancement
by the Company of any and all expenses (including, without limitation, attorneys&#146; fees and expenses) incurred in defending any such Proceeding in advance of its final disposition (an &#147;<B><I>Advancement of Expenses</I></B>&#148;);
<I><U>provided</U></I>, <I><U>however</U></I>, that, if the DGCL so requires, an Advancement of Expenses incurred by an Indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by
such Indemnitee, including without limitation service to an employee benefit plan) shall be made pursuant to this Section&nbsp;2 only upon delivery to the Company of an undertaking (an &#147;<B><I>Undertaking</I></B>&#148;), by or on behalf of such
Indemnitee, to repay, without interest, all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (a &#147;<B><I>Final Adjudication</I></B>&#148;) that such Indemnitee is
not entitled to be indemnified for such expenses under this <U>Bylaw 38</U>. An Indemnitee&#146;s right to an Advancement of Expenses pursuant to this <U>Bylaw 38</U> is not subject to the satisfaction of any standard of conduct and is not
conditioned upon any prior determination that Indemnitee is entitled to indemnification under <U>Bylaw 37</U> with respect to the related Proceeding or the absence of any prior determination to the contrary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39. <U>Contract Rights</U>. The rights to indemnification and to the Advancement of Expenses conferred in <U>Bylaws 37</U> and <U>38</U> shall
be contract rights and such rights shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the Indemnitee&#146;s heirs, executors and administrators. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">40. <U>Right of Indemnitee to Bring Suit</U>. If a claim under <U>Bylaw 37</U> or <U>38</U> is not paid in full by the Company within 60
calendar days after a written claim has been received by the Company, except in the case of a claim for an Advancement of Expenses, in which case the applicable period shall be 30 calendar days, the Indemnitee may at any time thereafter bring suit
against the Company to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Company to recover an Advancement of Expenses pursuant to the terms of an Undertaking, the Indemnitee
shall be entitled to the fullest extent permitted or required by the DGCL, as the same exists or may hereafter be amended, to be paid also the expense of prosecuting or defending such suit. In any suit brought by the Indemnitee to enforce a right to
indemnification hereunder (but not in a suit brought by the Indemnitee to enforce a right to an Advancement of Expenses), the Company may raise as a defense that the Indemnitee has not met any applicable standard for indemnification set forth in the
DGCL. In any suit brought by the Company to recover an Advancement of Expenses pursuant to the terms of an Undertaking, the Company shall be entitled to recover such expenses, without interest, upon a Final Adjudication that the Indemnitee has not
met any applicable standard for indemnification set forth in the DGCL. Neither the failure of the Company (including its Board or a committee thereof, its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">stockholders or independent legal counsel) to have made a determination prior to the commencement of such
suit that indemnification of the Indemnitee is proper in the circumstances because the Indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Company (including its Board or a committee
thereof, its stockholders or independent legal counsel) that the Indemnitee has not met such applicable standard of conduct, shall create a presumption that the Indemnitee has not met the applicable standard of conduct or, in the case of such a suit
brought by the Indemnitee, be a defense to such suit. In any suit brought by an Indemnitee to enforce a right to indemnification or to an Advancement of Expenses hereunder, or brought by the Company to recover an Advancement of Expenses hereunder
pursuant to the terms of an Undertaking, the burden of proving that the Indemnitee is not entitled to be indemnified, or to such Advancement of Expenses, shall be on the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">41. <U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</U>. The rights to indemnification and to the Advancement of Expenses
conferred these Bylaws shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, the Company&#146;s Certificate of Incorporation, these Bylaws, agreement, vote of stockholders or disinterested
directors or otherwise. Nothing contained in these Bylaws shall limit or otherwise affect any such other right or the Company&#146;s power to confer any such other right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">42. <U>Insurance</U>. The Company may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of
the Company or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Company would have the power to indemnify such person against such expense, liability or loss under
the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">43. <U>No Duplication of Payments</U>. The Company&#146;s obligation under these Bylaws to make any payment to an Indemnitee in
respect of any Indemnifiable Losses shall be reduced by any amount that the Indemnitee has otherwise actually received payment (net of any expenses incurred in connection therewith and any repayment by the Indemnitee made with respect thereto) under
any insurance policy or from any other source in respect of such Indemnifiable Losses. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>GENERAL</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">44. <U>Fiscal Year</U>. The fiscal year of the Company will end on December&nbsp;31 of each calendar year or such other date as may be fixed
from time to time by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">45. <U>Reliance Upon Books, Reports and Records</U>. Each director, each member of a committee designated
by the Board, and each officer of the Company will, in the performance of his or her duties, be fully protected in relying in good faith upon the records of the Company and upon such information, opinions, reports, or statements presented to the
Company by any of the Company&#146;s officers or employees, or committees of the Board, or by any other person or entity as to matters the director, committee member, or officer believes are within such other person&#146;s professional or expert
competence and who has been selected with reasonable care by or on behalf of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">46. <U>Amendments</U>. These Bylaws or any of
them may be amended in any respect or repealed at any time, either by the Board or the stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>5
<FILENAME>d894834dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDERS&#146; AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This STOCKHOLDERS&#146; AGREEMENT (this &#147;<U>Agreement</U>&#148;) is entered into as of September&nbsp;25, 2024 among Guardian Pharmacy
Services, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), Bindley Capital Partners I, LLC, an Indiana limited liability company (&#147;<U>Bindley Capital</U>&#148;), Pharmacy Investors, LLC, an Indiana limited liability company
(&#147;<U>Pharmacy Investors</U>&#148;), Cardinal Equity Fund LP, a Delaware limited partnership (&#147;<U>Cardinal</U>&#148; and, collectively with Pharmacy Investors, the &#147;<U>Cardinal Stockholders</U>&#148;), Fred P. Burke, an individual
(&#147;<U>Burke</U>&#148;), David K. Morris, an individual (&#147;<U>Morris</U>&#148;), and G. Kendall Forbes, an individual, and any Person who becomes a party hereto pursuant to <U>Section</U><U></U><U>&nbsp;3.1</U> (collectively, the
&#147;<U>Stockholders</U>&#148;, and each individually, a &#147;<U>Stockholder</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. The Stockholders and the Company are entering into this Agreement in connection with the underwritten initial public offering (the
&#147;<U>IPO</U>&#148;) of shares of Class&nbsp;A Common Stock, par value $0.001 per share of the Company (&#147;<U>Class</U><U></U><U>&nbsp;A Shares</U>&#148;) in order to govern certain of their rights and obligations with respect to the
Stockholders&#146; ownership of Shares and the governance of the Company following consummation of the IPO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. After giving effect to the
IPO, the Stockholders own the equity securities of the Company in the respective amounts indicated on <U>Schedule I</U> hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accordingly, the Company and the Stockholders agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1. <U>Certain Defined Terms</U>. As used herein, the following terms will have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means (a)&nbsp;with respect to any Person, any other Person directly or indirectly controlling, controlled by or
under common control with, such Person, and (b)&nbsp;with respect to any natural person, any spouse or lineal descendant of such person, and in each case, any trust therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>beneficial owner</U>&#148; or &#147;<U>beneficially own</U>&#148; has the meaning given such term in Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act, and a Person&#146;s beneficial ownership of Shares or other Equity Securities of the Company will be calculated in accordance with the provisions of such rule. For the avoidance of
doubt, no Person will be deemed to beneficially own any security solely as a result of such Person&#146;s execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day that is not a Saturday, Sunday or other day on
which banks are required or authorized by law to be closed in New York City. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bylaws</U>&#148; means the Bylaws of the Company,
as in effect on the date hereof and as may be amended from time to time in accordance with the terms thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter</U>&#148;
means the Certificate of Incorporation of the Company, as in effect on the date hereof and as may be amended from time to time in accordance with the terms thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Class</U><U></U><U>&nbsp;B Shares</U>&#148; means shares of Class&nbsp;B Common Stock, par value $0.001 per share, of the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Competing Entity</U>&#148; means any Person that competes, directly or indirectly, with the Company or any of its Subsidiaries.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>control</U>&#148; (including the terms &#147;<U>controlling</U>&#148;, &#147;<U>controlled by</U>&#148; and &#147;<U>under
common control with</U>&#148;), with respect to the relationship between or among two or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether
through the ownership of voting securities, as trustee or executor, by contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Director</U>&#148; means any
member of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Securities</U>&#148; means any and all Shares or other equity securities of the Company, securities
of the Company convertible into, or exchangeable or exercisable for (whether presently convertible, exchangeable or exercisable or not) Shares or other equity securities, and options, warrants or other rights (whether presently convertible,
exchangeable or exercisable or not) to Shares or other equity securities of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the
Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Group</U>&#148; has the
meaning set forth in Section&nbsp;13(d)(3) of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Director</U>&#148; means a Director who would
qualify as an &#147;Independent Director&#148; pursuant to the listing standards of the corporate governance rules for The NASDAQ Stock Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Information</U>&#148; means all confidential information about the Company or any of its Subsidiaries that is or has been furnished
to any Stockholder or any of its Representatives by or on behalf of the Company or any of its Subsidiaries, or any of their respective Representatives (whether written or oral or in electronic or other form and whether prepared by the Company or any
of its Subsidiaries or their respective Representatives), together with that portion of all written or electronically stored documentation prepared by such Stockholder or its Representatives based on or reflecting, in whole or in part, such
information; <U>provided</U>, <U>however</U>, that the term &#147;<U>Information</U>&#148; will not include any information that (a)&nbsp;is or becomes generally available to the public through no action or omission by such Stockholder or its
Representatives in violation of this Agreement, (b)&nbsp;is or becomes available to such Stockholder on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis from a source, other than the Company or any of its Subsidiaries, or any of
their respective Representatives, that, to such Stockholder&#146;s knowledge, after reasonable inquiry, is not prohibited from disclosing to such Stockholder by a contractual, legal or fiduciary obligation or (c)&nbsp;is independently developed by a
Stockholder or its Representatives or Affiliates without use of any Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Law</U>&#148; means the law of any jurisdiction, whether international,
multilateral, multinational, national, federal, state, provincial, local or common law, or an order, act, statute, ordinance, regulation, rule, extension order or code promulgated by a governmental authority (including any department, court, agency
or official, or <FONT STYLE="white-space:nowrap">non-governmental</FONT> self-regulatory organization, agency or authority and any political subdivision or instrumentality thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, corporation, limited liability company, limited or general partnership, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivisions thereof or any Group comprised of two or more of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148; means with respect to any Person, any of such Person&#146;s, or its Affiliates&#146;, directors, officers,
employees, general partners, Affiliates, direct or indirect shareholders, members or limited partners, attorneys, accountants, financial and other advisers, and other agents and representatives, including, in the case of any Stockholder, any
designee nominated for election to the Board or a committee thereof by such Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Group</U>&#148; means, with
respect to any Stockholder, (a)&nbsp;such Stockholder, (b)&nbsp;any Affiliate of such Stockholder (other than any portfolio company), and (c)&nbsp;any Group (that would be deemed to be a &#147;person&#148; under Section&nbsp;13(d)(3) of the Exchange
Act with respect to securities of the Company) of which such Stockholder or its Affiliate (other than any portfolio company) is a member<B>,</B> other than the Group formed by virtue of the existence of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sale of the Company</U>&#148; means, in any one or more related transactions, a merger (other than a merger solely for the purpose of
forming a holding company with no change in indirect ownership or to effect a change in the Company&#146;s state of incorporation), business combination or sale of all or substantially all of the Company&#146;s assets, in each case, as a result of
which the Directors immediately prior to such transaction do not represent a majority of the Board immediately following the consummation of such transaction (or series of transactions), or the stockholders of the Company immediately prior to such
transaction do not, immediately following the consummation of such transaction (or series of transactions), continue to own equity securities representing more than 50% of the vote and of the equity of the Company, of the ultimate controlling Person
(in the case of a merger or business combination) or Person succeeding to ownership of all or substantially all of the Company&#146;s assets (in the case of a sale of assets). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shares</U>&#148; means Class&nbsp;A Shares and Class&nbsp;B Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Significant Stockholder</U>&#148; means each Stockholder who, together with its
Affiliates, beneficially owns 10% or more of the Company&#146;s outstanding Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means, with respect to
any Person, (a)&nbsp;any corporation of which a majority of the securities entitled to vote generally in the election of directors thereof, at the time as of which any determination is being made, or a majority of the economic interests in such
Person&#146;s equity, are owned by such Person, either directly or indirectly, and (b)&nbsp;any joint venture, general or limited partnership, limited liability company or other legal entity in which such Person is the record or beneficial owner,
directly or indirectly, of a majority of the voting or equity interests or of which such Person is the general partner or managing member. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer</U>&#148; means mean any sale, assignment, transfer, conveyance, hypothecation or other transfer or disposition, whether or
not for value and whether voluntary or involuntary or by operation of law. The term &#147;<U>Transferred</U>&#148; has a correlative meaning. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transferee</U>&#148; means any Person to whom any Stockholder or any transferee thereof Transfers Equity Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Voting Securities</U>&#148; means at any time the then-issued and outstanding Shares and any other Equity Securities having power
generally to vote for the election of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2. As used herein, each capitalized term set forth below has the meaning
set forth in the corresponding Section of this Agreement set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bindley Capital</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Burke</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cardinal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cardinal Stockholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Class&nbsp;A Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Covered Claims</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Designating Stockholder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2.1(d)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">IPO</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Morris</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Pharmacy Investors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Secondary Indemnitors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.15</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Specified Indemnitee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.15</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stockholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3. <U>Other Definitional Provisions</U>. Unless otherwise expressly provided, for the purposes
of this Agreement, the following rules of interpretation will apply: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) When a reference is made in this Agreement to an article or a
section, paragraph, exhibit or schedule, such reference will be to an article or a section, paragraph, exhibit or schedule hereof unless otherwise clearly indicated to the contrary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148;
are used in this Agreement, they will be deemed to be followed by the words &#147;without limitation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The words
&#147;hereof,&#148; &#147;herein&#148; and &#147;herewith&#148; and words of similar import will, unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The meaning assigned to each term defined herein will be equally applicable to both the singular and the plural forms of such term, and
words denoting any gender will include all genders. Where a word or phrase is defined herein, each of its other grammatical forms will have a corresponding meaning. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A reference to any period of days will be deemed to be to the relevant number of calendar days, unless
otherwise specified. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The word &#147;dollars&#148; and symbol &#147;$&#148; mean U.S. dollars. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) References herein to any Person will include such Person&#146;s heirs, executors, personal representatives, administrators, successors and
assigns. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The word &#147;or&#148; will be disjunctive but not exclusive. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of
intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties, and no presumption or burden of proof will arise favoring or disfavoring any party by virtue of the authorship of any provisions hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Any statute or rule defined or referred to herein or in any agreement or instrument that is referred to herein means such statute or rule
as from time to time amended, modified or supplemented, including by succession of comparable successor statutes or rules and references to all attachments thereto and instruments incorporated therein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE
GOVERNANCE; VOTING </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1. <U>Board of Directors Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Board Size and Composition</U>. Effective as of the consummation of the IPO, in accordance with Section&nbsp;15 of the Bylaws, the size
of the Board has been fixed at eight Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Nomination of Directors</U>. Subject to <U>Section</U><U></U><U>&nbsp;2.1(e)</U>,
each Stockholder agrees with the Company that it will: (i)&nbsp;appear in person or by proxy at each annual meeting or special meeting of the stockholders of the Company at which Directors are to be elected for the purposes of obtaining a quorum;
(ii) at each such stockholders&#146; meeting, vote, in person or by proxy, all of the Voting Securities owned by it on the date of such meeting in favor of election of the following designees nominated for election to the Board pursuant to this
<U>Section</U><U></U><U>&nbsp;2.1(b)</U> and in accordance with the Bylaws and the nomination procedures of the Company; and (iii)&nbsp;in any action by written consent of the holders of Voting Securities for the purpose of electing Directors,
consent to election of the following designees nominated for election to the Board pursuant to this <U>Section</U><U></U><U>&nbsp;2.1(b</U>) and in accordance with the Bylaws and the nomination procedures of the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) one individual designated as nominee for election to the Board by the Cardinal Stockholders; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) two individuals designated as nominees for election to the Board by
Bindley Capital; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Burke, whom the Stockholders agree to nominate, or cause to be nominated, for election to the
Board; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Morris, whom the Stockholders agree to nominate, or cause to be nominated, for election to the Board; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) three other Persons nominated for election to the Board by the Board, each of whom must quality as an Independent Director
(with respect to both the Company and each Stockholder). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights of the Stockholders to designate nominees for election to the Board
as set forth in <U>Section</U><U></U><U>&nbsp;2.1(b)(i)</U> and <U>(ii)</U>&nbsp;are personal to such Stockholders and may not be exercised by any Transferee, except that in the event a Stockholder no longer holds any Shares but its Affiliates
continue to hold Shares transferred by such Stockholder to such Affiliates (whether directly or by Transfers through other Affiliates of such Stockholder), and such rights have not been terminated pursuant to
<U>Section</U><U></U><U>&nbsp;2.1(e)</U>, the rights of such Stockholder may be exercised by the Affiliates of such Stockholder to which such Shares were Transferred. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Chairman of the Board</U>. William Bindley will be the initial Chairman of the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Removal and Replacement; Vacancies</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If a vacancy on the Board is created at any time by the death, disability, retirement, resignation or removal of any Director nominated
for election to the Board pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)</U>, the Company, by action of the remaining Directors, will, and the Stockholders will use their reasonable best efforts to cause the remaining Directors to, fill the
vacancy created thereby with a replacement nominee designated by the Person or Persons that had designated such Director for nomination pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)</U> as promptly as practicable. Notwithstanding the foregoing,
if such vacant position had been held by a Person nominated under <U>Section</U><U></U><U>&nbsp;2.1(b)(iii)</U>, <U>(iv)</U> or <U>(v)</U>, then the vacancy will be filled by action of the majority of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If a vacancy on the Board is created at any time by the death, disability, retirement, resignation or removal of any Director nominated
for election to the Board pursuant to Section&nbsp;2.1(b) and the remaining Directors have not caused the vacancy created thereby to be filled pursuant to Section&nbsp;2.1(d)(i) by a new designee of the appropriate Person promptly after the
Stockholders have been notified of such vacancy, then in such case the Company will take all such actions as and when requested by the Stockholder entitled, pursuant to Section&nbsp;2.1(b) to designate a Person to fill such vacancy (the
&#147;Designating Stockholder&#148;), and each other Stockholder will vote, or act by written consent with respect to, all Voting Securities beneficially owned by it on the date of the relevant vote or action to fill the vacancy with a Person
designated as a replacement by the Designating Stockholder in accordance with Section&nbsp;2.1(b). Upon the written request of any Person having rights under Section&nbsp;2.1(b), each other Stockholder will vote, or act by written consent with
respect to, all Voting Securities beneficially owned by it on the date of the relevant action to, remove any Director nominated by such Person for election to the Board pursuant to Section&nbsp;2.1(b) and to elect any replacement Director designated
for nomination by such Person pursuant to this Section&nbsp;2.1(d). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Subject to <U>Section</U><U></U><U>&nbsp;2.1(e)</U>, unless otherwise requested in
writing by the Person entitled to nominate such Person for election to the Board under <U>Section</U><U></U><U>&nbsp;2.1(b)</U>, no other Stockholder will take any action to cause the removal of any Directors nominated by such Person for election to
the Board pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Any vacancy on the Board that results from the termination of rights
of nomination pursuant to <U>Section</U><U></U><U>&nbsp;2.1(e)</U> may be filled by action of a majority of the Board, in accordance with the Bylaws and applicable nomination procedures of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Termination of Rights of Nomination</U>. Notwithstanding anything in <U>Section</U><U></U><U>&nbsp;2.1(b)</U> to the contrary: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) In the case of the Cardinal Stockholders, upon the earlier of (A)&nbsp;such time as the Cardinal Stockholders and their Affiliates,
collectively, cease to beneficially own at least 6,084,400 Shares, as such number may be proportionately adjusted for stock splits, reverse stock splits and the like after the date hereof, and (B)&nbsp;the date, if any, on which the Cardinal
Stockholders or their Affiliates acquire beneficial ownership of, collectively, more than 10% of the outstanding equity of any Competing Entity, the Cardinal Stockholders will cease to have the right to designate any nominee for election to the
Board pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) In the case of Bindley Capital: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(A) upon the earlier of (A)&nbsp;such time as Bindley Capital and its Affiliates cease to beneficially own, collectively, at least 15,211,000
Shares, as such number may be proportionately adjusted for stock splits, reverse stock splits and the like after the date hereof, and (B)&nbsp;the date, if any, on which Bindley Capital or its Affiliates acquire beneficial ownership of,
collectively, more than 10% of the outstanding equity of any Competing Entity, Bindley Capital will cease to have the right to designate two nominees for election to the Board pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>, and will
thereafter only have the right to designate on such nominee pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>, subject to <U>Section</U><U></U><U>&nbsp;2.1(e)(ii)(B)</U> below; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(B) upon the earlier of (A)&nbsp;such time as Bindley Capital and its Affiliates cease to beneficially own, collectively, at least 6,084,400
Shares, as such number may be proportionately adjusted for stock splits, reverse stock splits and the like after the date hereof, and (B)&nbsp;the date, if any, on which Bindley Capital or its Affiliates acquire beneficial ownership of,
collectively, more than 10% of the outstanding equity of any Competing Entity, Bindley Capital will cease to have the right to designate any nominee for election to the Board pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) If at any time Burke or Morris ceases to be an executive officer of the Company, the obligation of the Stockholders to nominate such
Person for election to the Board pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)(iii)</U> or <U>(iv)</U>, as applicable, will terminate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2. <U>Company Cooperation</U>. The Company will take such action as may be
required under applicable Law, the Charter and the Bylaws (subject to such vote of the Board as may be required)&nbsp;(a) to cause the Board to consist of the number of Directors specified in <U>Section</U><U></U><U>&nbsp;2.1(a)</U>, (b) to cause
one of the Directors to be appointed and serve as the Chairman of the Board in accordance with <U>Section</U><U></U><U>&nbsp;2.1(c)</U>, and (c)&nbsp;to include in the slate of nominees to be voted upon by stockholders of the Company the Persons
designated for nomination to the Board in accordance with <U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3. <U>Affiliate
Transactions</U>. Except for such transactions as are contemplated by agreements to which the Company is a party on the date hereof or to be entered into on the date hereof, any transaction between the Company or any Subsidiary of the Company, on
the one hand, and a Stockholder or any Affiliate of such Stockholder, on the other, will require the approval of a majority of the disinterested members of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4. <U>Stockholder Votes</U>. In connection with any vote taken at any meeting of the stockholders of the Company or any action
by written consent of the stockholders of the Company in lieu thereof (other than with respect to the election of Directors, which is governed by <U>Section</U><U></U><U>&nbsp;2.1</U>), each Stockholder will vote, or act by written consent with
respect to, all of its Voting Securities in the manner determined by the Stockholders holding a majority of the Voting Securities held by all Stockholders at the time of such vote or action. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSFERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1. <U>Rights and Obligations of Transferees</U>. No Stockholder will Transfer any Equity Securities, except in
compliance with the Securities Act, the Charter, any applicable state or foreign securities Laws, and this Agreement. Any Transfers in violation of this Agreement will be null and void, and the Company will not in any way give effect to any such
impermissible Transfer. Prior to the consummation of a Transfer by any Stockholder to an Affiliate, and as a condition thereto, the applicable Transferee will agree in writing to be bound by the terms of this Agreement (if not already bound hereby)
to the same extent as the Transferring Stockholder is bound hereunder prior to giving effect to such Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2.
<U>Standstill Agreement</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Prior to the seventh anniversary of the date hereof, without the prior written consent of the Board,
except (i)&nbsp;by way of stock dividend, stock split, reorganization, recapitalization, merger, consolidation or other like distributions made to holders of Equity Securities generally or (ii)&nbsp;pursuant to the terms of any stock option, stock
purchase or other similar plans for Directors or officers of the Company, if any, each Significant Stockholder (so long as it is a Significant Stockholder) will not, and will not permit any other member of its Restricted Group to, directly or
indirectly, acquire, agree to acquire or make a proposal to acquire (or publicly announce or otherwise disclose an intention to propose to acquire) or offer to acquire, by purchase or otherwise, beneficial ownership of any Equity Securities not
beneficially owned by them as of the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;3.2</U> to the contrary,
a Significant Stockholder or any member of its Restricted Group will not be prohibited from making a confidential proposal to the Board to acquire additional Equity Securities if the Board (i)&nbsp;determines to effect, or to solicit proposals to
effect, a Sale of the Company, or (ii)&nbsp;causes the Company to enter into a definitive agreement providing for the Sale of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3. <U>Going Private Transactions</U>. Prior to the seventh anniversary of the date hereof, without the prior written consent of
the Board, no Significant Stockholder (so long as it is a Significant Stockholder) will, or will permit any other member of its Restricted Group to, make any public announcement with respect to, or submit a proposal for, or offer in respect of (with
or without conditions) any transaction or series of transactions that would constitute or result in a Going-Private Transaction, unless such Going-Private Transaction: (a)&nbsp;which <U>is not</U> a tender or exchange offer made by any member of
such Significant Stockholder&#146;s Restricted Group, is (i)&nbsp;approved by the Board and determined by the Board to be fair to the stockholders of the Company who are not members of such Significant Stockholder&#146;s Restricted Group, in each
case with the approval of a majority of the disinterested members of the Board, and (ii)&nbsp;approved by a majority of the outstanding Voting Securities not beneficially owned by members of such Significant Stockholder&#146;s Restricted Group;
<U>or</U> (b)&nbsp;which <U>is</U> a tender or exchange offer made by a member of such Significant Stockholder&#146;s Restricted Group and is contingent upon (i)&nbsp;the acquisition of a majority of the outstanding Shares not beneficially owned by
members of such Significant Stockholder&#146;s Restricted Group, and accompanied by an undertaking that such member of such Significant Stockholder&#146;s Restricted Group shall acquire all of the Shares, if any, that remain outstanding after the
completion of such tender or exchange offer in a merger at the same price per share paid in such tender or exchange offer and (ii)&nbsp;the disinterested members of the Board, being authorized on behalf of the full Board to take and disclose a
position contemplated by Rules <FONT STYLE="white-space:nowrap">14d-9</FONT> and <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> promulgated under the Exchange Act with respect to such tender or exchange offer, not recommending that holders of
Shares refrain from tendering their Shares in such tender or exchange offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4. <U>Additional Stock Transfer
Limitations</U>. Without the prior written consent of the Board, no Significant Stockholder will, and each Significant Stockholder will use commercially reasonable efforts to cause members of its Restricted Group not to, directly or indirectly,
Transfer Equity Securities to (a)&nbsp;any Person who is a Competing Entity or (b)&nbsp;any Person who, together with its Affiliates, would beneficially own 10% or more of the Company&#146;s outstanding Shares following such Transfer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1. <U>Representations and Warranties of the Company</U>. The Company represents and warrants to each Stockholder as follows:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Company has all requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder, and
to consummate the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its
terms, except to the extent that the enforcement hereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting the enforcement of creditors&#146; rights generally and general equitable principles,
regardless of whether such enforceability is considered in a proceeding at law or in equity; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the execution and delivery of this Agreement by the Company, the performance of its
obligations hereunder, and the consummation of the transactions contemplated hereby will not violate, conflict with or result in a breach, or constitute a default (with or without notice or lapse of time or both) under any provision of the Charter
or Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2. <U>Representations and Warranties of the Stockholders</U>. Each Stockholder, severally and not jointly,
represents and warrants, solely with respect to itself, to each other Stockholder and to the Company as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) such Stockholder has
all requisite power and authority to enter into this Agreement and to perform its obligations hereunder, and to consummate the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by such Stockholder and
constitutes a valid and binding obligation of such Stockholder enforceable against such Stockholder in accordance with its terms, except to the extent that the enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar Laws affecting the enforcement of creditors&#146; rights generally and general equitable principles, regardless of whether such enforceability is considered in a proceeding at law or in equity; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the execution and delivery of this Agreement by such Stockholder, the performance of its obligations hereunder, and the consummation of
the transactions contemplated hereby will not violate, conflict with or result in a breach, or constitute a default (with or without notice or lapse of time or both) under any provision of its charter, bylaws or other similar organizational
documents. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1. <U>Termination</U>. This Agreement will terminate upon the earlier of (a)&nbsp;the 15<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> anniversary of the date of this Agreement, (b)&nbsp;a Sale of the Company, and (c)&nbsp;the date on which both (i)&nbsp;the rights of each Stockholder pursuant to
<U>Section</U><U></U><U>&nbsp;2.1(b)</U> to nominate individuals for election to the Board (or to be nominated for election to the Board), have terminated in accordance with the terms of <U>Section</U><U></U><U>&nbsp;2.1(e)</U>, and (ii)&nbsp;no
Stockholder continues to be a Significant Stockholder; provided, however, that, notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;5.1</U> to the contrary, the rights and obligations of each Stockholder under this Agreement will
terminate on the date on which such Stockholder no longer beneficially owns any Equity Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2. <U>Confidentiality</U>. Each Stockholder agrees with the Company to, and
agrees with the Company to use commercially reasonable efforts to cause its Representatives to, keep confidential and not divulge any Information; <U>provided</U>, <U>however</U>, that nothing herein will prevent any Stockholder from disclosing such
Information (a)&nbsp;upon the order of any court or administrative agency, (b)&nbsp;upon the request or demand of any regulatory agency or authority having jurisdiction over such Stockholder or Representative, (c)&nbsp;to the extent required by Law
or legal process or required or requested pursuant to subpoena, interrogatories or other discovery requests, (d)&nbsp;to the extent necessary in connection with the exercise of any remedy hereunder, (e) to other Stockholders, or (f)&nbsp;to such
Stockholder&#146;s Representatives that in the reasonable judgment of such Stockholder need to know such Information; <U>provided</U>, <U>further</U>, that, in the case of clause (a), (b) or (c), such Stockholder will notify the Company of the
proposed disclosure as far in advance of such disclosure as reasonably practicable and, if requested by the Company, use commercially reasonable efforts (but at the sole expense of the Company) to ensure that any Information so disclosed is accorded
confidential treatment, when and to the extent available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3. <U>Amendments and Waivers</U>. Except as otherwise provided
herein, no modification, amendment or waiver of any provision of this Agreement will be effective without the approval of the Company and the Stockholders holding a majority of the outstanding Shares held by all Stockholders; <U>provided</U>,
<U>however</U>, that (a)&nbsp;this Agreement may not be amended, modified or waived in any manner adversely affecting the rights or obligations of any Stockholder without the prior written consent of such Stockholder, (b)&nbsp;no amendment,
modification or waiver to <U>Section</U><U></U><U>&nbsp;2.1</U> (directly or by amendment of the definitions used therein) will adversely affect the rights of a Stockholder to designate nominee(s) for election to the Board in accordance with this
Agreement without the consent of such Stockholder, as the case may be, (c)&nbsp;amendment, modification or waiver of this <U>Section</U><U></U><U>&nbsp;5.3</U> will require the prior written consent of each Stockholder, and (d)&nbsp;any Stockholder
may terminate or waive (in writing) the benefit of any provision of this Agreement with respect to itself for any purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4. <U>Successors, Assigns and Transferees</U>. Except as expressly set forth herein, this Agreement will bind and inure to the
benefit of, and be enforceable by, the parties hereto and their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5.
<U>Notices</U>. All notices and other communications to be given to any party hereunder will be sufficiently given for all purposes hereunder if in writing and delivered by hand, courier or overnight delivery service, or when received in the form of
an email or other electronic transmission (receipt confirmation requested), and will be directed to the address set forth below (or at such other address or email address as such party will designate by like notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to the Company, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Guardian
Pharmacy Services, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">300 Galleria Parkway SE, Suite 800 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Atlanta, Georgia 30339 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Fred P. Burke </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email:
[***] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to any Stockholder, to the address of such Stockholder as shown in <U>Schedule I</U> hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6. <U>Further Assurances</U>. At any time or from time to time after the date
hereof, the parties agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably request in order to
evidence or effectuate the consummation of the transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7. <U>Entire Agreement; Third Party Beneficiaries</U>. Except as otherwise expressly set forth herein, this Agreement embodies
the complete agreement and understanding among the parties hereto with respect to the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by or among the parties, written or oral, that they may
have related to the subject matter hereof in any way. This Agreement is not intended to confer in or on behalf of any Person not a party to this Agreement any rights, benefits, causes of action or remedies with respect to the subject matter or any
provision thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8. <U>Delays or Omissions</U>. It is agreed that no delay or omission to exercise any right, power or
remedy accruing to any party, upon any breach, default or noncompliance by another party under this Agreement, will impair any such right, power or remedy, nor will it be construed to be a waiver of any such breach, default or noncompliance, or any
acquiescence therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on the part of any party hereto of any breach, default or
noncompliance under this Agreement or any waiver on such party&#146;s part of any provisions or conditions of this Agreement, must be in writing and will be effective only to the extent specifically set forth in such writing. All remedies, either
under this Agreement, by Law, or otherwise afforded to any party, will be cumulative and not alternative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9. <U>Governing
Law</U>. This Agreement will be governed by and construed in accordance with the Laws of the State of Delaware applicable to contracts made and to be performed within the State of Delaware, without giving effect to conflicts of law rules that would
require or permit the application of the Laws of another jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10. <U>Specific Performance; Jurisdiction</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The parties agree that irreparable damage would occur for which money damages would not suffice in the event that any of the provisions of
this Agreement were not performed in accordance with their specific terms or were otherwise breached and that the parties would not have any adequate remedy at law. It is accordingly agreed that any
<FONT STYLE="white-space:nowrap">non-breaching</FONT> party will be entitled to seek an injunction, temporary restraining order or other equitable relief exclusively in the Delaware Court of Chancery enjoining any such breach and enforcing
specifically the terms and provisions hereof, or in the event (but only in the event) that such court does not have subject matter jurisdiction over such action or proceeding, in the United States District Court for the District of Delaware or
another court sitting in the state of Delaware. Each party agrees not to raise any objections to the availability of the equitable remedy of specific performance to prevent or restrain breaches or threatened breaches of, or to enforce compliance
with, the covenants and obligations of such party under this Agreement. The provisions of this <U>Section</U><U></U><U>&nbsp;5.10(a)</U> are in addition to any other remedy to which any party is entitled at law, in equity or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of the parties hereto irrevocably agrees that any legal action or proceeding in
connection with or with respect to this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement and the rights and obligations arising hereunder brought by the other
party hereto or its successors or assigns will be brought and determined exclusively in the Delaware Court of Chancery, or in the event (but only in the event) that such court does not have subject matter jurisdiction over such action or proceeding,
in the United States District Court for the District of Delaware or another court sitting in the state of Delaware. Each of the parties hereto hereby irrevocably submits with regard to any such action or proceeding for itself and in respect of its
property, generally and unconditionally, to the personal jurisdiction of the aforesaid courts and agrees that it will not bring any action in connection with or relating to this Agreement or any of the transactions contemplated by this Agreement in
any court other than the aforesaid courts. Each of the parties hereto hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action or proceeding in connection with or with respect to
this Agreement, (i)&nbsp;any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason other than the failure to serve in accordance with this <U>Section</U><U></U><U>&nbsp;5.10</U>, (ii) any claim that it
or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of
judgment or otherwise) and (iii) to the fullest extent permitted by the applicable Law, any claim that (A)&nbsp;the suit, action or proceeding in such court is brought in an inconvenient forum, (B)&nbsp;the venue of such suit, action or proceeding
is improper or (C)&nbsp;this Agreement, or the subject matter hereof, may not be enforced in or by such courts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each of the parties
hereto irrevocably consents to the service of any summons and complaint and any other process in any other action in connection with or relating to this Agreement, on behalf of itself or its property, by the personal delivery of copies of such
process to such party or by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for the giving of notices in <U>Section</U><U></U><U>&nbsp;4.5</U>. Nothing in this
<U>Section</U><U></U><U>&nbsp;5.10</U> will affect the right of any party hereto to serve legal process in any other manner permitted by Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11. <U>Waiver of Jury Trial</U>. Each party hereby waives, to the fullest extent permitted by applicable Law, any right it may
have to a trial by jury in respect of any suit, action or other proceeding arising out of this Agreement or any transaction contemplated hereby. Each party (a)&nbsp;certifies and acknowledges that no representative, agent or attorney of any other
party has represented, expressly or otherwise, that such other party would not, in the event of litigation, seek to enforce the foregoing waiver, and (b)&nbsp;acknowledges that it understands and has considered the implications of this waiver and
makes this waiver voluntarily, and that it and the other parties have been induced to enter into the Agreement by, among other things, the mutual waivers and certifications in this <U>Section</U><U></U><U>&nbsp;5.11</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12. <U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent
jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement will remain in full force and effect and will in no way be affected, impaired or invalidated
so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto. Upon such a determination, the parties will negotiate in good faith to modify this Agreement so
as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13. <U>Titles and Subtitles</U>. The titles of the sections and subsections
of this Agreement are for convenience of reference only and will not affect the meaning or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14. <U>Counterparts; Electronic Signatures</U>. This Agreement may be executed in counterparts, each of which will constitute
one and the same instrument. Signatures provided by electronic transmission in &#147;pdf&#148; or equivalent format will be deemed to be original signatures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15. <U>Certain Indemnification Matters</U>. The Company hereby acknowledges that an Indemnitee (as defined in the Charter) who
is an officer, director, partner, member, manager, employee, managing director or Affiliate of, or a Director nominee pursuant to <U>Section</U><U></U><U>&nbsp;2.1</U> of, a Stockholder (each such Indemnitee, a &#147;<U>Specified
Indemnitee</U>&#148;) may have certain rights to indemnification, advancement of expenses and/or insurance pursuant to charter documents, constitutive agreements or other agreements with such Stockholder or Affiliates of such Stockholder or other
Person (other than the Company and its Affiliates) of which such Specified Indemnitee is an officer, director, partner, member, manager, employee, managing director or Affiliate (collectively, the &#147;<U>Secondary Indemnitors</U>&#148;). In
furtherance of the foregoing, the Company hereby covenants and agrees as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company will be the indemnitor of first resort
for any claims or proceedings (collectively, &#147;<U>Covered Claims</U>&#148;) for which any Specified Indemnitee is entitled, under the Charter or otherwise, to indemnification by the Company (<I>i.e.</I>, the Company&#146;s obligations to each
such Specified Indemnitee with respect to any Covered Claim are primary and any obligations of any Secondary Indemnitor to advance expenses or to provide indemnification for the same expenses or liabilities incurred by any such Specified Indemnitee
with respect Covered Claims are secondary). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Subject to Sections 1 and 2 of Article IX of the Charter, the Company will pay the
expenses (including attorneys&#146; fees and expenses) incurred by any Specified Indemnitee in defending any Covered Claim in advance of such Covered Claim&#146;s final disposition, without regard to any rights any such Specified Indemnitee may have
against any Secondary Indemnitor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company hereby irrevocably waives, relinquishes and releases each Secondary Indemnitor from any
and all claims against such Secondary Indemnitor for contribution, subrogation or any other recovery of any kind in respect of any Covered Claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company further agrees that no advancement or payment by any Secondary Indemnitor on behalf of any such Specified Indemnitee with respect
to any Covered Claim for which any such Specified Indemnitee has sought indemnification from the Company will affect the foregoing and any such Secondary Indemnitor will have a right of contribution and/or subrogation to the extent of such
advancement or payment to all of the rights of recovery of such Specified Indemnitee against the Company. Any amendment, repeal or modification of this <U>Section</U><U></U><U>&nbsp;5.15</U> will not adversely affect any right or protection of a
Specified Indemnitee or Secondary Indemnitor existing prior to such repeal or modification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of page intentionally left blank] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Stockholders&#146; Agreement to be
executed effective as of the date set forth in the first paragraph hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUARDIAN PHARMACY SERVICES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Stockholders&#146; Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BINDLEY CAPITAL PARTNERS I, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Thomas J. Salentine, Jr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Thomas J. Salentine, Jr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PHARMACY INVESTORS, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ James L. Smeltzer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>James L. Smeltzer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Managing Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CARDINAL EQUITY FUND LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">By:&#8194;Cardinal Equity Partners, LLC, its General Partner</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ James L. Smeltzer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>James L. Smeltzer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Managing Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FRED P. BURKE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ David K. Morris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>DAVID K. MORRIS</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Kendall Forbes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>G. KENDALL FORBES</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Stockholders&#146; Agreement] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>d894834dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">THIS EMPLOYMENT AGREEMENT by and between Guardian Pharmacy Services Management, LLC, a Georgia limited liability company with its principal
place of business located at 300 Galleria Parkway SE, Suite 800, Atlanta, GA 30339 (the &#147;<U>Company</U>&#148;) and a wholly owned subsidiary of Guardian Pharmacy Services, Inc. (&#147;<U>Parent</U>&#148;), and Fred P. Burke
(&#147;<U>Executive</U>&#148;), is dated as of the 26th day of September, 2024 (the &#147;<U>Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company wishes to
employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive desires to be employed by the Company on such terms and conditions and for such consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In consideration of the promises provided for in this Agreement, the Company and Executive agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>Employment Period</U>. This Agreement shall become effective as of September&nbsp;27, 2024 (the &#147;<U>Effective Date</U>&#148;). The
Company hereby agrees to employ Executive, and Executive hereby agrees to be employed by the Company, on an <FONT STYLE="white-space:nowrap">at-will</FONT> basis on the terms and conditions <FONT STYLE="white-space:nowrap">set-forth</FONT> herein
for the period commencing on the Effective Date and ending as provided in Section&nbsp;3 hereof (the &#147;<U>Employment Period</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Terms of Employment</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Position and Duties</U>. (i)&nbsp;During the Employment Period, Executive shall (A)&nbsp;serve as President and Chief Executive Officer
of the Parent with such duties and responsibilities as are customarily commensurate with or incident to such position for an entity similar in size to, and in a business similar to that of, Parent, (B)&nbsp;report to the Board of Directors of
Parent, and (C)&nbsp;perform Executive&#146;s services at 300 Galleria Parkway SE, Suite 800, Atlanta, GA 30339 (subject to reasonable travel requirements commensurate with Executive&#146;s position). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) During the Employment Period, and excluding any periods of vacation and sick leave to which Executive is entitled, Executive agrees to
devote Executive&#146;s full business time and attention to the business and affairs of the Company, Parent and their affiliates. During the Employment Period, it will not be a violation of this Agreement for Executive to (A)&nbsp;serve on civic or
charitable boards or committees, (B)&nbsp;deliver lectures, fulfill speaking engagements or teach at educational institutions and (C)&nbsp;manage personal investments, so long as such activities described in clauses (A), (B) and (C)&nbsp;do not
significantly interfere with the performance of Executive&#146;s responsibilities as an employee of the Company in accordance with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Compensation</U>. (i)<U>&nbsp;Base Salary</U>. During the Employment Period, Executive shall receive an annual base salary
(&#147;<U>Annual Base Salary</U>&#148;) of $450,000 paid in accordance with the normal payroll practices of the Company as may be in effect from time to time, which Annual Base Salary shall be reviewed for increase at least annually. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Annual Cash Bonus</U>. Executive shall be eligible, for each fiscal year of Parent
(beginning with fiscal year 2025) ending during the Employment Period, for an annual incentive bonus in cash (the &#147;<U>Annual Bonus</U>&#148;), with a target Annual Bonus opportunity equal to no less than 60% of Annual Base Salary
(&#147;<U>Target Bonus</U>&#148;) and a maximum Annual Bonus opportunity of no less than 150% of the Target Bonus. For each such fiscal year, Parent&#146;s Board of Directors (the &#147;<U>Board</U>&#148;) (or an applicable committee of the Board)
will establish the performance metrics and their relative weighting to be used in, and any specific performance goals applicable to, the determination of the Annual Bonus for Executive for such period. There is no guaranteed Annual Bonus under this
Agreement, and for each applicable fiscal year, Executive&#146;s Annual Bonus could be as low as zero or as high as the maximum percentage set forth in this paragraph. Notwithstanding anything in this Agreement to the contrary, each Annual Bonus
shall be on the terms and subject to such conditions as are specified for the particular Company or Parent plans or programs pursuant to which the Annual Bonus is granted. Any Annual Bonus earned with respect to a particular fiscal year will be paid
no later than March&nbsp;15 following the end of the fiscal year to which the Annual Bonus relates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Equity Compensation
Program</U>. During the Employment Period, subject to approval by the Board (or an applicable committee of the Board), Executive shall be eligible to participate in Parent&#146;s long-term incentive compensation program as may be in effect from time
to time for senior executives of Parent and the Company generally, with such participation occurring in accordance with the approval of the Board (or an applicable committee of the Board), Parent and the Company&#146;s policies, and the applicable
award agreement and incentive compensation plan under which such awards will be granted, as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Employee
Benefits</U>. During the Employment Period, Executive shall be eligible to participate in the employee benefit plans, programs, and policies, as may be in effect from time to time, for senior executives of Parent and the Company generally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) <U>Vacation</U>. During the Employment Period, Executive shall be entitled to paid vacation during each calendar year, consistent with the
Company&#146;s policies then applicable to executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) <U>Expenses</U>. During the Employment Period, Executive shall be
entitled to receive prompt reimbursement for all reasonable expenses incurred by Executive in accordance with the performance of Executive&#146;s duties under this Agreement and in accordance with the Company&#146;s business expense reimbursement
policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <U>Termination of Employment</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Generally</U>. Except as hereinafter provided, the Employment Period shall continue until, and shall end upon, the second anniversary
of the Effective Date (the &#147;<U>Initial Employment Period</U>&#148;). At the end of the Initial Employment Period and on each anniversary thereafter, unless the Company shall have given Executive sixty (60)&nbsp;days written notice that the
Employment Period will not be extended, the Employment Period shall be extended for an additional year. The term &#147;Employment Period&#148; as used in this Agreement shall refer to the Initial Employment Period or the Employment Period as so
extended. If the Company gives Executive sixty (60)&nbsp;days written notice that the Employment Period will not be extended, then, unless otherwise agreed by the Company and Executive, Executive&#146;s employment with the Company shall terminate
immediately following the last day of the Employment Period. Notwithstanding the foregoing, the Employment Period (to the extent then in effect) will cease on the Date of Termination (as defined in Section&nbsp;3(g)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Death or Disability</U>. Executive&#146;s employment shall terminate automatically if
Executive dies during the Employment Period. If the Company determines in good faith that the Disability (as defined herein) of Executive has occurred during the Employment Period (pursuant to the definition of &#147;Disability&#148; set forth
below), it may give to Executive written notice in accordance with Section&nbsp;14(b) of its intention to terminate Executive&#146;s employment. In such event, Executive&#146;s employment with the Company shall terminate effective on the 30th day
after receipt of such notice by Executive (the &#147;<U>Disability Effective Date</U>&#148;), provided that, within the 30 days after such receipt, Executive shall not have returned to full-time performance of Executive&#146;s duties.
&#147;<U>Disability</U>&#148; means the absence of Executive from Executive&#146;s duties with the Company on a full-time basis for 90 consecutive business days, or 90 business days during any period of 120 consecutive business days, as a result of
incapacity due to mental or physical illness that is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to Executive or Executive&#146;s legal representative (such agreement as to acceptability
not to be unreasonably withheld). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>By the Company</U>. The Company may terminate Executive&#146;s employment during the Employment
Period for any, or no reason, with or without Cause. For purposes of this Agreement, &#147;<U>Cause</U>&#148; will be deemed to exist upon: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any use or misappropriation by Executive of the funds, assets or property of Parent, the Company, or their subsidiaries or
affiliates for any personal or other improper purpose; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any act of moral turpitude, dishonesty, fraud by or felony
conviction of Executive whether or not such acts were committed in connection with the business of the Company, an affiliate or a subsidiary, if such act or conviction, in the reasonable good faith judgment of the Board, could reasonably be expected
to be materially injurious to the financial condition or business reputation of Parent, the Company, or their subsidiaries or affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any failure by Executive substantially to perform the lawful instructions of the person(s) to whom Executive reports
(other than as a result of total or partial incapacity due to physical or mental illness) following written notice by the Company to Executive of such failure and 15 days within which to cure such failure; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any willful or gross misconduct by Executive in connection with Executive&#146;s duties to the Company which, in the
reasonable good faith judgment of the Board, could reasonably be expected to be materially injurious to the financial condition or business reputation of Parent, the Company or their subsidiaries or affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) any failure by Executive to follow a material Company or Parent policy; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) any material breach by Executive of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The cessation of employment of Executive shall not be deemed to be for Cause unless and until there shall
have been delivered to Executive a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of the entire membership of the Board (excluding Executive, if Executive is a member of the Board) at a meeting of the Board
called and held for such purpose (after reasonable notice is provided to Executive and Executive is given an opportunity, together with counsel for Executive, to be heard before the Board), finding that, in the good faith opinion of the Board,
Executive has engaged in the conduct described in Section&nbsp;3(c), and specifying the particulars thereof in detail. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>By
Executive</U>. Executive&#146;s employment may be terminated during the Employment Period by Executive for Good Reason or by Executive without Good Reason. For purposes of this Agreement, &#147;<U>Good Reason</U>&#148; shall mean, in the absence of
the prior written consent of Executive: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a material diminution in Executive&#146;s duties, authorities or
responsibilities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a material reduction of Executive&#146;s Annual Base Salary or Target Bonus; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) relocation of Executive&#146;s primary workplace, as assigned to Executive by the Company in accordance with
Section&nbsp;2(a)(i), beyond a 50 mile radius from such workplace; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any other material breach by the Company of
this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that Executive&#146;s termination of employment shall not be deemed to be for Good Reason unless
(A)&nbsp;Executive has notified the Company in writing describing the occurrence of one or more Good Reason events within 90 days of such occurrence, (B)&nbsp;the Company fails to cure such Good Reason event within 30 days after its receipt of such
written notice and (C)&nbsp;the termination of employment occurs within 180 days after the occurrence of the applicable Good Reason event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Notice of Termination; Expiration of Employment Period</U>. Any termination of employment by the Company for Cause, or by Executive for
Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section&nbsp;14(b) of this Agreement. &#147;<U>Notice of Termination</U>&#148; means a written notice that (i)&nbsp;indicates the specific
termination provision in this Agreement relied upon, (ii)&nbsp;to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive&#146;s employment under the provision so
indicated, and (iii)&nbsp;if the Date of Termination (as defined herein) is other than the date of receipt of such notice, specifies the Date of Termination (which Date of Termination shall be not more than 30 days after the giving of such notice).
The failure by Executive or the Company to set forth in the Notice of Termination any fact or circumstance that contributes to a showing of Good Reason or Cause shall not waive any right of Executive or the Company, respectively, hereunder or
preclude Executive or the Company, respectively, from asserting such fact or circumstance in enforcing Executive&#146;s or the Company&#146;s respective rights hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Resignation</U>. Upon any termination of Executive&#146;s employment with the
Company, Executive shall be deemed to resign from any position as an officer, director, or fiduciary of the Company, Parent and any related entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Date of Termination</U>. &#147;<U>Date of Termination</U>&#148; means (i)&nbsp;if Executive&#146;s employment is terminated by the
Company for Cause, or by Executive for Good Reason, the date of receipt of the Notice of Termination or such later date specified in the Notice of Termination, as the case may be, (ii)&nbsp;if Executive&#146;s employment is terminated by the Company
other than for Cause or Disability, the date on which the Company notifies Executive of such termination, (iii)&nbsp;if Executive resigns without Good Reason, the date on which Executive notifies the Company of such termination, and (iv)&nbsp;if
Executive&#146;s employment is terminated by reason of death or Disability, the date of Executive&#146;s death or the Disability Effective Date, as the case may be. Notwithstanding the foregoing, in no event shall the Date of Termination occur until
Executive experiences a &#147;separation from service&#148; within the meaning of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), and the date on which such separation from service takes place shall
be the &#147;Date of Termination.&#148; Upon the expiration of the Employment Period and in the event Executive continues employment with the Company, Executive&#146;s employment will be <FONT STYLE="white-space:nowrap">at-will</FONT> and the terms
of this Agreement (other than Section&nbsp;8) will have no further effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <U>Obligations of the Company upon Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>By Executive for Good Reason or by the Company other than for Cause, Death or Disability Not During the Change in Control Period</U>.
If, during the Employment Period, the Company terminates Executive&#146;s employment other than for Cause, death or Disability, including by providing notice to Executive pursuant to Section&nbsp;3(a) that the Employment Period will not be extended
and Executive&#146;s employment is terminated, or Executive terminates employment for Good Reason, and, in each case, Executive is not entitled to any amounts or benefits pursuant to Section&nbsp;4(b): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company shall pay to Executive, in a lump sum in cash within 30 days after the Date of Termination (or earlier, if
required by applicable law), the aggregate of the following amounts: the sum of (A)&nbsp;Executive&#146;s Annual Base Salary through the Date of Termination to the extent not theretofore paid, (B)&nbsp;Executive&#146;s business expenses that are
reimbursable pursuant to Section&nbsp;2(b)(vi) of this Agreement but have not been reimbursed by the Company as of the Date of Termination; (C)&nbsp;Executive&#146;s Annual Bonus for the fiscal year immediately preceding the fiscal year in which the
Date of Termination occurs, if such Annual Bonus has been earned but not paid as of the Date of Termination; and (D)&nbsp;any accrued vacation pay to the extent not theretofore paid (the sum of the amounts described in subclauses (A), (B), (C) and
(D), the &#147;<U>Accrued</U> <U>Obligations</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Subject to Section&nbsp;11(b), on the 61st day after the
Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;two by (B)&nbsp;the sum of (1)&nbsp;Executive&#146;s Annual Base Salary (without
regard to any reduction thereto) and (2)&nbsp;Executive&#146;s Target Bonus (without regard to any reduction thereto); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to Section&nbsp;11(b), on the 61<SUP
STYLE="font-size:75%; vertical-align:top">st</SUP> day after the Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;Executive&#146;s
Target Bonus for the fiscal year in which the Date of Termination occurs, by (B)&nbsp;a fraction, the numerator of which is the total number of days that have elapsed during such fiscal year through the Date of Termination and the denominator of
which is the total number of days in the applicable fiscal year; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) If Executive timely and properly elects health
continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;<U>COBRA</U>&#148;), the Company shall reimburse Executive for the difference between the monthly COBRA premium paid by Executive for Executive
and Executive&#146;s dependents and the monthly premium amount paid by Executive for such coverage immediately prior to the Date of Termination. Such reimbursement shall be paid to Executive on the first of the month immediately following the month
in which Executive timely remits the premium payment. Executive shall be eligible to receive such reimbursement until the earliest of (A) 24 months following the Date of Termination, (B)&nbsp;the time Executive is no longer eligible for such COBRA
coverage, or (C)&nbsp;the date Executive becomes eligible for group health care insurance coverage from another employer; provided, that Executive shall promptly notify the Company of any such circumstances. For the avoidance of doubt, nothing in
this Agreement (including Section&nbsp;4(b)) shall prohibit the Company or any of its affiliates from amending or terminating any group health plan. Notwithstanding anything in this Agreement (including Section&nbsp;4(b)) to the contrary, in the
event that the payment of amounts payable under this clause (iv)&nbsp;or in Section&nbsp;4(b)(iv), as applicable, shall result in adverse tax consequences under Chapter 100 of the Code, Code Section&nbsp;4980D or otherwise to the Company or its
affiliates, the parties shall undertake commercially reasonable efforts to restructure such benefit in an economically equivalent manner to avoid the imposition of such taxes on the Company or the affiliate, <U>provided</U>, <U>however</U>, that
should the Company&#146;s auditors determine in good faith that no such alternative arrangement is achievable, Executive shall not be entitled to his or her rights to payment under this clause (iv)&nbsp;or Section&nbsp;4(b)(iv), as applicable.
Further, neither the Company nor any of its employees, directors, managers, board members, affiliates, parents, stakeholders, equityholders, agents, successors, predecessors or related parties guarantees the tax treatment of any benefit under this
clause (iv)&nbsp;or Section&nbsp;4(b)(iv), as applicable, and no such party shall have liability to Executive or his or her beneficiaries with respect to the taxation of such benefits or amounts payable in respect thereof; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) To the extent not theretofore paid or provided, the Company shall timely pay or provide to Executive any Other Benefits (as
defined in Section&nbsp;5) in accordance with the terms of the underlying plans or agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as set forth in this Section&nbsp;4(a), in the
event of a termination of Executive&#146;s employment by the Company without Cause (other than due to death or Disability) or by Executive for Good Reason, the Company shall have no further obligation to Executive under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>By Executive for Good Reason or By the Company Other than for Cause, Death, or
Disability During the Change in Control Period</U>. If, during the Employment Period, the Company terminates Executive&#146;s employment other than for Cause, death or disability, including by providing notice to Executive pursuant to
Section&nbsp;3(a) that the Employment Period will not be extended and Executive&#146;s employment is terminated, or Executive terminates employment for Good Reason, in each case, within a period of two years after a Change in Control (the
&#147;<U>Change in Control Period</U>&#148;), the Company will pay and provide to Executive the amounts and benefits specified in Section&nbsp;4(b)(i)-(vi) herein in lieu of the amounts and benefits provided in Section&nbsp;4(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company shall pay to Executive, in a lump sum in cash within 30 days after the Date of Termination (or earlier, if
required by applicable law), the aggregate of the Accrued Obligations (as defined in Section&nbsp;4(a)(i)). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Subject
to Section&nbsp;11(b), on the 61st day after the Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;three by (B)&nbsp;the sum of
(1)&nbsp;Executive&#146;s Annual Base Salary (without regard to any reduction thereto) and (2)&nbsp;Executive&#146;s Target Bonus (without regard to any reduction thereto); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to Section&nbsp;11(b), on the 61<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> day after the Date of
Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;Executive&#146;s Target Bonus for the fiscal year in which the Date of Termination occurs, by
(B)&nbsp;a fraction, the numerator of which is the total number of days that have elapsed during such fiscal year through the Date of Termination and the denominator of which is the total number of days in the applicable fiscal year; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) If Executive timely and properly elects health continuation coverage under COBRA, the Company shall reimburse Executive
for the difference between the monthly COBRA premium paid by Executive for Executive and Executive&#146;s dependents and the monthly premium amount paid by Executive for such coverage immediately prior to the Date of Termination. Such reimbursement
shall be paid to Executive on the first of the month immediately following the month in which Executive timely remits the premium payment. Executive shall be eligible to receive such reimbursement until the earliest of (A) 36 months following the
Date of Termination, (B)&nbsp;the time Executive is no longer eligible for such COBRA coverage, or (C)&nbsp;the date Executive becomes eligible for group health care insurance coverage from another employer; provided, that Executive shall promptly
notify the Company of any such circumstances; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Any outstanding equity-based awards granted to Executive under
Parent&#146;s 2024 Equity and Incentive Compensation Plan (or any successor plan) (the &#147;<U>Equity Plan</U>&#148;) shall vest in full (with performance-based awards vesting at the greater of target performance and actual performance measured as
of the Date of Termination) and shall be paid in accordance with the terms of the Equity Plan and the applicable equity award agreements; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) To the extent not theretofore paid or provided, the Company shall
timely pay or provide to Executive any Other Benefits (as defined in Section&nbsp;5) in accordance with the terms of the underlying plans or agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Death or Disability</U>. If Executive&#146;s employment is terminated by reason of Executive&#146;s death or Disability during the
Employment Period, the Company shall provide Executive or, in the event of death, Executive&#146;s estate or beneficiaries, with the Accrued Obligations and the timely payment or delivery of the Other Benefits in accordance with the terms of the
underlying plans or agreements, and shall have no further obligations under this Agreement. The Accrued Obligations shall be paid to Executive or, in the event of death, Executive&#146;s estate or beneficiaries, in a lump sum in cash within 30 days
of the applicable Date of Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Cause; Other than for Good Reason</U>. If Executive&#146;s employment is terminated for
Cause during the Employment Period, the Company shall provide Executive with Executive&#146;s Annual Base Salary through the Date of Termination, and the timely payment or delivery of the Other Benefits in accordance with the terms of the underlying
plans or agreements, and shall have no further obligations under this Agreement. If Executive voluntarily terminates employment other than for Good Reason during the Employment Period, the Company shall provide to Executive the Accrued Obligations
and the timely payment or delivery of the Other Benefits in accordance with the terms of the underlying plans or agreements, and shall have no further obligations under this Agreement. In such case, all the Accrued Obligations shall be paid to
Executive in a lump sum in cash within 30 days of the Date of Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Release</U>. Notwithstanding anything herein to the
contrary, the Company shall not be obligated to make any payment under Sections 4(a) (ii)-(iv) or Sections 4(b)(ii)-(v) of this Agreement, as applicable, unless (i)&nbsp;prior to the 60th day following the Date of Termination, Executive executes a
release of claims against the Company and its affiliates in a form provided by the Company (the &#147;<U>Release</U>&#148;), and (ii)&nbsp;any applicable revocation period has expired during such <FONT STYLE="white-space:nowrap">60-day</FONT> period
without Executive revoking such Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Change in Control</U>. For purposes of this Agreement, &#147;<U>Change in
Control</U>&#148; means the occurrence (after the date of the consummation of the initial public offering Parent&#146;s common stock (the &#147;<U>IPO Date</U>&#148;)) of any of the following events; <U>provided</U>, that, for the avoidance of
doubt, the initial public offering of Parent&#146;s common stock shall not constitute a Change in Control for purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the acquisition by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or 14(d)(2) of the
Securities Exchange Act of 1934, as amended from time to time (the &#147;<U>Exchange Act</U>&#148;), and the rules and regulations thereunder, as such law, rules and regulations may be amended from time to time) (a &#147;<U>Person</U>&#148;) of
beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of voting securities of Parent where such acquisition causes such Person to own 50% or more of the combined voting
power of the then outstanding voting securities of Parent entitled to vote generally in the election of directors (the &#147;<U>Outstanding Company Voting Securities</U>&#148;); <U>provided</U>, <U>however</U>, that for purposes of this subsection
(i), the following acquisitions shall not be deemed to result in a Change in Control: (A)&nbsp;any acquisition </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">directly from Parent that is approved by the Incumbent Board (as defined in subsection
(ii)&nbsp;below), (B) any acquisition by Parent, (C)&nbsp;any acquisition by any employee benefit plan (or related trust) sponsored or maintained by Parent or any corporation controlled by Parent or (D)&nbsp;any acquisition by any corporation
pursuant to a transaction that complies with clauses (A), (B) and (C)&nbsp;of subsection (iii)&nbsp;below; <U>provided</U>, <U>further</U>, that if any Person&#146;s beneficial ownership of the Outstanding Company Voting Securities reaches or
exceeds 50% as a result of a transaction described in clause (A)&nbsp;or (B) above, and such Person subsequently acquires beneficial ownership of additional voting securities of Parent, such subsequent acquisition shall be treated as an acquisition
that causes such Person to own 50% or more of the Outstanding Company Voting Securities; and <U>provided</U>, <U>further</U>, that if at least a majority of the members of the Incumbent Board determines in good faith that a Person has acquired
beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of 50% or more of the Outstanding Company Voting Securities inadvertently, and such Person divests as promptly as
practicable a sufficient number of shares so that such Person beneficially owns (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) less than 50% of the Outstanding Company Voting Securities,
then no Change in Control shall have occurred as a result of such Person&#146;s acquisition; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) individuals who, as of
the IPO Date, constitute the Board (the &#147;<U>Incumbent Board</U>&#148; as modified by this subsection (ii)) cease for any reason to constitute at least a majority of the Board; <U>provided</U>, <U>however</U>, that any individual becoming a
director subsequent to the IPO Date whose election, or nomination for election by Parent&#146;s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (either by specific vote or by approval
of the proxy statement of Parent in which such person is named as a nominee for director, without objection to such nomination) shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any
such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf
of a Person other than the Board; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the consummation of a reorganization, merger or consolidation or sale or other
disposition of all or substantially all of the assets of Parent or the acquisition of assets of another corporation or other transaction (&#147;<U>Business Combination</U>&#148;) excluding, however, such a Business Combination pursuant to which
(A)&nbsp;the individuals and entities who were the beneficial owners of the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then
outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination
(including, without limitation, an entity that as a result of such transaction owns Parent or all or substantially all of Parent&#146;s assets either directly or through one or more subsidiaries), (B) no Person (excluding any employee benefit plan
(or related trust) of Parent, Parent or such entity resulting from such Business Combination) beneficially owns, directly or indirectly, 50% or more of the combined voting power of the then outstanding securities entitled to vote generally in the
election of directors of the entity resulting from such Business Combination and (C)&nbsp;at least a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Incumbent Board at
the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) approval by Parent&#146;s stockholders of a complete liquidation or
dissolution of Parent except pursuant to a Business Combination that complies with clauses (A), (B) and (C)&nbsp;of subsection (iii)&nbsp;above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</U>. Amounts that Executive is otherwise entitled to receive under any
plan, policy, practice or program of or any other contract or agreement with the Company or its affiliates at or subsequent to the Date of Termination (&#147;<U>Other Benefits</U>&#148;) shall be payable in accordance with such plan, policy,
practice or program or contract or agreement, except as explicitly modified by this Agreement. Notwithstanding the foregoing, Executive shall not be eligible to participate in any other severance plan, program or policy of the Company or its
affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <U><FONT STYLE="white-space:nowrap">Set-off;</FONT> No Mitigation</U>. The Company&#146;s obligation to make the payments
provided for in this Agreement and otherwise to perform its obligations hereunder shall be subject to <FONT STYLE="white-space:nowrap">set-off,</FONT> counterclaim, recoupment, defense, or other claim, right or action that the Company or its
affiliates may have against Executive to the extent such <FONT STYLE="white-space:nowrap">set-off</FONT> or other action does not violate Section&nbsp;409A of the Code. In no event shall Executive be obligated to seek other employment or take any
other action by way of mitigation of the amounts payable to Executive under any of the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <U>Limitations on
Payments Under Certain Circumstances</U>. Notwithstanding any provision of any other plan, program, arrangement or agreement to the contrary, in the event that it shall be determined that any payment or benefit to be provided by the Company to
Executive pursuant to the terms of this Agreement or any other payments or benefits received or to be received by Executive (a &#147;<U>Payment</U>&#148;) in connection with or as a result of any event which is deemed by the U.S. Internal Revenue
Service or any other taxing authority to constitute a change in the ownership or effective control of Parent or the Company, or in the ownership of a substantial portion of the assets of Parent or the Company and subject to the tax (the
&#147;<U>Excise</U> <U>Tax</U>&#148;) imposed by Section&nbsp;4999 (or any successor section) of the Code, the Payments, whether under this Agreement or otherwise, shall be reduced so that the Payment, in the aggregate, is reduced to the greatest
amount that could be paid to Executive without giving rise to any Excise Tax; provided that in the event that Executive would be placed in a better <FONT STYLE="white-space:nowrap">after-tax</FONT> position after receiving all Payments and not
having any reduction of Payments as provided hereunder, Executive shall, notwithstanding the provisions of any other plan, program, arrangement or agreement to the contrary, receive all Payments and pay any applicable Excise Tax. All determinations
under this Section&nbsp;7 shall be made by a nationally recognized accounting firm selected by Parent or the Company (the &#147;<U>Accounting Firm</U>&#148;). Without limiting the generality of the foregoing, any determination by the Accounting Firm
under this Section&nbsp;7 shall take into account the value of any reasonable compensation for services to be rendered by Executive (or for holding oneself out as available to perform services and refraining from performing services (such as under a
covenant not to compete)). If the Payments are to be reduced pursuant to this Section&nbsp;7, the Payments shall be reduced in the following order: (a)&nbsp;Payments which do not constitute &#147;nonqualified deferred compensation&#148; subject to
Section&nbsp;409A of the Code shall be reduced first; and (b)&nbsp;all other Payments shall then be reduced, in each case as follows: (i)&nbsp;cash payments shall be reduced before <FONT STYLE="white-space:nowrap">non-cash</FONT> payments and
(ii)&nbsp;payments to be made on a later payment date shall be reduced before payments to be made on an earlier payment date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <U>Restrictive Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Acknowledgements and Agreements</U>. Executive hereby acknowledges and agrees that in the performance of Executive&#146;s duties to the
Company during Executive&#146;s employment, Executive shall be brought into frequent contact with existing and potential customers of the Company throughout the continental Unites States. Executive also agrees that Executive will obtain knowledge
and skill relevant to the Company&#146;s industry, methods of doing business, and marketing strategies by virtue of Executive&#146;s employment. Executive further agrees that trade secrets and confidential information of the Company, more fully
described in Section&nbsp;8(i), have been developed by the Company through substantial expenditures of time, effort and money and constitute valuable and unique property of the Company with great competitive importance and commercial value to the
Company. Executive further understands and agrees that the foregoing makes it necessary for the protection of the Company&#146;s legitimate business interests that Executive comply with the restrictive covenants, as further provided in the following
sections. Executive acknowledges and agrees that the terms and conditions of this Section&nbsp;8 are fair, reasonable, and not unduly restrictive on Executive and are reasonably necessary to protect the legitimate business interests of the Company
and to prevent irreparable harm to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Competitive Activity During Employment.</U> Executive will not compete with the
Company anywhere within the United States during Executive&#146;s employment with the Company, including, without limitation: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) entering into or engaging in any business which competes with the Company&#146;s Business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) soliciting customers, business, patronage or orders for, or selling, any products or services in competition with, or for
any business that competes with, the Company&#146;s Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) diverting, enticing or otherwise taking away any
customers, business, patronage, or orders of the Company or attempting to do so; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) soliciting any employee, sales
representative, agent or consultant of the Company to terminate their employment, relationship or other association with the Company or attempting to do so; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) promoting or assisting, financially or otherwise, any person, firm, association, partnership, corporation or other entity
engaged in any business which competes with the Company&#146;s Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Following Termination.</U> For a period of two years
following Executive&#146;s termination of employment with the Company, for any reason, Executive shall not, on Executive&#146;s own account or as a partner, joint venturer, employee, agent, contractor, salesperson, consultant, officer and/or
director of any firm, association, partnership, corporation or other entity: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Provide services the same or
substantially similar to those duties performed by Executive as President and Chief Executive Officer for the Company for any person or entity that competes with the Company&#146;s Business (as hereinafter defined) within the Restricted Territory
(as hereinafter defined); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Directly or indirectly, solicit or attempt to solicit business,
patronage or orders for products or services in competition with those provided by the Company, on Executive&#146;s own behalf or for any person or entity, wherever located, from any Company customers or actively sought prospective customers with
whom Executive had Material Contact (as hereinafter defined). This Section&nbsp;8(c)(ii) does not prohibit Executive from accepting as a customer any Company customer or actively sought prospective customer who: (A)&nbsp;responds to a general
advertisement or solicitation, including but not limited to advertisements or solicitations through newspapers, trade publications, periodicals or internet databases, not specifically directed at customers or prospective customers of the Company; or
(B)&nbsp;unilaterally contacts Executive in the absence of any violation of this Section&nbsp;8(c)(ii) by Executive; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)
Directly or indirectly, within the Restricted Territory, solicit or recruit, or attempt to solicit or recruit, for purposes of terminating employment, relationship or other association with the Company, any employee, sales representative, agent or
consultant of the Company with whom Executive worked or about whom Executive came to know confidential information as a result of Executive&#146;s employment with the Company, and who has not prior thereto ceased to be employed or retained by the
Company, to terminate their employment, relationship or other association with the Company. This Section&nbsp;8(c)(iii) shall not prohibit Executive from soliciting or hiring any person who: (A)&nbsp;responds to a general advertisement or
solicitation, including but not limited to advertisements or solicitations through newspapers, trade publications, periodicals, internet databases or recruiting or employment agencies, not specifically directed at employees, sales representatives,
agents or consultants of the Company; or (B)&nbsp;unilaterally contacts Executive in the absence of any violation of this Section&nbsp;8(c)(iii) by Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>The &#147;Company.&#148;</U> For the purposes of this Section&nbsp;8, the &#147;Company&#148; shall include any and all direct and
indirect subsidiaries, parents, and affiliated or related companies thereof or the Company for which Executive worked or had responsibility at the time of termination of Executive&#146;s employment and at any time during the two year period prior to
such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>The Company&#146;s &#147;Business.&#148;</U> For the purposes of this Section&nbsp;8, the Company&#146;s
Business is defined to mean owning, operating or providing business consulting services to pharmacies that offer pharmaceutical products and services to long-term care facilities, including skilled nursing facilities, assisted living facilities and
behavioral health facilities, as such activities are conducted by the Company, or the provision of any other products or services conducted, authorized, offered or provided by the Company within the two year period prior to Executive&#146;s
termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>&#147;Material Contact.&#148;</U> For purposes of this Section&nbsp;8, Material
Contact is defined to be contact between Executive and each customer and prospective customer: (i)&nbsp;with whom or which the Executive dealt on behalf of the Company; (ii)&nbsp;whose dealings with the Company were coordinated or supervised by
Executive; (iii)&nbsp;about whom Executive obtained Confidential Information in the ordinary course of business as a result of Executive&#146;s association with the Company; or (iv)&nbsp;who received products or services authorized by the Company,
the sale or provision of which results or resulted in compensation, commissions, or earnings for Executive within the two years prior to the Executive&#146;s termination from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>&#147;Restricted Territory.&#148;</U> For the purposes of Section&nbsp;8, the Restricted Territory shall be defined as and limited to:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) (A) the geographic area(s) within a 100 mile radius of any and all of the Company&#146;s location(s) in, to, or for
which Executive worked, to which Executive was assigned or had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT>
period prior to such termination; or (B)&nbsp;in the event that the foregoing definition of Restricted Territory in this Section&nbsp;8(g)(i)(A) is deemed to be overbroad or otherwise enforceable even after judicial modification, then this
Section&nbsp;8(g)(i)(A) shall mean the geographic area(s) within a 50 mile radius of any and all of the Company&#146;s location(s) in, to, or for which Executive worked, to which Executive was assigned or had any responsibility (either direct or
supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) (A) the geographic areas(a) within a 100 mile radius of any and all of the specific customer accounts, whether within or
outside of the geographic area described in (i)&nbsp;above, with which Executive had any contact or for which Executive had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time
during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination; (B)&nbsp;in the event that the foregoing definition of Restricted Territory in this Section&nbsp;8(g)(ii)(B) is deemed to be overbroad or otherwise
enforceable even after judicial modification, then this Section&nbsp;8(g)(i) shall mean the geographic area(s) within a 50 mile radius of any and all of the Company&#146;s location(s) in, to, or for which Executive worked, to which Executive was
assigned or had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U><FONT STYLE="white-space:nowrap">Non-Disclosure/Return</FONT> of Company Property and Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Confidential Information Defined</U>. Executive acknowledges that, in the course of Executive&#146;s employment with the
Company, Executive has had and will have access to, and will be making use of, acquiring, and adding to the Company&#146;s confidential and proprietary information, including, without limitation, any of the following: trade secrets; patent
applications and invention disclosures; confidential business records; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
computer software programs or any portions or logic comprising said programs; technical or <FONT STYLE="white-space:nowrap">non-technical</FONT> data, formulae or compilations; vendor and product
information; customer and prospective customer lists; information about customers, prospective customers and consultants requirements; terms of contracts with customers and consultants; research, production, programming, development, engineering,
and distribution processes or techniques; the Company&#146;s unique selling, manufacturing and servicing methods and business techniques; training, service and business manuals; promotional materials; training courses and other training and
instructional materials; methods of doing business; costs and pricing information; advertising, promotions, marketing information, or sales techniques; planning and financial information of the Company; business opportunities; business plans; target
markets; pricing formulas; financial models; working methods; profit formulas; studies; servicing plans; portfolio management strategies; and any other proprietary and/or confidential business information of the Company (hereinafter referred to as
the &#147;Confidential Information&#148;). Executive further understands that the term Confidential Information does not include any information that is in the public domain or becomes generally known or available from a source other than the
Company without a breach of any agreement with the Company and without any restriction on disclosure. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Duty of <FONT
STYLE="white-space:nowrap">Non-Disclosure</FONT> and <FONT STYLE="white-space:nowrap">Non-Use</FONT></U>. In consideration of employment by the Company, Executive agrees that Executive shall not, for any purpose whatsoever other than to the extent
necessary to render services to the Company, directly or indirectly, divulge or disclose to any individual or entity, or use in any manner or allow others to use in any manner through Executive, any of the Confidential Information, but shall hold
all of the same confidential for so long as such Confidential Information: (A)&nbsp;constitutes trade secrets; and/or (B)&nbsp;is not publicly and widely known or made generally available through no wrongful act of Executive in violation of this
Agreement or others who were under confidentiality obligations as to the relevant Confidential Information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)
<U>Return of Information</U>. Any Confidential Information furnished to Executive by the Company, used by Executive on the Company&#146;s behalf, or generated or obtained by Executive during the course of Executive&#146;s employment with the
Company, is and shall at all times remain the property of the Company. Executive acknowledges that this property is confidential and is not readily accessible to the Company&#146;s competitors. Upon termination of the employment relationship between
Executive and the Company, or prior thereto at the Company&#146;s request, Executive shall immediately deliver to the Company all such property, including all copies, remaining in Executive&#146;s possession or control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Notwithstanding the foregoing, nothing in this Agreement prohibits Executive from reporting possible violations of law or
regulation to any governmental agency or entity, or making other disclosures that are protected under the whistleblower provisions of federal or state law or regulation. Likewise, nothing in this Agreement is intended to or shall prevent, impede or
interfere with Executive from providing truthful testimony and information in the course of, or otherwise participating in, an investigation or proceeding conducted by a governmental agency or entity in connection with the lawful exercise of such
agency&#146;s or entity&#146;s functions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) The U.S. Defend Trade Secrets Act of 2016 (&#147;<U>DTSA</U>&#148;)
provides that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A)&nbsp;is made in confidence to a federal, state or local government official, either
directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made
under seal. In addition, the DTSA provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Discoveries and Inventions.</U> Executive agrees that any discoveries, inventions, <FONT STYLE="white-space:nowrap">know-how,</FONT>
and improvements (collectively &#147;<U>Inventions</U>&#148;), whether patentable or not, made, conceived or suggested, either solely or jointly with others, by Executive while in the Company&#146;s employ, whether in the course of Executive&#146;s
employment with the use of the Company&#146;s time, material or facilities or that is in any way within or related to the existing or contemplated scope of the Company&#146;s business, shall be solely the property of the Company. Any Inventions
relating to any subject matter with which the Company was concerned during Executive&#146;s employment and made, conceived or suggested by Executive, either solely or jointly with others, within one year following termination of Executive&#146;s
employment under this Agreement or any successor agreements shall be irrebuttably presumed to have been so made, conceived or suggested in the course of such employment with the use of the Company&#146;s time, materials or facilities, and to be
solely the property of the Company. Executive agrees, both during and after employment with the Company, to disclose promptly and in writing to the Company all Inventions that Executive, whether solely or jointly with others, makes, discovers,
develops, conceives, and/or reduces to practice. Executive hereby assigns and agrees to assign to the Company or its designee, without further consideration, Executive&#146;s entire right and interest in and to all such Inventions. Upon request by
the Company with respect to any such Inventions, Executive will execute and deliver to the Company, at any time during or after Executive&#146;s employment, all appropriate documents for use in applying for, obtaining and maintaining such domestic
and foreign patents as the Company may desire, and all proper assignments therefor, when so requested, at the expense of the Company, but without further or additional consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Work Made For Hire.</U> Executive acknowledges that, to the extent permitted by law, all work papers, reports, documentation, drawings,
specifications, photographs, negatives, tapes and masters therefore, prototypes and other materials (hereinafter, &#147;items&#148;), including without limitation, any and all such items generated and maintained on any form of electronic media,
authored or generated by Executive during Executive&#146;s employment with the Company shall be considered a &#147;work made for hire&#148; and that ownership of any and all copyrights in any and all such items shall belong solely to the Company.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Remedies</U>. The parties acknowledge and agree that any breach by Executive of the
terms of this Agreement may cause the Company irreparable harm and injury for which money damages would be inadequate. Accordingly, the Company, in addition to any other remedies available at law or equity, shall be entitled, as a matter of right,
to injunctive relief in any court of competent jurisdiction. The parties agree that such injunctive relief may be granted without the necessity of proving actual damages. Nothing in this Agreement shall limit the Company&#146;s remedies under state
for federal law or elsewhere. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Reasonableness</U>. Executive acknowledges and agrees that Executive&#146;s obligations under this
Section&nbsp;8 are reasonable in the context of the nature of the Company&#146;s Business and the competitive injuries likely to be sustained by the Company if Executive were to violate such obligations. Executive further acknowledges and agrees
that this Agreement is made in consideration of, and is adequately supported by, the agreement of the Company to perform its obligations under this Agreement and by other consideration, which Executive acknowledges constitutes good, valuable and
sufficient consideration. Executive further acknowledges and agrees that Executive&#146;s obligations under this Section&nbsp;8 will not prohibit Executive from engaging in other businesses or employment for the purpose of earning a livelihood
following the termination of his employment with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Modification/Reformation</U>. If any restriction set forth in this
Section&nbsp;8 is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period of time, or over too great a range of activities, or in too broad a geographic territory, it shall be interpreted to extend
only over the maximum period of time, range of activities, or geographic territory as to which it would otherwise be enforceable. If any provision or covenant, or any part thereof, of this Section&nbsp;8 should be held by any court to be invalid,
illegal or unenforceable, either in whole or in part, such invalidity, illegality or unenforceability will not affect the validity, legality or enforceability of the remaining provisions or covenants, or any part thereof, of this Section&nbsp;8 or
this Agreement, all of which will remain in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Additional Acknowledgements</U>. Executive acknowledges and
agrees that, in the event that Executive becomes subject to any other contractual arrangements with the Company regarding competition with the Company, the restrictive covenants set forth in this Agreement were executed first and shall be deemed
supplemented, and in no event diminished or replaced, by such other contractual arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <U>Successors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement is personal to Executive and without the prior written consent of the Company shall not be assignable by Executive
otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of, and be enforceable by, Executive&#146;s legal representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. As used in this Agreement,
&#147;Company&#148; shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <U>Indemnification</U>. The Company or an affiliate thereof shall indemnify Executive to
the maximum extent permitted under applicable law for acts taken within the scope of Executive&#146;s employment and Executive&#146;s service as an officer or director of the Company or any of its subsidiaries or affiliates. To the extent that the
Company or an affiliate thereof obtains coverage under a director and officer indemnification policy, Executive will be entitled to such coverage on a basis that is no less favorable than the coverage provided to any other officer or director of the
Company or Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11. <U>Section</U><U></U><U>&nbsp;409A of the Code</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Section&nbsp;409A of the Code
and the regulations and guidance promulgated thereunder (collectively &#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148;) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any provision of this Agreement to the contrary, in the event that Executive is a &#147;specified employee&#148; within
the meaning of Section&nbsp;409A (as determined in accordance with the methodology established by the Company as in effect on the Date of Termination) (a &#147;<U>Specified Employee</U>&#148;), any payments or benefits that are considered <FONT
STYLE="white-space:nowrap">non-qualified</FONT> deferred compensation under Section&nbsp;409A payable under this Agreement on account of a &#147;separation from service&#148; during the <FONT STYLE="white-space:nowrap">six-month</FONT> period
immediately following the Date of Termination shall, to the extent necessary to comply with Section&nbsp;409A, instead be paid, or provided, as the case may be, on the first business day after the date that is six months following Executive&#146;s
&#147;separation from service&#148; within the meaning of Section&nbsp;409A. For purposes of Section&nbsp;409A, Executive&#146;s right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of
separate and distinct payments. In no event may Executive, directly or indirectly, designate the calendar year of any payment to be made under this Agreement that is considered nonqualified deferred compensation, subject to Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) With regard to any provision herein that provides for reimbursement of costs and expenses or
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits that are deferred compensation subject to Section&nbsp;409A, (i)&nbsp;the right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation
or exchange for another benefit, (ii)&nbsp;the amount of expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable year and (iii)&nbsp;such payments shall be made on or before the last day of Executive&#146;s taxable year following the taxable year in which the expense
occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <U>Compensation Recoupment Policy</U>. Notwithstanding anything in this Agreement to the contrary, Executive acknowledges
and agrees that the terms and conditions set forth in Parent&#146;s compensation recoupment policy as in effect from time to time, including specifically to implement Section&nbsp;10D of the Exchange Act, and any applicable rules or regulations
promulgated thereunder (including applicable rules and regulations of any national securities exchange on which the shares of Parent&#146;s common stock may be traded) (the &#147;<U>Compensation Recovery Policy</U>&#148;) are incorporated into this
Agreement by reference. To the extent the Compensation Recovery Policy is applicable to Executive, it creates additional rights </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">for the Company and Parent with respect to certain compensation, including, without limitation,
incentive-based compensation. Notwithstanding any provisions to the contrary, certain compensation will be subject to potential mandatory cancellation, forfeiture and/or repayment by Executive to the Company or Parent to the extent Executive is, or
in the future becomes, subject to (a)&nbsp;any Parent clawback or recoupment policy, including the Compensation Recovery Policy, and any other policies that are adopted to comply with the requirements of any applicable laws, rules, regulations,
stock exchange listing standards or otherwise, or (b)&nbsp;any applicable laws that impose mandatory clawback or recoupment requirements under the circumstances set forth in such laws, including as required by the Sarbanes-Oxley Act of 2002, the
Dodd-Frank Wall Street Reform and Consumer Protection Act, or other applicable laws, rules, regulations or stock exchange listing standards, as may be in effect from time to time, and which may operate to create additional rights for the Company or
Parent with respect to awards and the recovery of amounts relating thereto. Executive consents to be bound by the terms of the Compensation Recovery Policy, if applicable, and agrees and acknowledges that Executive is obligated to cooperate with,
and provide any and all assistance necessary to, the Company and Parent in their efforts to recover or recoup an award, any gains or earnings related to an award, or any other applicable compensation or amounts, including, without limitation, annual
cash incentive compensation, that is subject to clawback or recoupment pursuant to such laws, rules, regulations, stock exchange listing standards or Company or Parent policy. Such cooperation and assistance shall include, but is not limited to,
executing, completing and submitting any documentation necessary to facilitate the recovery or recoupment by the Company or Parent from Executive of any such amounts, including from Executive&#146;s accounts or from any other compensation, to the
extent permissible under Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <U>Complete Agreement</U>. This Agreement sets forth the entire agreement of the parties
hereto in respect of the subject matter contained herein, and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of
any party hereto in respect of the subject matter contained herein, including any previous Employment Agreement between Guardian Pharmacy, LLC and Executive. Notwithstanding the foregoing, Executive acknowledges and agrees that he remains bound by
the terms of that certain Restrictive Covenant Agreement entered into between Guardian Pharmacy, LLC and Executive (the &#147;RCA&#148;), and that the terms of the RCA are not superseded by this Agreement but are in addition to the terms of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall be governed by and construed in accordance with the laws of the State of Georgia, without reference to principles of
conflict of laws. Executive agrees that the state and federal courts located in the State of Georgia shall have jurisdiction in any action, suit or proceeding against Executive based on or arising out of this Agreement and Executive hereby:
(a)&nbsp;submits to the personal jurisdiction of such courts; (b) consents to service of process in connection with any action, suit or proceeding against Executive; and (c)&nbsp;waives any other requirement (whether imposed by statute, rule of
court or otherwise) with respect to personal jurisdiction, venue or service of process. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified otherwise
than by a written agreement executed by the parties hereto or their respective successors and legal representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All notices and other communications hereunder shall be in writing and shall be given by
hand delivery to the other party or by registered or certified mail, return receipt requested, or nationally-recognized overnight courier service, postage prepaid, addressed as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>If to Executive:</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the most recent address on file at the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>If to the Company:</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">300 Galleria Parkway SE</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Suite 800</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Atlanta, GA 30339</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as either party shall have furnished to the other in writing in accordance herewith (including via
electronic mail). Notice and communications shall be effective when actually received by the addressee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The invalidity or
unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company, its subsidiaries and affiliates may withhold from any amounts payable under this Agreement such Federal, state, local or
foreign taxes or social security charges as shall be required to be withheld pursuant to any applicable law or regulation. None of the Company, its subsidiaries or affiliates guarantees any tax result with respect to payments or benefits provided
hereunder. Executive is responsible for all taxes owed with respect to all such payments and benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to any limits on
applicability contained therein, Section&nbsp;8 of this Agreement shall survive and continue in full force in accordance with its terms notwithstanding any termination or expiration of the Employment Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will
constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Executive&#146;s or the Company&#146;s failure to insist upon strict compliance with any
provision of this Agreement or the failure to assert any right Executive or the Company may have hereunder shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) With respect to any controversy or claim arising out of or relating to or concerning injunctive relief for Executive&#146;s breach or
purported breach of Section&nbsp;8 of this Agreement, the Company shall have the right, in addition to any other remedies it may have, to seek specific performance and injunctive relief with a court of competent jurisdiction, without the need to
post a bond or other security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15. <U>Other Acknowledgements</U>. Nothing in this Agreement prevents Executive from
providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding
possible legal violations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Remainder of page intentionally left blank] </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Executive and the Company have executed this Agreement on the date first
above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fred P. Burke</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FRED P. BURKE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GUARDIAN PHARMACY SERVICES</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>MANAGEMENT, LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David K. Morris</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">David K. Morris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President and Chief Executive</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Officer</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>d894834dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">THIS EMPLOYMENT AGREEMENT by and between Guardian Pharmacy Services Management, LLC, a Georgia limited liability company with its principal
place of business located at 300 Galleria Parkway SE, Suite 800, Atlanta, GA 30339 (the &#147;<U>Company</U>&#148;) and a wholly owned subsidiary of Guardian Pharmacy Services, Inc. (&#147;<U>Parent</U>&#148;), and David K. Morris
(&#147;<U>Executive</U>&#148;), is dated as of the 26th day of September, 2024 (the &#147;<U>Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company wishes to
employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive desires to be employed by the Company on such terms and conditions and for such consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In consideration of the promises provided for in this Agreement, the Company and Executive agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>Employment Period</U>. This Agreement shall become effective as of September&nbsp;27, 2024 (the &#147;<U>Effective Date</U>&#148;). The
Company hereby agrees to employ Executive, and Executive hereby agrees to be employed by the Company, on an <FONT STYLE="white-space:nowrap">at-will</FONT> basis on the terms and conditions <FONT STYLE="white-space:nowrap">set-forth</FONT> herein
for the period commencing on the Effective Date and ending as provided in Section&nbsp;3 hereof (the &#147;<U>Employment Period</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">2. <U>Terms of Employment</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Position and Duties</U>. (i)&nbsp;During the Employment Period, Executive shall (A)&nbsp;serve as Executive Vice President and Chief
Financial Officer of the Parent with such duties and responsibilities as are customarily commensurate with or incident to such position for an entity similar in size to, and in a business similar to that of, Parent, (B)&nbsp;report to the Chief
Executive Officer of Parent, and (C)&nbsp;perform Executive&#146;s services at 300 Galleria Parkway SE, Suite 800, Atlanta, GA 30339 (subject to reasonable travel requirements commensurate with Executive&#146;s position). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) During the Employment Period, and excluding any periods of vacation and sick leave to which Executive is entitled, Executive agrees to
devote Executive&#146;s full business time and attention to the business and affairs of the Company, Parent and their affiliates. During the Employment Period, it will not be a violation of this Agreement for Executive to (A)&nbsp;serve on civic or
charitable boards or committees, (B)&nbsp;deliver lectures, fulfill speaking engagements or teach at educational institutions and (C)&nbsp;manage personal investments, so long as such activities described in clauses (A), (B) and (C)&nbsp;do not
significantly interfere with the performance of Executive&#146;s responsibilities as an employee of the Company in accordance with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Compensation</U>. (i)<U>&nbsp;Base Salary</U>. During the Employment Period, Executive shall receive an annual base salary
(&#147;<U>Annual Base Salary</U>&#148;) of $400,000 paid in accordance with the normal payroll practices of the Company as may be in effect from time to time, which Annual Base Salary shall be reviewed for increase at least annually. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Annual Cash Bonus</U>. Executive shall be eligible, for each fiscal year of Parent
(beginning with fiscal year 2025) ending during the Employment Period, for an annual incentive bonus in cash (the &#147;<U>Annual Bonus</U>&#148;), with a target Annual Bonus opportunity equal to no less than 60% of Annual Base Salary
(&#147;<U>Target Bonus</U>&#148;) and a maximum Annual Bonus opportunity of no less than 150% of the Target Bonus. For each such fiscal year, Parent&#146;s Board of Directors (the &#147;<U>Board</U>&#148;) (or an applicable committee of the Board)
will establish the performance metrics and their relative weighting to be used in, and any specific performance goals applicable to, the determination of the Annual Bonus for Executive for such period. There is no guaranteed Annual Bonus under this
Agreement, and for each applicable fiscal year, Executive&#146;s Annual Bonus could be as low as zero or as high as the maximum percentage set forth in this paragraph. Notwithstanding anything in this Agreement to the contrary, each Annual Bonus
shall be on the terms and subject to such conditions as are specified for the particular Company or Parent plans or programs pursuant to which the Annual Bonus is granted. Any Annual Bonus earned with respect to a particular fiscal year will be paid
no later than March&nbsp;15 following the end of the fiscal year to which the Annual Bonus relates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Equity Compensation
Program</U>. During the Employment Period, subject to approval by the Board (or an applicable committee of the Board), Executive shall be eligible to participate in Parent&#146;s long-term incentive compensation program as may be in effect from time
to time for senior executives of Parent and the Company generally, with such participation occurring in accordance with the approval of the Board (or an applicable committee of the Board), Parent and the Company&#146;s policies, and the applicable
award agreement and incentive compensation plan under which such awards will be granted, as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Employee
Benefits</U>. During the Employment Period, Executive shall be eligible to participate in the employee benefit plans, programs, and policies, as may be in effect from time to time, for senior executives of Parent and the Company generally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) <U>Vacation</U>. During the Employment Period, Executive shall be entitled to paid vacation during each calendar year, consistent with the
Company&#146;s policies then applicable to executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) <U>Expenses</U>. During the Employment Period, Executive shall be
entitled to receive prompt reimbursement for all reasonable expenses incurred by Executive in accordance with the performance of Executive&#146;s duties under this Agreement and in accordance with the Company&#146;s business expense reimbursement
policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3. <U>Termination of Employment</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Generally</U>. Except as hereinafter provided, the Employment Period shall continue until, and shall end upon, the second anniversary
of the Effective Date (the &#147;<U>Initial Employment Period</U>&#148;). At the end of the Initial Employment Period and on each anniversary thereafter, unless the Company shall have given Executive sixty (60)&nbsp;days written notice that the
Employment Period will not be extended, the Employment Period shall be extended for an additional year. The term &#147;Employment Period&#148; as used in this Agreement shall refer to the Initial Employment Period or the Employment Period as so
extended. If the Company gives Executive sixty (60)&nbsp;days written notice that the Employment Period will not be extended, then, unless otherwise agreed by the Company and Executive, Executive&#146;s employment with the Company shall terminate
immediately following the last day of the Employment Period. Notwithstanding the foregoing, the Employment Period (to the extent then in effect) will cease on the Date of Termination (as defined in Section&nbsp;3(g)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Death or Disability</U>. Executive&#146;s employment shall terminate automatically if
Executive dies during the Employment Period. If the Company determines in good faith that the Disability (as defined herein) of Executive has occurred during the Employment Period (pursuant to the definition of &#147;Disability&#148; set forth
below), it may give to Executive written notice in accordance with Section&nbsp;14(b) of its intention to terminate Executive&#146;s employment. In such event, Executive&#146;s employment with the Company shall terminate effective on the 30th day
after receipt of such notice by Executive (the &#147;<U>Disability Effective Date</U>&#148;), provided that, within the 30 days after such receipt, Executive shall not have returned to full-time performance of Executive&#146;s duties.
&#147;<U>Disability</U>&#148; means the absence of Executive from Executive&#146;s duties with the Company on a full-time basis for 90 consecutive business days, or 90 business days during any period of 120 consecutive business days, as a result of
incapacity due to mental or physical illness that is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to Executive or Executive&#146;s legal representative (such agreement as to acceptability
not to be unreasonably withheld). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>By the Company</U>. The Company may terminate Executive&#146;s employment during the Employment
Period for any, or no reason, with or without Cause. For purposes of this Agreement, &#147;<U>Cause</U>&#148; will be deemed to exist upon: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any use or misappropriation by Executive of the funds, assets or property of Parent, the Company, or their subsidiaries or
affiliates for any personal or other improper purpose; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any act of moral turpitude, dishonesty, fraud by or felony
conviction of Executive whether or not such acts were committed in connection with the business of the Company, an affiliate or a subsidiary, if such act or conviction, in the reasonable good faith judgment of the Board, could reasonably be expected
to be materially injurious to the financial condition or business reputation of Parent, the Company, or their subsidiaries or affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any failure by Executive substantially to perform the lawful instructions of the person(s) to whom Executive reports
(other than as a result of total or partial incapacity due to physical or mental illness) following written notice by the Company to Executive of such failure and 15 days within which to cure such failure; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any willful or gross misconduct by Executive in connection with Executive&#146;s duties to the Company which, in the
reasonable good faith judgment of the Board, could reasonably be expected to be materially injurious to the financial condition or business reputation of Parent, the Company or their subsidiaries or affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) any failure by Executive to follow a material Company or Parent policy; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) any material breach by Executive of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The cessation of employment of Executive shall not be deemed to be for Cause unless and until there shall
have been delivered to Executive a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of the entire membership of the Board (excluding Executive, if Executive is a member of the Board) at a meeting of the Board
called and held for such purpose (after reasonable notice is provided to Executive and Executive is given an opportunity, together with counsel for Executive, to be heard before the Board), finding that, in the good faith opinion of the Board,
Executive has engaged in the conduct described in Section&nbsp;3(c), and specifying the particulars thereof in detail. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>By
Executive</U>. Executive&#146;s employment may be terminated during the Employment Period by Executive for Good Reason or by Executive without Good Reason. For purposes of this Agreement, &#147;<U>Good Reason</U>&#148; shall mean, in the absence of
the prior written consent of Executive: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a material diminution in Executive&#146;s duties, authorities or
responsibilities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a material reduction of Executive&#146;s Annual Base Salary or Target Bonus; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) relocation of Executive&#146;s primary workplace, as assigned to Executive by the Company in accordance with
Section&nbsp;2(a)(i), beyond a 50 mile radius from such workplace; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any other material breach by the Company of
this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that Executive&#146;s termination of employment shall not be deemed to be for Good Reason unless
(A)&nbsp;Executive has notified the Company in writing describing the occurrence of one or more Good Reason events within 90 days of such occurrence, (B)&nbsp;the Company fails to cure such Good Reason event within 30 days after its receipt of such
written notice and (C)&nbsp;the termination of employment occurs within 180 days after the occurrence of the applicable Good Reason event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Notice of Termination; Expiration of Employment Period</U>. Any termination of employment by the Company for Cause, or by Executive for
Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section&nbsp;14(b) of this Agreement. &#147;<U>Notice of Termination</U>&#148; means a written notice that (i)&nbsp;indicates the specific
termination provision in this Agreement relied upon, (ii)&nbsp;to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive&#146;s employment under the provision so
indicated, and (iii)&nbsp;if the Date of Termination (as defined herein) is other than the date of receipt of such notice, specifies the Date of Termination (which Date of Termination shall be not more than 30 days after the giving of such notice).
The failure by Executive or the Company to set forth in the Notice of Termination any fact or circumstance that contributes to a showing of Good Reason or Cause shall not waive any right of Executive or the Company, respectively, hereunder or
preclude Executive or the Company, respectively, from asserting such fact or circumstance in enforcing Executive&#146;s or the Company&#146;s respective rights hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Resignation</U>. Upon any termination of Executive&#146;s employment with the
Company, Executive shall be deemed to resign from any position as an officer, director, or fiduciary of the Company, Parent and any related entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Date of Termination</U>. &#147;<U>Date of Termination</U>&#148; means (i)&nbsp;if Executive&#146;s employment is terminated by the
Company for Cause, or by Executive for Good Reason, the date of receipt of the Notice of Termination or such later date specified in the Notice of Termination, as the case may be, (ii)&nbsp;if Executive&#146;s employment is terminated by the Company
other than for Cause or Disability, the date on which the Company notifies Executive of such termination, (iii)&nbsp;if Executive resigns without Good Reason, the date on which Executive notifies the Company of such termination, and (iv)&nbsp;if
Executive&#146;s employment is terminated by reason of death or Disability, the date of Executive&#146;s death or the Disability Effective Date, as the case may be. Notwithstanding the foregoing, in no event shall the Date of Termination occur until
Executive experiences a &#147;separation from service&#148; within the meaning of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), and the date on which such separation from service takes place shall
be the &#147;Date of Termination.&#148; Upon the expiration of the Employment Period and in the event Executive continues employment with the Company, Executive&#146;s employment will be <FONT STYLE="white-space:nowrap">at-will</FONT> and the terms
of this Agreement (other than Section&nbsp;8) will have no further effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">4. <U>Obligations of the Company upon Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>By Executive for Good Reason or by the Company other than for Cause, Death or Disability Not During the Change in Control Period</U>.
If, during the Employment Period, the Company terminates Executive&#146;s employment other than for Cause, death or Disability, including by providing notice to Executive pursuant to Section&nbsp;3(a) that the Employment Period will not be extended
and Executive&#146;s employment is terminated, or Executive terminates employment for Good Reason, and, in each case, Executive is not entitled to any amounts or benefits pursuant to Section&nbsp;4(b): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company shall pay to Executive, in a lump sum in cash within 30 days after the Date of Termination (or earlier, if
required by applicable law), the aggregate of the following amounts: the sum of (A)&nbsp;Executive&#146;s Annual Base Salary through the Date of Termination to the extent not theretofore paid, (B)&nbsp;Executive&#146;s business expenses that are
reimbursable pursuant to Section&nbsp;2(b)(vi) of this Agreement but have not been reimbursed by the Company as of the Date of Termination; (C)&nbsp;Executive&#146;s Annual Bonus for the fiscal year immediately preceding the fiscal year in which the
Date of Termination occurs, if such Annual Bonus has been earned but not paid as of the Date of Termination; and (D)&nbsp;any accrued vacation pay to the extent not theretofore paid (the sum of the amounts described in subclauses (A), (B), (C) and
(D), the &#147;<U>Accrued</U> <U>Obligations</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Subject to Section&nbsp;11(b), on the 61st day after the
Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;two by (B)&nbsp;the sum of (1)&nbsp;Executive&#146;s Annual Base Salary (without
regard to any reduction thereto) and (2)&nbsp;Executive&#146;s Target Bonus (without regard to any reduction thereto); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to Section&nbsp;11(b), on the 61<SUP
STYLE="font-size:75%; vertical-align:top">st</SUP> day after the Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;Executive&#146;s
Target Bonus for the fiscal year in which the Date of Termination occurs, by (B)&nbsp;a fraction, the numerator of which is the total number of days that have elapsed during such fiscal year through the Date of Termination and the denominator of
which is the total number of days in the applicable fiscal year; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) If Executive timely and properly elects health
continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;<U>COBRA</U>&#148;), the Company shall reimburse Executive for the difference between the monthly COBRA premium paid by Executive for Executive
and Executive&#146;s dependents and the monthly premium amount paid by Executive for such coverage immediately prior to the Date of Termination. Such reimbursement shall be paid to Executive on the first of the month immediately following the month
in which Executive timely remits the premium payment. Executive shall be eligible to receive such reimbursement until the earliest of (A) 24 months following the Date of Termination, (B)&nbsp;the time Executive is no longer eligible for such COBRA
coverage, or (C)&nbsp;the date Executive becomes eligible for group health care insurance coverage from another employer; provided, that Executive shall promptly notify the Company of any such circumstances. For the avoidance of doubt, nothing in
this Agreement (including Section&nbsp;4(b)) shall prohibit the Company or any of its affiliates from amending or terminating any group health plan. Notwithstanding anything in this Agreement (including Section&nbsp;4(b)) to the contrary, in the
event that the payment of amounts payable under this clause (iv)&nbsp;or in Section&nbsp;4(b)(iv), as applicable, shall result in adverse tax consequences under Chapter 100 of the Code, Code Section&nbsp;4980D or otherwise to the Company or its
affiliates, the parties shall undertake commercially reasonable efforts to restructure such benefit in an economically equivalent manner to avoid the imposition of such taxes on the Company or the affiliate, <U>provided</U>, <U>however</U>, that
should the Company&#146;s auditors determine in good faith that no such alternative arrangement is achievable, Executive shall not be entitled to his or her rights to payment under this clause (iv)&nbsp;or Section&nbsp;4(b)(iv), as applicable.
Further, neither the Company nor any of its employees, directors, managers, board members, affiliates, parents, stakeholders, equityholders, agents, successors, predecessors or related parties guarantees the tax treatment of any benefit under this
clause (iv)&nbsp;or Section&nbsp;4(b)(iv), as applicable, and no such party shall have liability to Executive or his or her beneficiaries with respect to the taxation of such benefits or amounts payable in respect thereof; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) To the extent not theretofore paid or provided, the Company shall timely pay or provide to Executive any Other Benefits (as
defined in Section&nbsp;5) in accordance with the terms of the underlying plans or agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as set forth in this Section&nbsp;4(a), in the
event of a termination of Executive&#146;s employment by the Company without Cause (other than due to death or Disability) or by Executive for Good Reason, the Company shall have no further obligation to Executive under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>By Executive for Good Reason or By the Company Other than for Cause, Death, or
Disability During the Change in Control Period</U>. If, during the Employment Period, the Company terminates Executive&#146;s employment other than for Cause, death or disability, including by providing notice to Executive pursuant to
Section&nbsp;3(a) that the Employment Period will not be extended and Executive&#146;s employment is terminated, or Executive terminates employment for Good Reason, in each case, within a period of two years after a Change in Control (the
&#147;<U>Change in Control Period</U>&#148;), the Company will pay and provide to Executive the amounts and benefits specified in Section&nbsp;4(b)(i)-(vi) herein in lieu of the amounts and benefits provided in Section&nbsp;4(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company shall pay to Executive, in a lump sum in cash within 30 days after the Date of Termination (or earlier, if
required by applicable law), the aggregate of the Accrued Obligations (as defined in Section&nbsp;4(a)(i)). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Subject
to Section&nbsp;11(b), on the 61st day after the Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;three by (B)&nbsp;the sum of
(1)&nbsp;Executive&#146;s Annual Base Salary (without regard to any reduction thereto) and (2)&nbsp;Executive&#146;s Target Bonus (without regard to any reduction thereto); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to Section&nbsp;11(b), on the 61<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> day after the Date of
Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;Executive&#146;s Target Bonus for the fiscal year in which the Date of Termination occurs, by
(B)&nbsp;a fraction, the numerator of which is the total number of days that have elapsed during such fiscal year through the Date of Termination and the denominator of which is the total number of days in the applicable fiscal year; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) If Executive timely and properly elects health continuation coverage under COBRA, the Company shall reimburse Executive
for the difference between the monthly COBRA premium paid by Executive for Executive and Executive&#146;s dependents and the monthly premium amount paid by Executive for such coverage immediately prior to the Date of Termination. Such reimbursement
shall be paid to Executive on the first of the month immediately following the month in which Executive timely remits the premium payment. Executive shall be eligible to receive such reimbursement until the earliest of (A) 36 months following the
Date of Termination, (B)&nbsp;the time Executive is no longer eligible for such COBRA coverage, or (C)&nbsp;the date Executive becomes eligible for group health care insurance coverage from another employer; provided, that Executive shall promptly
notify the Company of any such circumstances; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Any outstanding equity-based awards granted to Executive under
Parent&#146;s 2024 Equity and Incentive Compensation Plan (or any successor plan) (the &#147;<U>Equity Plan</U>&#148;) shall vest in full (with performance-based awards vesting at the greater of target performance and actual performance measured as
of the Date of Termination) and shall be paid in accordance with the terms of the Equity Plan and the applicable equity award agreements; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) To the extent not theretofore paid or provided, the Company shall
timely pay or provide to Executive any Other Benefits (as defined in Section&nbsp;5) in accordance with the terms of the underlying plans or agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Death or Disability</U>. If Executive&#146;s employment is terminated by reason of Executive&#146;s death or Disability during the
Employment Period, the Company shall provide Executive or, in the event of death, Executive&#146;s estate or beneficiaries, with the Accrued Obligations and the timely payment or delivery of the Other Benefits in accordance with the terms of the
underlying plans or agreements, and shall have no further obligations under this Agreement. The Accrued Obligations shall be paid to Executive or, in the event of death, Executive&#146;s estate or beneficiaries, in a lump sum in cash within 30 days
of the applicable Date of Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Cause; Other than for Good Reason</U>. If Executive&#146;s employment is terminated for
Cause during the Employment Period, the Company shall provide Executive with Executive&#146;s Annual Base Salary through the Date of Termination, and the timely payment or delivery of the Other Benefits in accordance with the terms of the underlying
plans or agreements, and shall have no further obligations under this Agreement. If Executive voluntarily terminates employment other than for Good Reason during the Employment Period, the Company shall provide to Executive the Accrued Obligations
and the timely payment or delivery of the Other Benefits in accordance with the terms of the underlying plans or agreements, and shall have no further obligations under this Agreement. In such case, all the Accrued Obligations shall be paid to
Executive in a lump sum in cash within 30 days of the Date of Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Release</U>. Notwithstanding anything herein to the
contrary, the Company shall not be obligated to make any payment under Sections 4(a) (ii)-(iv) or Sections 4(b)(ii)-(v) of this Agreement, as applicable, unless (i)&nbsp;prior to the 60th day following the Date of Termination, Executive executes a
release of claims against the Company and its affiliates in a form provided by the Company (the &#147;<U>Release</U>&#148;), and (ii)&nbsp;any applicable revocation period has expired during such <FONT STYLE="white-space:nowrap">60-day</FONT> period
without Executive revoking such Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Change in Control</U>. For purposes of this Agreement, &#147;<U>Change in
Control</U>&#148; means the occurrence (after the date of the consummation of the initial public offering Parent&#146;s common stock (the &#147;<U>IPO Date</U>&#148;)) of any of the following events; <U>provided</U>, that, for the avoidance of
doubt, the initial public offering of Parent&#146;s common stock shall not constitute a Change in Control for purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the acquisition by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or 14(d)(2) of the
Securities Exchange Act of 1934, as amended from time to time (the &#147;<U>Exchange Act</U>&#148;), and the rules and regulations thereunder, as such law, rules and regulations may be amended from time to time) (a &#147;<U>Person</U>&#148;) of
beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of voting securities of Parent where such acquisition causes such Person to own 50% or more of the combined voting
power of the then outstanding voting securities of Parent entitled to vote generally in the election of directors (the &#147;<U>Outstanding Company Voting Securities</U>&#148;); <U>provided</U>, <U>however</U>, that for purposes of this subsection
(i), the following acquisitions shall not be deemed to result in a Change in Control: (A)&nbsp;any acquisition </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">directly from Parent that is approved by the Incumbent Board (as defined in subsection
(ii)&nbsp;below), (B) any acquisition by Parent, (C)&nbsp;any acquisition by any employee benefit plan (or related trust) sponsored or maintained by Parent or any corporation controlled by Parent or (D)&nbsp;any acquisition by any corporation
pursuant to a transaction that complies with clauses (A), (B) and (C)&nbsp;of subsection (iii)&nbsp;below; <U>provided</U>, <U>further</U>, that if any Person&#146;s beneficial ownership of the Outstanding Company Voting Securities reaches or
exceeds 50% as a result of a transaction described in clause (A)&nbsp;or (B) above, and such Person subsequently acquires beneficial ownership of additional voting securities of Parent, such subsequent acquisition shall be treated as an acquisition
that causes such Person to own 50% or more of the Outstanding Company Voting Securities; and <U>provided</U>, <U>further</U>, that if at least a majority of the members of the Incumbent Board determines in good faith that a Person has acquired
beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of 50% or more of the Outstanding Company Voting Securities inadvertently, and such Person divests as promptly as
practicable a sufficient number of shares so that such Person beneficially owns (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) less than 50% of the Outstanding Company Voting Securities,
then no Change in Control shall have occurred as a result of such Person&#146;s acquisition; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) individuals who, as of
the IPO Date, constitute the Board (the &#147;<U>Incumbent Board</U>&#148; as modified by this subsection (ii)) cease for any reason to constitute at least a majority of the Board; <U>provided</U>, <U>however</U>, that any individual becoming a
director subsequent to the IPO Date whose election, or nomination for election by Parent&#146;s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (either by specific vote or by approval
of the proxy statement of Parent in which such person is named as a nominee for director, without objection to such nomination) shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any
such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf
of a Person other than the Board; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the consummation of a reorganization, merger or consolidation or sale or other
disposition of all or substantially all of the assets of Parent or the acquisition of assets of another corporation or other transaction (&#147;<U>Business Combination</U>&#148;) excluding, however, such a Business Combination pursuant to which
(A)&nbsp;the individuals and entities who were the beneficial owners of the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then
outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination
(including, without limitation, an entity that as a result of such transaction owns Parent or all or substantially all of Parent&#146;s assets either directly or through one or more subsidiaries), (B) no Person (excluding any employee benefit plan
(or related trust) of Parent, Parent or such entity resulting from such Business Combination) beneficially owns, directly or indirectly, 50% or more of the combined voting power of the then outstanding securities entitled to vote generally in the
election of directors of the entity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">resulting from such Business Combination and (C)&nbsp;at least a majority of the members of
the board of directors of the corporation resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination; or
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) approval by Parent&#146;s stockholders of a complete liquidation or dissolution of Parent except pursuant to a
Business Combination that complies with clauses (A), (B) and (C)&nbsp;of subsection (iii)&nbsp;above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <U><FONT
STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</U>. Amounts that Executive is otherwise entitled to receive under any plan, policy, practice or program of or any other contract or agreement with the Company or its affiliates at or
subsequent to the Date of Termination (&#147;<U>Other Benefits</U>&#148;) shall be payable in accordance with such plan, policy, practice or program or contract or agreement, except as explicitly modified by this Agreement. Notwithstanding the
foregoing, Executive shall not be eligible to participate in any other severance plan, program or policy of the Company or its affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <U><FONT STYLE="white-space:nowrap">Set-off;</FONT> No Mitigation</U>. The Company&#146;s obligation to make the payments provided for in
this Agreement and otherwise to perform its obligations hereunder shall be subject to <FONT STYLE="white-space:nowrap">set-off,</FONT> counterclaim, recoupment, defense, or other claim, right or action that the Company or its affiliates may have
against Executive to the extent such <FONT STYLE="white-space:nowrap">set-off</FONT> or other action does not violate Section&nbsp;409A of the Code. In no event shall Executive be obligated to seek other employment or take any other action by way of
mitigation of the amounts payable to Executive under any of the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <U>Limitations on Payments Under Certain
Circumstances</U>. Notwithstanding any provision of any other plan, program, arrangement or agreement to the contrary, in the event that it shall be determined that any payment or benefit to be provided by the Company to Executive pursuant to the
terms of this Agreement or any other payments or benefits received or to be received by Executive (a &#147;<U>Payment</U>&#148;) in connection with or as a result of any event which is deemed by the U.S. Internal Revenue Service or any other taxing
authority to constitute a change in the ownership or effective control of Parent or the Company, or in the ownership of a substantial portion of the assets of Parent or the Company and subject to the tax (the &#147;<U>Excise</U> <U>Tax</U>&#148;)
imposed by Section&nbsp;4999 (or any successor section) of the Code, the Payments, whether under this Agreement or otherwise, shall be reduced so that the Payment, in the aggregate, is reduced to the greatest amount that could be paid to Executive
without giving rise to any Excise Tax; provided that in the event that Executive would be placed in a better <FONT STYLE="white-space:nowrap">after-tax</FONT> position after receiving all Payments and not having any reduction of Payments as provided
hereunder, Executive shall, notwithstanding the provisions of any other plan, program, arrangement or agreement to the contrary, receive all Payments and pay any applicable Excise Tax. All determinations under this Section&nbsp;7 shall be made by a
nationally recognized accounting firm selected by Parent or the Company (the &#147;<U>Accounting Firm</U>&#148;). Without limiting the generality of the foregoing, any determination by the Accounting Firm under this Section&nbsp;7 shall take into
account the value of any reasonable compensation for services to be rendered by Executive (or for holding oneself out as available to perform services and refraining from performing services (such as under a covenant not to compete)). If the
Payments are to be reduced pursuant to this Section&nbsp;7, the Payments shall be reduced in the following order: (a)&nbsp;Payments which do not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
constitute &#147;nonqualified deferred compensation&#148; subject to Section&nbsp;409A of the Code shall be reduced first; and (b)&nbsp;all other Payments shall then be reduced, in each case as
follows: (i)&nbsp;cash payments shall be reduced before <FONT STYLE="white-space:nowrap">non-cash</FONT> payments and (ii)&nbsp;payments to be made on a later payment date shall be reduced before payments to be made on an earlier payment date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <U>Restrictive Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Acknowledgements and Agreements</U>. Executive hereby acknowledges and agrees that in the performance of Executive&#146;s duties to the
Company during Executive&#146;s employment, Executive shall be brought into frequent contact with existing and potential customers of the Company throughout the continental Unites States. Executive also agrees that Executive will obtain knowledge
and skill relevant to the Company&#146;s industry, methods of doing business, and marketing strategies by virtue of Executive&#146;s employment. Executive further agrees that trade secrets and confidential information of the Company, more fully
described in Section&nbsp;8(i), have been developed by the Company through substantial expenditures of time, effort and money and constitute valuable and unique property of the Company with great competitive importance and commercial value to the
Company. Executive further understands and agrees that the foregoing makes it necessary for the protection of the Company&#146;s legitimate business interests that Executive comply with the restrictive covenants, as further provided in the following
sections. Executive acknowledges and agrees that the terms and conditions of this Section&nbsp;8 are fair, reasonable, and not unduly restrictive on Executive and are reasonably necessary to protect the legitimate business interests of the Company
and to prevent irreparable harm to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Competitive Activity During Employment.</U> Executive will not compete with the
Company anywhere within the United States during Executive&#146;s employment with the Company, including, without limitation: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) entering into or engaging in any business which competes with the Company&#146;s Business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) soliciting customers, business, patronage or orders for, or selling, any products or services in competition with, or for
any business that competes with, the Company&#146;s Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) diverting, enticing or otherwise taking away any
customers, business, patronage, or orders of the Company or attempting to do so; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) soliciting any employee, sales
representative, agent or consultant of the Company to terminate their employment, relationship or other association with the Company or attempting to do so; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) promoting or assisting, financially or otherwise, any person, firm, association, partnership, corporation or other entity
engaged in any business which competes with the Company&#146;s Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Following Termination.</U> For a period of two years
following Executive&#146;s termination of employment with the Company, for any reason, Executive shall not, on Executive&#146;s own account or as a partner, joint venturer, employee, agent, contractor, salesperson, consultant, officer and/or
director of any firm, association, partnership, corporation or other entity: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Provide services the same or
substantially similar to those duties performed by Executive as Executive Vice President and Chief Financial Officer for the Company for any person or entity that competes with the Company&#146;s Business (as hereinafter defined) within the
Restricted Territory (as hereinafter defined); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Directly or indirectly, solicit or attempt to solicit business,
patronage or orders for products or services in competition with those provided by the Company, on Executive&#146;s own behalf or for any person or entity, wherever located, from any Company customers or actively sought prospective customers with
whom Executive had Material Contact (as hereinafter defined). This Section&nbsp;8(c)(ii) does not prohibit Executive from accepting as a customer any Company customer or actively sought prospective customer who: (A)&nbsp;responds to a general
advertisement or solicitation, including but not limited to advertisements or solicitations through newspapers, trade publications, periodicals or internet databases, not specifically directed at customers or prospective customers of the Company; or
(B)&nbsp;unilaterally contacts Executive in the absence of any violation of this Section&nbsp;8(c)(ii) by Executive; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)
Directly or indirectly, within the Restricted Territory, solicit or recruit, or attempt to solicit or recruit, for purposes of terminating employment, relationship or other association with the Company, any employee, sales representative, agent or
consultant of the Company with whom Executive worked or about whom Executive came to know confidential information as a result of Executive&#146;s employment with the Company, and who has not prior thereto ceased to be employed or retained by the
Company, to terminate their employment, relationship or other association with the Company. This Section&nbsp;8(c)(iii) shall not prohibit Executive from soliciting or hiring any person who: (A)&nbsp;responds to a general advertisement or
solicitation, including but not limited to advertisements or solicitations through newspapers, trade publications, periodicals, internet databases or recruiting or employment agencies, not specifically directed at employees, sales representatives,
agents or consultants of the Company; or (B)&nbsp;unilaterally contacts Executive in the absence of any violation of this Section&nbsp;8(c)(iii) by Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>The &#147;Company.&#148;</U> For the purposes of this Section&nbsp;8, the &#147;Company&#148; shall include any and all direct and
indirect subsidiaries, parents, and affiliated or related companies thereof or the Company for which Executive worked or had responsibility at the time of termination of Executive&#146;s employment and at any time during the two year period prior to
such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>The Company&#146;s &#147;Business.&#148;</U> For the purposes of this Section&nbsp;8, the Company&#146;s
Business is defined to mean owning, operating or providing business consulting services to pharmacies that offer pharmaceutical products and services to long-term care facilities, including skilled nursing facilities, assisted living facilities and
behavioral health facilities, as such activities are conducted by the Company, or the provision of any other products or services conducted, authorized, offered or provided by the Company within the two year period prior to Executive&#146;s
termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>&#147;Material Contact.&#148;</U> For purposes of this Section&nbsp;8, Material
Contact is defined to be contact between Executive and each customer and prospective customer: (i)&nbsp;with whom or which the Executive dealt on behalf of the Company; (ii)&nbsp;whose dealings with the Company were coordinated or supervised by
Executive; (iii)&nbsp;about whom Executive obtained Confidential Information in the ordinary course of business as a result of Executive&#146;s association with the Company; or (iv)&nbsp;who received products or services authorized by the Company,
the sale or provision of which results or resulted in compensation, commissions, or earnings for Executive within the two years prior to the Executive&#146;s termination from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>&#147;Restricted Territory.&#148;</U> For the purposes of Section&nbsp;8, the Restricted Territory shall be defined as and limited to:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) (A) the geographic area(s) within a 100 mile radius of any and all of the Company&#146;s location(s) in, to, or for
which Executive worked, to which Executive was assigned or had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT>
period prior to such termination; or (B)&nbsp;in the event that the foregoing definition of Restricted Territory in this Section&nbsp;8(g)(i)(A) is deemed to be overbroad or otherwise enforceable even after judicial modification, then this
Section&nbsp;8(g)(i)(A) shall mean the geographic area(s) within a 50 mile radius of any and all of the Company&#146;s location(s) in, to, or for which Executive worked, to which Executive was assigned or had any responsibility (either direct or
supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) (A) the geographic areas(a) within a 100 mile radius of any and all of the specific customer accounts, whether within or
outside of the geographic area described in (i)&nbsp;above, with which Executive had any contact or for which Executive had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time
during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination; (B)&nbsp;in the event that the foregoing definition of Restricted Territory in this Section&nbsp;8(g)(ii)(B) is deemed to be overbroad or otherwise
enforceable even after judicial modification, then this Section&nbsp;8(g)(i) shall mean the geographic area(s) within a 50 mile radius of any and all of the Company&#146;s location(s) in, to, or for which Executive worked, to which Executive was
assigned or had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U><FONT STYLE="white-space:nowrap">Non-Disclosure/Return</FONT> of Company Property and Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Confidential Information Defined</U>. Executive acknowledges that, in the course of Executive&#146;s employment with the
Company, Executive has had and will have access to, and will be making use of, acquiring, and adding to the Company&#146;s confidential and proprietary information, including, without limitation, any of the following: trade secrets; patent
applications and invention disclosures; confidential business records; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
computer software programs or any portions or logic comprising said programs; technical or <FONT STYLE="white-space:nowrap">non-technical</FONT> data, formulae or compilations; vendor and product
information; customer and prospective customer lists; information about customers, prospective customers and consultants requirements; terms of contracts with customers and consultants; research, production, programming, development, engineering,
and distribution processes or techniques; the Company&#146;s unique selling, manufacturing and servicing methods and business techniques; training, service and business manuals; promotional materials; training courses and other training and
instructional materials; methods of doing business; costs and pricing information; advertising, promotions, marketing information, or sales techniques; planning and financial information of the Company; business opportunities; business plans; target
markets; pricing formulas; financial models; working methods; profit formulas; studies; servicing plans; portfolio management strategies; and any other proprietary and/or confidential business information of the Company (hereinafter referred to as
the &#147;Confidential Information&#148;). Executive further understands that the term Confidential Information does not include any information that is in the public domain or becomes generally known or available from a source other than the
Company without a breach of any agreement with the Company and without any restriction on disclosure. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Duty of <FONT
STYLE="white-space:nowrap">Non-Disclosure</FONT> and <FONT STYLE="white-space:nowrap">Non-Use</FONT></U>. In consideration of employment by the Company, Executive agrees that Executive shall not, for any purpose whatsoever other than to the extent
necessary to render services to the Company, directly or indirectly, divulge or disclose to any individual or entity, or use in any manner or allow others to use in any manner through Executive, any of the Confidential Information, but shall hold
all of the same confidential for so long as such Confidential Information: (A)&nbsp;constitutes trade secrets; and/or (B)&nbsp;is not publicly and widely known or made generally available through no wrongful act of Executive in violation of this
Agreement or others who were under confidentiality obligations as to the relevant Confidential Information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)
<U>Return of Information</U>. Any Confidential Information furnished to Executive by the Company, used by Executive on the Company&#146;s behalf, or generated or obtained by Executive during the course of Executive&#146;s employment with the
Company, is and shall at all times remain the property of the Company. Executive acknowledges that this property is confidential and is not readily accessible to the Company&#146;s competitors. Upon termination of the employment relationship between
Executive and the Company, or prior thereto at the Company&#146;s request, Executive shall immediately deliver to the Company all such property, including all copies, remaining in Executive&#146;s possession or control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Notwithstanding the foregoing, nothing in this Agreement prohibits Executive from reporting possible violations of law or
regulation to any governmental agency or entity, or making other disclosures that are protected under the whistleblower provisions of federal or state law or regulation. Likewise, nothing in this Agreement is intended to or shall prevent, impede or
interfere with Executive from providing truthful testimony and information in the course of, or otherwise participating in, an investigation or proceeding conducted by a governmental agency or entity in connection with the lawful exercise of such
agency&#146;s or entity&#146;s functions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) The U.S. Defend Trade Secrets Act of 2016 (&#147;<U>DTSA</U>&#148;)
provides that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A)&nbsp;is made in confidence to a federal, state or local government official, either
directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made
under seal. In addition, the DTSA provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Discoveries and Inventions.</U> Executive agrees that any discoveries, inventions, <FONT STYLE="white-space:nowrap">know-how,</FONT>
and improvements (collectively &#147;<U>Inventions</U>&#148;), whether patentable or not, made, conceived or suggested, either solely or jointly with others, by Executive while in the Company&#146;s employ, whether in the course of Executive&#146;s
employment with the use of the Company&#146;s time, material or facilities or that is in any way within or related to the existing or contemplated scope of the Company&#146;s business, shall be solely the property of the Company. Any Inventions
relating to any subject matter with which the Company was concerned during Executive&#146;s employment and made, conceived or suggested by Executive, either solely or jointly with others, within one year following termination of Executive&#146;s
employment under this Agreement or any successor agreements shall be irrebuttably presumed to have been so made, conceived or suggested in the course of such employment with the use of the Company&#146;s time, materials or facilities, and to be
solely the property of the Company. Executive agrees, both during and after employment with the Company, to disclose promptly and in writing to the Company all Inventions that Executive, whether solely or jointly with others, makes, discovers,
develops, conceives, and/or reduces to practice. Executive hereby assigns and agrees to assign to the Company or its designee, without further consideration, Executive&#146;s entire right and interest in and to all such Inventions. Upon request by
the Company with respect to any such Inventions, Executive will execute and deliver to the Company, at any time during or after Executive&#146;s employment, all appropriate documents for use in applying for, obtaining and maintaining such domestic
and foreign patents as the Company may desire, and all proper assignments therefor, when so requested, at the expense of the Company, but without further or additional consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Work Made For Hire.</U> Executive acknowledges that, to the extent permitted by law, all work papers, reports, documentation, drawings,
specifications, photographs, negatives, tapes and masters therefore, prototypes and other materials (hereinafter, &#147;items&#148;), including without limitation, any and all such items generated and maintained on any form of electronic media,
authored or generated by Executive during Executive&#146;s employment with the Company shall be considered a &#147;work made for hire&#148; and that ownership of any and all copyrights in any and all such items shall belong solely to the Company.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Remedies</U>. The parties acknowledge and agree that any breach by Executive of the
terms of this Agreement may cause the Company irreparable harm and injury for which money damages would be inadequate. Accordingly, the Company, in addition to any other remedies available at law or equity, shall be entitled, as a matter of right,
to injunctive relief in any court of competent jurisdiction. The parties agree that such injunctive relief may be granted without the necessity of proving actual damages. Nothing in this Agreement shall limit the Company&#146;s remedies under state
for federal law or elsewhere. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Reasonableness</U>. Executive acknowledges and agrees that Executive&#146;s obligations under this
Section&nbsp;8 are reasonable in the context of the nature of the Company&#146;s Business and the competitive injuries likely to be sustained by the Company if Executive were to violate such obligations. Executive further acknowledges and agrees
that this Agreement is made in consideration of, and is adequately supported by, the agreement of the Company to perform its obligations under this Agreement and by other consideration, which Executive acknowledges constitutes good, valuable and
sufficient consideration. Executive further acknowledges and agrees that Executive&#146;s obligations under this Section&nbsp;8 will not prohibit Executive from engaging in other businesses or employment for the purpose of earning a livelihood
following the termination of his employment with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Modification/Reformation</U>. If any restriction set forth in this
Section&nbsp;8 is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period of time, or over too great a range of activities, or in too broad a geographic territory, it shall be interpreted to extend
only over the maximum period of time, range of activities, or geographic territory as to which it would otherwise be enforceable. If any provision or covenant, or any part thereof, of this Section&nbsp;8 should be held by any court to be invalid,
illegal or unenforceable, either in whole or in part, such invalidity, illegality or unenforceability will not affect the validity, legality or enforceability of the remaining provisions or covenants, or any part thereof, of this Section&nbsp;8 or
this Agreement, all of which will remain in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Additional Acknowledgements</U>. Executive acknowledges and
agrees that, in the event that Executive becomes subject to any other contractual arrangements with the Company regarding competition with the Company, the restrictive covenants set forth in this Agreement were executed first and shall be deemed
supplemented, and in no event diminished or replaced, by such other contractual arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <U>Successors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement is personal to Executive and without the prior written consent of the Company shall not be assignable by Executive
otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of, and be enforceable by, Executive&#146;s legal representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. As used in this Agreement,
&#147;Company&#148; shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <U>Indemnification</U>. The Company or an affiliate thereof shall indemnify Executive to
the maximum extent permitted under applicable law for acts taken within the scope of Executive&#146;s employment and Executive&#146;s service as an officer or director of the Company or any of its subsidiaries or affiliates. To the extent that the
Company or an affiliate thereof obtains coverage under a director and officer indemnification policy, Executive will be entitled to such coverage on a basis that is no less favorable than the coverage provided to any other officer or director of the
Company or Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11. <U>Section</U><U></U><U>&nbsp;409A of the Code</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Section&nbsp;409A of the Code
and the regulations and guidance promulgated thereunder (collectively &#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148;) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any provision of this Agreement to the contrary, in the event that Executive is a &#147;specified employee&#148; within
the meaning of Section&nbsp;409A (as determined in accordance with the methodology established by the Company as in effect on the Date of Termination) (a &#147;<U>Specified Employee</U>&#148;), any payments or benefits that are considered <FONT
STYLE="white-space:nowrap">non-qualified</FONT> deferred compensation under Section&nbsp;409A payable under this Agreement on account of a &#147;separation from service&#148; during the <FONT STYLE="white-space:nowrap">six-month</FONT> period
immediately following the Date of Termination shall, to the extent necessary to comply with Section&nbsp;409A, instead be paid, or provided, as the case may be, on the first business day after the date that is six months following Executive&#146;s
&#147;separation from service&#148; within the meaning of Section&nbsp;409A. For purposes of Section&nbsp;409A, Executive&#146;s right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of
separate and distinct payments. In no event may Executive, directly or indirectly, designate the calendar year of any payment to be made under this Agreement that is considered nonqualified deferred compensation, subject to Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) With regard to any provision herein that provides for reimbursement of costs and expenses or
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits that are deferred compensation subject to Section&nbsp;409A, (i)&nbsp;the right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation
or exchange for another benefit, (ii)&nbsp;the amount of expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable year and (iii)&nbsp;such payments shall be made on or before the last day of Executive&#146;s taxable year following the taxable year in which the expense
occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <U>Compensation Recoupment Policy</U>. Notwithstanding anything in this Agreement to the contrary, Executive acknowledges
and agrees that the terms and conditions set forth in Parent&#146;s compensation recoupment policy as in effect from time to time, including specifically to implement Section&nbsp;10D of the Exchange Act, and any applicable rules or regulations
promulgated thereunder (including applicable rules and regulations of any national securities exchange on which the shares of Parent&#146;s common stock may be traded) (the &#147;<U>Compensation Recovery Policy</U>&#148;) are incorporated into this
Agreement by reference. To the extent the Compensation Recovery Policy is applicable to Executive, it creates additional rights </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for the Company and Parent with respect to certain compensation, including, without limitation, incentive-based compensation. Notwithstanding any provisions to the contrary, certain compensation
will be subject to potential mandatory cancellation, forfeiture and/or repayment by Executive to the Company or Parent to the extent Executive is, or in the future becomes, subject to (a)&nbsp;any Parent clawback or recoupment policy, including the
Compensation Recovery Policy, and any other policies that are adopted to comply with the requirements of any applicable laws, rules, regulations, stock exchange listing standards or otherwise, or (b)&nbsp;any applicable laws that impose mandatory
clawback or recoupment requirements under the circumstances set forth in such laws, including as required by the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or other applicable laws, rules, regulations
or stock exchange listing standards, as may be in effect from time to time, and which may operate to create additional rights for the Company or Parent with respect to awards and the recovery of amounts relating thereto. Executive consents to be
bound by the terms of the Compensation Recovery Policy, if applicable, and agrees and acknowledges that Executive is obligated to cooperate with, and provide any and all assistance necessary to, the Company and Parent in their efforts to recover or
recoup an award, any gains or earnings related to an award, or any other applicable compensation or amounts, including, without limitation, annual cash incentive compensation, that is subject to clawback or recoupment pursuant to such laws, rules,
regulations, stock exchange listing standards or Company or Parent policy. Such cooperation and assistance shall include, but is not limited to, executing, completing and submitting any documentation necessary to facilitate the recovery or
recoupment by the Company or Parent from Executive of any such amounts, including from Executive&#146;s accounts or from any other compensation, to the extent permissible under Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <U>Complete Agreement</U>. This Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained
herein, and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party hereto in respect of the subject matter
contained herein, including any previous Employment Agreement between Guardian Pharmacy, LLC and Executive. Notwithstanding the foregoing, Executive acknowledges and agrees that he remains bound by the terms of that certain Restrictive Covenant
Agreement entered into between Guardian Pharmacy, LLC and Executive (the &#147;RCA&#148;), and that the terms of the RCA are not superseded by this Agreement but are in addition to the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14. <U>Miscellaneous</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
This Agreement shall be governed by and construed in accordance with the laws of the State of Georgia, without reference to principles of conflict of laws. Executive agrees that the state and federal courts located in the State of Georgia shall have
jurisdiction in any action, suit or proceeding against Executive based on or arising out of this Agreement and Executive hereby: (a)&nbsp;submits to the personal jurisdiction of such courts; (b) consents to service of process in connection with any
action, suit or proceeding against Executive; and (c)&nbsp;waives any other requirement (whether imposed by statute, rule of court or otherwise) with respect to personal jurisdiction, venue or service of process. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All notices and other communications hereunder shall be in writing and shall be given by
hand delivery to the other party or by registered or certified mail, return receipt requested, or nationally-recognized overnight courier service, postage prepaid, addressed as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to Executive:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the most recent address</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">on file at the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to the Company:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">300 Galleria Parkway SE</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Suite 800</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Atlanta, GA 30339</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as either party shall have furnished to the other in writing in accordance herewith (including via
electronic mail). Notice and communications shall be effective when actually received by the addressee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The invalidity or
unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company, its subsidiaries and affiliates may withhold from any amounts payable under this Agreement such Federal, state, local or
foreign taxes or social security charges as shall be required to be withheld pursuant to any applicable law or regulation. None of the Company, its subsidiaries or affiliates guarantees any tax result with respect to payments or benefits provided
hereunder. Executive is responsible for all taxes owed with respect to all such payments and benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to any limits on
applicability contained therein, Section&nbsp;8 of this Agreement shall survive and continue in full force in accordance with its terms notwithstanding any termination or expiration of the Employment Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will
constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Executive&#146;s or the Company&#146;s failure to insist upon strict compliance with any
provision of this Agreement or the failure to assert any right Executive or the Company may have hereunder shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) With respect to any controversy or claim arising out of or relating to or concerning injunctive relief for Executive&#146;s breach or
purported breach of Section&nbsp;8 of this Agreement, the Company shall have the right, in addition to any other remedies it may have, to seek specific performance and injunctive relief with a court of competent jurisdiction, without the need to
post a bond or other security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15. <U>Other Acknowledgements</U>. Nothing in this Agreement prevents Executive from
providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding
possible legal violations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Remainder of page intentionally left blank] </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Executive and the Company have executed this Agreement on the date first
above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ David K. Morris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>DAVID K. MORRIS</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>GUARDIAN PHARMACY SERVICES</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>MANAGEMENT, LLC</B></TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>d894834dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">THIS EMPLOYMENT AGREEMENT by and between Guardian Pharmacy Services Management, LLC, a Georgia limited liability company with its principal
place of business located at 300 Galleria Parkway SE, Suite 800, Atlanta, GA 30339 (the &#147;<U>Company</U>&#148;) and a wholly owned subsidiary of Guardian Pharmacy Services, Inc. (&#147;<U>Parent</U>&#148;), and G. Kendall Forbes
(&#147;<U>Executive</U>&#148;), is dated as of the 26th day of September, 2024 (the &#147;<U>Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company wishes to
employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive desires to be employed by the Company on such terms and conditions and for such consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In consideration of the promises provided for in this Agreement, the Company and Executive agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>Employment Period</U>. This Agreement shall become effective as of September&nbsp;27, 2024 (the &#147;<U>Effective Date</U>&#148;). The
Company hereby agrees to employ Executive, and Executive hereby agrees to be employed by the Company, on an <FONT STYLE="white-space:nowrap">at-will</FONT> basis on the terms and conditions <FONT STYLE="white-space:nowrap">set-forth</FONT> herein
for the period commencing on the Effective Date and ending as provided in Section&nbsp;3 hereof (the &#147;<U>Employment Period</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">2. <U>Terms of Employment</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Position and Duties</U>. (i)&nbsp;During the Employment Period, Executive shall (A)&nbsp;serve as Executive Vice President,
Sales&nbsp;&amp; Operations of the Parent with such duties and responsibilities as are customarily commensurate with or incident to such position for an entity similar in size to, and in a business similar to that of, Parent, (B)&nbsp;report to the
Chief Executive Officer of Parent, and (C)&nbsp;perform Executive&#146;s services at 300 Galleria Parkway SE, Suite 800, Atlanta, GA 30339, 5597 US Highway 98 West, Santa Rosa Beach, Florida 32459, or at such location as reasonably agreed to by the
Chief Executive Officer of Parent (subject to reasonable travel requirements commensurate with Executive&#146;s position). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) During
the Employment Period, and excluding any periods of vacation and sick leave to which Executive is entitled, Executive agrees to devote Executive&#146;s full business time and attention to the business and affairs of the Company, Parent and their
affiliates. During the Employment Period, it will not be a violation of this Agreement for Executive to (A)&nbsp;serve on civic or charitable boards or committees, (B)&nbsp;deliver lectures, fulfill speaking engagements or teach at educational
institutions and (C)&nbsp;manage personal investments, so long as such activities described in clauses (A), (B) and (C)&nbsp;do not significantly interfere with the performance of Executive&#146;s responsibilities as an employee of the Company in
accordance with this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Compensation</U>. (i)<U>&nbsp;Base Salary</U>. During the Employment Period, Executive shall
receive an annual base salary (&#147;<U>Annual Base Salary</U>&#148;) of $400,000 paid in accordance with the normal payroll practices of the Company as may be in effect from time to time, which Annual Base Salary shall be reviewed for increase at
least annually. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Annual Cash Bonus</U>. Executive shall be eligible, for each fiscal year of Parent
(beginning with fiscal year 2025) ending during the Employment Period, for an annual incentive bonus in cash (the &#147;<U>Annual Bonus</U>&#148;), with a target Annual Bonus opportunity equal to no less than 60% of Annual Base Salary
(&#147;<U>Target Bonus</U>&#148;) and a maximum Annual Bonus opportunity of no less than 150% of the Target Bonus. For each such fiscal year, Parent&#146;s Board of Directors (the &#147;<U>Board</U>&#148;) (or an applicable committee of the Board)
will establish the performance metrics and their relative weighting to be used in, and any specific performance goals applicable to, the determination of the Annual Bonus for Executive for such period. There is no guaranteed Annual Bonus under this
Agreement, and for each applicable fiscal year, Executive&#146;s Annual Bonus could be as low as zero or as high as the maximum percentage set forth in this paragraph. Notwithstanding anything in this Agreement to the contrary, each Annual Bonus
shall be on the terms and subject to such conditions as are specified for the particular Company or Parent plans or programs pursuant to which the Annual Bonus is granted. Any Annual Bonus earned with respect to a particular fiscal year will be paid
no later than March&nbsp;15 following the end of the fiscal year to which the Annual Bonus relates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Equity Compensation
Program</U>. During the Employment Period, subject to approval by the Board (or an applicable committee of the Board), Executive shall be eligible to participate in Parent&#146;s long-term incentive compensation program as may be in effect from time
to time for senior executives of Parent and the Company generally, with such participation occurring in accordance with the approval of the Board (or an applicable committee of the Board), Parent and the Company&#146;s policies, and the applicable
award agreement and incentive compensation plan under which such awards will be granted, as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Employee
Benefits</U>. During the Employment Period, Executive shall be eligible to participate in the employee benefit plans, programs, and policies, as may be in effect from time to time, for senior executives of Parent and the Company generally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) <U>Vacation</U>. During the Employment Period, Executive shall be entitled to paid vacation during each calendar year, consistent with the
Company&#146;s policies then applicable to executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) <U>Expenses</U>. During the Employment Period, Executive shall be
entitled to receive prompt reimbursement for all reasonable expenses incurred by Executive in accordance with the performance of Executive&#146;s duties under this Agreement and in accordance with the Company&#146;s business expense reimbursement
policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3. <U>Termination of Employment</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Generally</U>. Except as hereinafter provided, the Employment Period shall continue until, and shall end upon, the second anniversary
of the Effective Date (the &#147;<U>Initial Employment Period</U>&#148;). At the end of the Initial Employment Period and on each anniversary thereafter, unless the Company shall have given Executive sixty (60)&nbsp;days written notice that the
Employment Period will not be extended, the Employment Period shall be extended for an additional year. The term &#147;Employment Period&#148; as used in this Agreement shall refer to the Initial Employment Period or the Employment Period as so
extended. If the Company gives Executive sixty (60)&nbsp;days written notice that the Employment Period will not be extended, then, unless otherwise agreed by the Company and Executive, Executive&#146;s employment with the Company shall terminate
immediately following the last day of the Employment Period. Notwithstanding the foregoing, the Employment Period (to the extent then in effect) will cease on the Date of Termination (as defined in Section&nbsp;3(g)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Death or Disability</U>. Executive&#146;s employment shall terminate automatically if
Executive dies during the Employment Period. If the Company determines in good faith that the Disability (as defined herein) of Executive has occurred during the Employment Period (pursuant to the definition of &#147;Disability&#148; set forth
below), it may give to Executive written notice in accordance with Section&nbsp;14(b) of its intention to terminate Executive&#146;s employment. In such event, Executive&#146;s employment with the Company shall terminate effective on the 30th day
after receipt of such notice by Executive (the &#147;<U>Disability Effective Date</U>&#148;), provided that, within the 30 days after such receipt, Executive shall not have returned to full-time performance of Executive&#146;s duties.
&#147;<U>Disability</U>&#148; means the absence of Executive from Executive&#146;s duties with the Company on a full-time basis for 90 consecutive business days, or 90 business days during any period of 120 consecutive business days, as a result of
incapacity due to mental or physical illness that is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to Executive or Executive&#146;s legal representative (such agreement as to acceptability
not to be unreasonably withheld). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>By the Company</U>. The Company may terminate Executive&#146;s employment during the Employment
Period for any, or no reason, with or without Cause. For purposes of this Agreement, &#147;<U>Cause</U>&#148; will be deemed to exist upon: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any use or misappropriation by Executive of the funds, assets or property of Parent, the Company, or their subsidiaries or
affiliates for any personal or other improper purpose; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any act of moral turpitude, dishonesty, fraud by or felony
conviction of Executive whether or not such acts were committed in connection with the business of the Company, an affiliate or a subsidiary, if such act or conviction, in the reasonable good faith judgment of the Board, could reasonably be expected
to be materially injurious to the financial condition or business reputation of Parent, the Company, or their subsidiaries or affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any failure by Executive substantially to perform the lawful instructions of the person(s) to whom Executive reports
(other than as a result of total or partial incapacity due to physical or mental illness) following written notice by the Company to Executive of such failure and 15 days within which to cure such failure; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any willful or gross misconduct by Executive in connection with Executive&#146;s duties to the Company which, in the
reasonable good faith judgment of the Board, could reasonably be expected to be materially injurious to the financial condition or business reputation of Parent, the Company or their subsidiaries or affiliates; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) any failure by Executive to follow a material Company or Parent policy; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) any material breach by Executive of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The cessation of employment of Executive shall not be deemed to be for Cause unless and until there shall have been delivered to Executive a copy of a
resolution duly adopted by the affirmative vote of not less than three-quarters of the entire membership of the Board (excluding Executive, if Executive is a member of the Board) at a meeting of the Board called and held for such purpose (after
reasonable notice is provided to Executive and Executive is given an opportunity, together with counsel for Executive, to be heard before the Board), finding that, in the good faith opinion of the Board, Executive has engaged in the conduct
described in Section&nbsp;3(c), and specifying the particulars thereof in detail. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>By Executive</U>. Executive&#146;s employment
may be terminated during the Employment Period by Executive for Good Reason or by Executive without Good Reason. For purposes of this Agreement, &#147;<U>Good Reason</U>&#148; shall mean, in the absence of the prior written consent of Executive:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a material diminution in Executive&#146;s duties, authorities or responsibilities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a material reduction of Executive&#146;s Annual Base Salary or Target Bonus; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) relocation of Executive&#146;s primary workplace, as assigned to Executive by the Company in accordance with
Section&nbsp;2(a)(i), beyond a 50 mile radius from such workplace; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any other material breach by the Company of
this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that Executive&#146;s termination of employment shall not be deemed to be for Good Reason unless
(A)&nbsp;Executive has notified the Company in writing describing the occurrence of one or more Good Reason events within 90 days of such occurrence, (B)&nbsp;the Company fails to cure such Good Reason event within 30 days after its receipt of such
written notice and (C)&nbsp;the termination of employment occurs within 180 days after the occurrence of the applicable Good Reason event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Notice of Termination; Expiration of Employment Period</U>. Any termination of employment by the Company for Cause, or by Executive for
Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section&nbsp;14(b) of this Agreement. &#147;<U>Notice of Termination</U>&#148; means a written notice that (i)&nbsp;indicates the specific
termination provision in this Agreement relied upon, (ii)&nbsp;to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive&#146;s employment under the provision so
indicated, and (iii)&nbsp;if the Date of Termination (as defined herein) is other than the date of receipt of such notice, specifies the Date of Termination (which Date of Termination shall be not more than 30 days after the giving of such notice).
The failure by Executive or the Company to set forth in the Notice of Termination any fact or circumstance that contributes to a showing of Good Reason or Cause shall not waive any right of Executive or the Company, respectively, hereunder or
preclude Executive or the Company, respectively, from asserting such fact or circumstance in enforcing Executive&#146;s or the Company&#146;s respective rights hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Resignation</U>. Upon any termination of Executive&#146;s employment with the
Company, Executive shall be deemed to resign from any position as an officer, director, or fiduciary of the Company, Parent and any related entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Date of Termination</U>. &#147;<U>Date of Termination</U>&#148; means (i)&nbsp;if Executive&#146;s employment is terminated by the
Company for Cause, or by Executive for Good Reason, the date of receipt of the Notice of Termination or such later date specified in the Notice of Termination, as the case may be, (ii)&nbsp;if Executive&#146;s employment is terminated by the Company
other than for Cause or Disability, the date on which the Company notifies Executive of such termination, (iii)&nbsp;if Executive resigns without Good Reason, the date on which Executive notifies the Company of such termination, and (iv)&nbsp;if
Executive&#146;s employment is terminated by reason of death or Disability, the date of Executive&#146;s death or the Disability Effective Date, as the case may be. Notwithstanding the foregoing, in no event shall the Date of Termination occur until
Executive experiences a &#147;separation from service&#148; within the meaning of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), and the date on which such separation from service takes place shall
be the &#147;Date of Termination.&#148; Upon the expiration of the Employment Period and in the event Executive continues employment with the Company, Executive&#146;s employment will be <FONT STYLE="white-space:nowrap">at-will</FONT> and the terms
of this Agreement (other than Section&nbsp;8) will have no further effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <U>Obligations of the Company upon Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>By Executive for Good Reason or by the Company other than for Cause, Death or Disability Not During the Change in Control Period</U>.
If, during the Employment Period, the Company terminates Executive&#146;s employment other than for Cause, death or Disability, including by providing notice to Executive pursuant to Section&nbsp;3(a) that the Employment Period will not be extended
and Executive&#146;s employment is terminated, or Executive terminates employment for Good Reason, and, in each case, Executive is not entitled to any amounts or benefits pursuant to Section&nbsp;4(b): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company shall pay to Executive, in a lump sum in cash within 30 days after the Date of Termination (or earlier, if
required by applicable law), the aggregate of the following amounts: the sum of (A)&nbsp;Executive&#146;s Annual Base Salary through the Date of Termination to the extent not theretofore paid, (B)&nbsp;Executive&#146;s business expenses that are
reimbursable pursuant to Section&nbsp;2(b)(vi) of this Agreement but have not been reimbursed by the Company as of the Date of Termination; (C)&nbsp;Executive&#146;s Annual Bonus for the fiscal year immediately preceding the fiscal year in which the
Date of Termination occurs, if such Annual Bonus has been earned but not paid as of the Date of Termination; and (D)&nbsp;any accrued vacation pay to the extent not theretofore paid (the sum of the amounts described in subclauses (A), (B), (C) and
(D), the &#147;<U>Accrued</U> <U>Obligations</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Subject to Section&nbsp;11(b), on the 61st day after the
Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;two by (B)&nbsp;the sum of (1)&nbsp;Executive&#146;s Annual Base Salary (without
regard to any reduction thereto) and (2)&nbsp;Executive&#146;s Target Bonus (without regard to any reduction thereto); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to Section&nbsp;11(b), on the 61<SUP
STYLE="font-size:75%; vertical-align:top">st</SUP> day after the Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;Executive&#146;s
Target Bonus for the fiscal year in which the Date of Termination occurs, by (B)&nbsp;a fraction, the numerator of which is the total number of days that have elapsed during such fiscal year through the Date of Termination and the denominator of
which is the total number of days in the applicable fiscal year; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) If Executive timely and properly elects health
continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;<U>COBRA</U>&#148;), the Company shall reimburse Executive for the difference between the monthly COBRA premium paid by Executive for Executive
and Executive&#146;s dependents and the monthly premium amount paid by Executive for such coverage immediately prior to the Date of Termination. Such reimbursement shall be paid to Executive on the first of the month immediately following the month
in which Executive timely remits the premium payment. Executive shall be eligible to receive such reimbursement until the earliest of (A) 24 months following the Date of Termination, (B)&nbsp;the time Executive is no longer eligible for such COBRA
coverage, or (C)&nbsp;the date Executive becomes eligible for group health care insurance coverage from another employer; provided, that Executive shall promptly notify the Company of any such circumstances. For the avoidance of doubt, nothing in
this Agreement (including Section&nbsp;4(b)) shall prohibit the Company or any of its affiliates from amending or terminating any group health plan. Notwithstanding anything in this Agreement (including Section&nbsp;4(b)) to the contrary, in the
event that the payment of amounts payable under this clause (iv)&nbsp;or in Section&nbsp;4(b)(iv), as applicable, shall result in adverse tax consequences under Chapter 100 of the Code, Code Section&nbsp;4980D or otherwise to the Company or its
affiliates, the parties shall undertake commercially reasonable efforts to restructure such benefit in an economically equivalent manner to avoid the imposition of such taxes on the Company or the affiliate, <U>provided</U>, <U>however</U>, that
should the Company&#146;s auditors determine in good faith that no such alternative arrangement is achievable, Executive shall not be entitled to his or her rights to payment under this clause (iv)&nbsp;or Section&nbsp;4(b)(iv), as applicable.
Further, neither the Company nor any of its employees, directors, managers, board members, affiliates, parents, stakeholders, equityholders, agents, successors, predecessors or related parties guarantees the tax treatment of any benefit under this
clause (iv)&nbsp;or Section&nbsp;4(b)(iv), as applicable, and no such party shall have liability to Executive or his or her beneficiaries with respect to the taxation of such benefits or amounts payable in respect thereof; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) To the extent not theretofore paid or provided, the Company shall timely pay or provide to Executive any Other Benefits (as
defined in Section&nbsp;5) in accordance with the terms of the underlying plans or agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as set forth in this Section&nbsp;4(a), in the
event of a termination of Executive&#146;s employment by the Company without Cause (other than due to death or Disability) or by Executive for Good Reason, the Company shall have no further obligation to Executive under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>By Executive for Good Reason or By the Company Other than for Cause, Death, or
Disability During the Change in Control Period</U>. If, during the Employment Period, the Company terminates Executive&#146;s employment other than for Cause, death or disability, including by providing notice to Executive pursuant to
Section&nbsp;3(a) that the Employment Period will not be extended and Executive&#146;s employment is terminated, or Executive terminates employment for Good Reason, in each case, within a period of two years after a Change in Control (the
&#147;<U>Change in Control Period</U>&#148;), the Company will pay and provide to Executive the amounts and benefits specified in Section&nbsp;4(b)(i)-(vi) herein in lieu of the amounts and benefits provided in Section&nbsp;4(a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company shall pay to Executive, in a lump sum in cash within 30 days after the Date of Termination (or earlier, if
required by applicable law), the aggregate of the Accrued Obligations (as defined in Section&nbsp;4(a)(i)). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Subject
to Section&nbsp;11(b), on the 61st day after the Date of Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;three by (B)&nbsp;the sum of
(1)&nbsp;Executive&#146;s Annual Base Salary (without regard to any reduction thereto) and (2)&nbsp;Executive&#146;s Target Bonus (without regard to any reduction thereto); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to Section&nbsp;11(b), on the 61<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> day after the Date of
Termination, the Company shall, subject to Section&nbsp;4(e), pay to Executive a lump sum cash amount equal to the product obtained by multiplying (A)&nbsp;Executive&#146;s Target Bonus for the fiscal year in which the Date of Termination occurs, by
(B)&nbsp;a fraction, the numerator of which is the total number of days that have elapsed during such fiscal year through the Date of Termination and the denominator of which is the total number of days in the applicable fiscal year; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) If Executive timely and properly elects health continuation coverage under COBRA, the Company shall reimburse Executive
for the difference between the monthly COBRA premium paid by Executive for Executive and Executive&#146;s dependents and the monthly premium amount paid by Executive for such coverage immediately prior to the Date of Termination. Such reimbursement
shall be paid to Executive on the first of the month immediately following the month in which Executive timely remits the premium payment. Executive shall be eligible to receive such reimbursement until the earliest of (A) 36 months following the
Date of Termination, (B)&nbsp;the time Executive is no longer eligible for such COBRA coverage, or (C)&nbsp;the date Executive becomes eligible for group health care insurance coverage from another employer; provided, that Executive shall promptly
notify the Company of any such circumstances; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Any outstanding equity-based awards granted to Executive under
Parent&#146;s 2024 Equity and Incentive Compensation Plan (or any successor plan) (the &#147;<U>Equity Plan</U>&#148;) shall vest in full (with performance-based awards vesting at the greater of target performance and actual performance measured as
of the Date of Termination) and shall be paid in accordance with the terms of the Equity Plan and the applicable equity award agreements; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) To the extent not theretofore paid or provided, the Company shall
timely pay or provide to Executive any Other Benefits (as defined in Section&nbsp;5) in accordance with the terms of the underlying plans or agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Death or Disability</U>. If Executive&#146;s employment is terminated by reason of Executive&#146;s death or Disability during the
Employment Period, the Company shall provide Executive or, in the event of death, Executive&#146;s estate or beneficiaries, with the Accrued Obligations and the timely payment or delivery of the Other Benefits in accordance with the terms of the
underlying plans or agreements, and shall have no further obligations under this Agreement. The Accrued Obligations shall be paid to Executive or, in the event of death, Executive&#146;s estate or beneficiaries, in a lump sum in cash within 30 days
of the applicable Date of Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Cause; Other than for Good Reason</U>. If Executive&#146;s employment is terminated for
Cause during the Employment Period, the Company shall provide Executive with Executive&#146;s Annual Base Salary through the Date of Termination, and the timely payment or delivery of the Other Benefits in accordance with the terms of the underlying
plans or agreements, and shall have no further obligations under this Agreement. If Executive voluntarily terminates employment other than for Good Reason during the Employment Period, the Company shall provide to Executive the Accrued Obligations
and the timely payment or delivery of the Other Benefits in accordance with the terms of the underlying plans or agreements, and shall have no further obligations under this Agreement. In such case, all the Accrued Obligations shall be paid to
Executive in a lump sum in cash within 30 days of the Date of Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Release</U>. Notwithstanding anything herein to the
contrary, the Company shall not be obligated to make any payment under Sections 4(a) (ii)-(iv) or Sections 4(b)(ii)-(v) of this Agreement, as applicable, unless (i)&nbsp;prior to the 60th day following the Date of Termination, Executive executes a
release of claims against the Company and its affiliates in a form provided by the Company (the &#147;<U>Release</U>&#148;), and (ii)&nbsp;any applicable revocation period has expired during such <FONT STYLE="white-space:nowrap">60-day</FONT> period
without Executive revoking such Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Change in Control</U>. For purposes of this Agreement, &#147;<U>Change in
Control</U>&#148; means the occurrence (after the date of the consummation of the initial public offering Parent&#146;s common stock (the &#147;<U>IPO Date</U>&#148;)) of any of the following events; <U>provided</U>, that, for the avoidance of
doubt, the initial public offering of Parent&#146;s common stock shall not constitute a Change in Control for purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the acquisition by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or 14(d)(2) of the
Securities Exchange Act of 1934, as amended from time to time (the &#147;<U>Exchange Act</U>&#148;), and the rules and regulations thereunder, as such law, rules and regulations may be amended from time to time) (a &#147;<U>Person</U>&#148;) of
beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of voting securities of Parent where such acquisition causes such Person to own 50% or more of the combined voting
power of the then outstanding voting securities of Parent entitled to vote generally in the election of directors (the &#147;<U>Outstanding Company Voting Securities</U>&#148;); <U>provided</U>, <U>however</U>, that for purposes of this subsection
(i), the following acquisitions shall not be deemed to result in a Change in Control: (A)&nbsp;any acquisition </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
directly from Parent that is approved by the Incumbent Board (as defined in subsection (ii)&nbsp;below), (B) any acquisition by Parent, (C)&nbsp;any acquisition by any employee benefit plan (or
related trust) sponsored or maintained by Parent or any corporation controlled by Parent or (D)&nbsp;any acquisition by any corporation pursuant to a transaction that complies with clauses (A), (B) and (C)&nbsp;of subsection (iii)&nbsp;below;
<U>provided</U>, <U>further</U>, that if any Person&#146;s beneficial ownership of the Outstanding Company Voting Securities reaches or exceeds 50% as a result of a transaction described in clause (A)&nbsp;or (B) above, and such Person subsequently
acquires beneficial ownership of additional voting securities of Parent, such subsequent acquisition shall be treated as an acquisition that causes such Person to own 50% or more of the Outstanding Company Voting Securities; and <U>provided</U>,
<U>further</U>, that if at least a majority of the members of the Incumbent Board determines in good faith that a Person has acquired beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under
the Exchange Act) of 50% or more of the Outstanding Company Voting Securities inadvertently, and such Person divests as promptly as practicable a sufficient number of shares so that such Person beneficially owns (within the meaning of Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) less than 50% of the Outstanding Company Voting Securities, then no Change in Control shall have occurred as a result of such Person&#146;s acquisition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) individuals who, as of the IPO Date, constitute the Board (the &#147;<U>Incumbent Board</U>&#148; as modified by this
subsection (ii)) cease for any reason to constitute at least a majority of the Board; <U>provided</U>, <U>however</U>, that any individual becoming a director subsequent to the IPO Date whose election, or nomination for election by Parent&#146;s
stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (either by specific vote or by approval of the proxy statement of Parent in which such person is named as a nominee for director,
without objection to such nomination) shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or
threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of
the assets of Parent or the acquisition of assets of another corporation or other transaction (&#147;<U>Business Combination</U>&#148;) excluding, however, such a Business Combination pursuant to which (A)&nbsp;the individuals and entities who were
the beneficial owners of the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding shares of common stock and the combined
voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that as a result of
such transaction owns Parent or all or substantially all of Parent&#146;s assets either directly or through one or more subsidiaries), (B) no Person (excluding any employee benefit plan (or related trust) of Parent, Parent or such entity resulting
from such Business Combination) beneficially owns, directly or indirectly, 50% or more of the combined voting power of the then outstanding securities entitled to vote generally in the election of directors of the entity resulting from such Business
Combination and (C)&nbsp;at least a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the
action of the Board, providing for such Business Combination; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) approval by Parent&#146;s stockholders of a complete liquidation or
dissolution of Parent except pursuant to a Business Combination that complies with clauses (A), (B) and (C)&nbsp;of subsection (iii)&nbsp;above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</U>. Amounts that Executive is otherwise entitled to receive under any
plan, policy, practice or program of or any other contract or agreement with the Company or its affiliates at or subsequent to the Date of Termination (&#147;<U>Other Benefits</U>&#148;) shall be payable in accordance with such plan, policy,
practice or program or contract or agreement, except as explicitly modified by this Agreement. Notwithstanding the foregoing, Executive shall not be eligible to participate in any other severance plan, program or policy of the Company or its
affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <U><FONT STYLE="white-space:nowrap">Set-off;</FONT> No Mitigation</U>. The Company&#146;s obligation to make the payments
provided for in this Agreement and otherwise to perform its obligations hereunder shall be subject to <FONT STYLE="white-space:nowrap">set-off,</FONT> counterclaim, recoupment, defense, or other claim, right or action that the Company or its
affiliates may have against Executive to the extent such <FONT STYLE="white-space:nowrap">set-off</FONT> or other action does not violate Section&nbsp;409A of the Code. In no event shall Executive be obligated to seek other employment or take any
other action by way of mitigation of the amounts payable to Executive under any of the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <U>Limitations on
Payments Under Certain Circumstances</U>. Notwithstanding any provision of any other plan, program, arrangement or agreement to the contrary, in the event that it shall be determined that any payment or benefit to be provided by the Company to
Executive pursuant to the terms of this Agreement or any other payments or benefits received or to be received by Executive (a &#147;<U>Payment</U>&#148;) in connection with or as a result of any event which is deemed by the U.S. Internal Revenue
Service or any other taxing authority to constitute a change in the ownership or effective control of Parent or the Company, or in the ownership of a substantial portion of the assets of Parent or the Company and subject to the tax (the
&#147;<U>Excise</U> <U>Tax</U>&#148;) imposed by Section&nbsp;4999 (or any successor section) of the Code, the Payments, whether under this Agreement or otherwise, shall be reduced so that the Payment, in the aggregate, is reduced to the greatest
amount that could be paid to Executive without giving rise to any Excise Tax; provided that in the event that Executive would be placed in a better <FONT STYLE="white-space:nowrap">after-tax</FONT> position after receiving all Payments and not
having any reduction of Payments as provided hereunder, Executive shall, notwithstanding the provisions of any other plan, program, arrangement or agreement to the contrary, receive all Payments and pay any applicable Excise Tax. All determinations
under this Section&nbsp;7 shall be made by a nationally recognized accounting firm selected by Parent or the Company (the &#147;<U>Accounting Firm</U>&#148;). Without limiting the generality of the foregoing, any determination by the Accounting Firm
under this Section&nbsp;7 shall take into account the value of any reasonable compensation for services to be rendered by Executive (or for holding oneself out as available to perform services and refraining from performing services (such as under a
covenant not to compete)). If the Payments are to be reduced pursuant to this Section&nbsp;7, the Payments shall be reduced in the following order: (a)&nbsp;Payments which do not constitute &#147;nonqualified deferred compensation&#148; subject to
Section&nbsp;409A of the Code shall be reduced first; and (b)&nbsp;all other Payments shall then be reduced, in each case as follows: (i)&nbsp;cash payments shall be reduced before <FONT STYLE="white-space:nowrap">non-cash</FONT> payments and
(ii)&nbsp;payments to be made on a later payment date shall be reduced before payments to be made on an earlier payment date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">8. <U>Restrictive Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Acknowledgements and Agreements</U>. Executive hereby acknowledges and agrees that in the performance of Executive&#146;s duties to the
Company during Executive&#146;s employment, Executive shall be brought into frequent contact with existing and potential customers of the Company throughout the continental Unites States. Executive also agrees that Executive will obtain knowledge
and skill relevant to the Company&#146;s industry, methods of doing business, and marketing strategies by virtue of Executive&#146;s employment. Executive further agrees that trade secrets and confidential information of the Company, more fully
described in Section&nbsp;8(i), have been developed by the Company through substantial expenditures of time, effort and money and constitute valuable and unique property of the Company with great competitive importance and commercial value to the
Company. Executive further understands and agrees that the foregoing makes it necessary for the protection of the Company&#146;s legitimate business interests that Executive comply with the restrictive covenants, as further provided in the following
sections. Executive acknowledges and agrees that the terms and conditions of this Section&nbsp;8 are fair, reasonable, and not unduly restrictive on Executive and are reasonably necessary to protect the legitimate business interests of the Company
and to prevent irreparable harm to the Company. Executive further acknowledges and agrees that: he is executing this Agreement in Atlanta, Georgia; he reports into and routinely works in the Company&#146;s headquarters in Atlanta, Georgia and the
Company&#146;s office in Santa Rosa Beach, Florida; and he has responsibility for overseeing the Company&#146;s key pharmacy management personnel and operations across the Company&#146;s entire operations in the Restricted Territory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Competitive Activity During Employment.</U> Executive will not compete with the Company anywhere within the United States during
Executive&#146;s employment with the Company, including, without limitation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) entering into or engaging in any business
which competes with the Company&#146;s Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) soliciting customers, business, patronage or orders for, or selling,
any products or services in competition with, or for any business that competes with, the Company&#146;s Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)
diverting, enticing or otherwise taking away any customers, business, patronage, or orders of the Company or attempting to do so; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) soliciting any employee, sales representative, agent or consultant of the Company to terminate their employment,
relationship or other association with the Company or attempting to do so; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) promoting or assisting, financially or otherwise, any person, firm,
association, partnership, corporation or other entity engaged in any business which competes with the Company&#146;s Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Following Termination.</U> For a period of two years following Executive&#146;s termination of employment with the Company, for any reason, Executive shall not, on Executive&#146;s own account or as a partner, joint venturer, employee, agent,
contractor, salesperson, consultant, officer and/or director of any firm, association, partnership, corporation or other entity: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Provide services the same or substantially similar to those duties performed by Executive as Executive Vice President,
Sales&nbsp;&amp; Operations for the Company for any person or entity that competes with the Company&#146;s Business (as hereinafter defined) within the Restricted Territory (as hereinafter defined); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Directly or indirectly, solicit or attempt to solicit business, patronage or orders for products or services in
competition with those provided by the Company, on Executive&#146;s own behalf or for any person or entity, wherever located, from any Company customers or actively sought prospective customers with whom Executive had Material Contact (as
hereinafter defined). This Section&nbsp;8(c)(ii) does not prohibit Executive from accepting as a customer any Company customer or actively sought prospective customer who: (A)&nbsp;responds to a general advertisement or solicitation, including but
not limited to advertisements or solicitations through newspapers, trade publications, periodicals or internet databases, not specifically directed at customers or prospective customers of the Company; or (B)&nbsp;unilaterally contacts Executive in
the absence of any violation of this Section&nbsp;8(c)(ii) by Executive; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Directly or indirectly, within the
Restricted Territory, solicit or recruit, or attempt to solicit or recruit, for purposes of terminating employment, relationship or other association with the Company, any employee, sales representative, agent or consultant of the Company with whom
Executive worked or about whom Executive came to know confidential information as a result of Executive&#146;s employment with the Company, and who has not prior thereto ceased to be employed or retained by the Company, to terminate their
employment, relationship or other association with the Company. This Section&nbsp;8(c)(iii) shall not prohibit Executive from soliciting or hiring any person who: (A)&nbsp;responds to a general advertisement or solicitation, including but not
limited to advertisements or solicitations through newspapers, trade publications, periodicals, internet databases or recruiting or employment agencies, not specifically directed at employees, sales representatives, agents or consultants of the
Company; or (B)&nbsp;unilaterally contacts Executive in the absence of any violation of this Section&nbsp;8(c)(iii) by Executive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<U>The &#147;Company.&#148;</U> For the purposes of this Section&nbsp;8, the &#147;Company&#148; shall include any and all direct and indirect subsidiaries, parents, and affiliated or related companies thereof or the Company for which Executive
worked or had responsibility at the time of termination of Executive&#146;s employment and at any time during the two year period prior to such termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>The Company&#146;s &#147;Business.&#148;</U> For the purposes of this Section&nbsp;8,
the Company&#146;s Business is defined to mean owning, operating or providing business consulting services to pharmacies that offer pharmaceutical products and services to long-term care facilities, including skilled nursing facilities, assisted
living facilities and behavioral health facilities, as such activities are conducted by the Company, or the provision of any other products or services conducted, authorized, offered or provided by the Company within the two year period prior to
Executive&#146;s termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>&#147;Material Contact.&#148;</U> For purposes of this Section&nbsp;8, Material Contact is defined
to be contact between Executive and each customer and prospective customer: (i)&nbsp;with whom or which the Executive dealt on behalf of the Company; (ii)&nbsp;whose dealings with the Company were coordinated or supervised by Executive;
(iii)&nbsp;about whom Executive obtained Confidential Information in the ordinary course of business as a result of Executive&#146;s association with the Company; or (iv)&nbsp;who received products or services authorized by the Company, the sale or
provision of which results or resulted in compensation, commissions, or earnings for Executive within the two years prior to the Executive&#146;s termination from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>&#147;Restricted Territory.&#148;</U> For the purposes of Section&nbsp;8, the Restricted Territory shall be defined as and limited to:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) (A) the geographic area(s) within a 100 mile radius of any and all of the Company&#146;s location(s) in, to, or for
which Executive worked, to which Executive was assigned or had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT>
period prior to such termination; or (B)&nbsp;in the event that the foregoing definition of Restricted Territory in this Section&nbsp;8(g)(i)(A) is deemed to be overbroad or otherwise enforceable even after judicial modification, then this
Section&nbsp;8(g)(i)(A) shall mean the geographic area(s) within a 50 mile radius of any and all of the Company&#146;s location(s) in, to, or for which Executive worked, to which Executive was assigned or had any responsibility (either direct or
supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) (A) the geographic areas(a) within a 100 mile radius of any and all of the specific customer accounts, whether within or
outside of the geographic area described in (i)&nbsp;above, with which Executive had any contact or for which Executive had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time
during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination; (B)&nbsp;in the event that the foregoing definition of Restricted Territory in this Section&nbsp;8(g)(ii)(B) is deemed to be overbroad or otherwise
enforceable even after judicial modification, then this Section&nbsp;8(g)(i) shall mean the geographic area(s) within a 50 mile radius of any and all of the Company&#146;s location(s) in, to, or for which Executive worked, to which Executive was
assigned or had any responsibility (either direct or supervisory) at the time of termination of Executive&#146;s employment and at any time during the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to such termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U><FONT STYLE="white-space:nowrap">Non-Disclosure/Return</FONT> of Company Property and Information</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Confidential Information Defined</U>. Executive acknowledges that, in
the course of Executive&#146;s employment with the Company, Executive has had and will have access to, and will be making use of, acquiring, and adding to the Company&#146;s confidential and proprietary information, including, without limitation,
any of the following: trade secrets; patent applications and invention disclosures; confidential business records; computer software programs or any portions or logic comprising said programs; technical or
<FONT STYLE="white-space:nowrap">non-technical</FONT> data, formulae or compilations; vendor and product information; customer and prospective customer lists; information about customers, prospective customers and consultants requirements; terms of
contracts with customers and consultants; research, production, programming, development, engineering, and distribution processes or techniques; the Company&#146;s unique selling, manufacturing and servicing methods and business techniques;
training, service and business manuals; promotional materials; training courses and other training and instructional materials; methods of doing business; costs and pricing information; advertising, promotions, marketing information, or sales
techniques; planning and financial information of the Company; business opportunities; business plans; target markets; pricing formulas; financial models; working methods; profit formulas; studies; servicing plans; portfolio management strategies;
and any other proprietary and/or confidential business information of the Company (hereinafter referred to as the &#147;Confidential Information&#148;). Executive further understands that the term Confidential Information does not include any
information that is in the public domain or becomes generally known or available from a source other than the Company without a breach of any agreement with the Company and without any restriction on disclosure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Duty of <FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> and <FONT STYLE="white-space:nowrap">Non-Use</FONT></U>.
In consideration of employment by the Company, Executive agrees that Executive shall not, for any purpose whatsoever other than to the extent necessary to render services to the Company, directly or indirectly, divulge or disclose to any individual
or entity, or use in any manner or allow others to use in any manner through Executive, any of the Confidential Information, but shall hold all of the same confidential for so long as such Confidential Information: (A)&nbsp;constitutes trade
secrets; and/or (B)&nbsp;is not publicly and widely known or made generally available through no wrongful act of Executive in violation of this Agreement or others who were under confidentiality obligations as to the relevant Confidential
Information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <U>Return of Information</U>. Any Confidential Information furnished to Executive by the Company, used
by Executive on the Company&#146;s behalf, or generated or obtained by Executive during the course of Executive&#146;s employment with the Company, is and shall at all times remain the property of the Company. Executive acknowledges that this
property is confidential and is not readily accessible to the Company&#146;s competitors. Upon termination of the employment relationship between Executive and the Company, or prior thereto at the Company&#146;s request, Executive shall immediately
deliver to the Company all such property, including all copies, remaining in Executive&#146;s possession or control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Notwithstanding the foregoing, nothing in this Agreement prohibits
Executive from reporting possible violations of law or regulation to any governmental agency or entity, or making other disclosures that are protected under the whistleblower provisions of federal or state law or regulation. Likewise, nothing in
this Agreement is intended to or shall prevent, impede or interfere with Executive from providing truthful testimony and information in the course of, or otherwise participating in, an investigation or proceeding conducted by a governmental agency
or entity in connection with the lawful exercise of such agency&#146;s or entity&#146;s functions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) The U.S. Defend
Trade Secrets Act of 2016 (&#147;<U>DTSA</U>&#148;) provides that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A)&nbsp;is made in confidence to a
federal, state or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or other document filed in a
lawsuit or other proceeding, if such filing is made under seal. In addition, the DTSA provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the
attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Discoveries and Inventions.</U> Executive agrees that any discoveries, inventions, <FONT STYLE="white-space:nowrap">know-how,</FONT>
and improvements (collectively &#147;<U>Inventions</U>&#148;), whether patentable or not, made, conceived or suggested, either solely or jointly with others, by Executive while in the Company&#146;s employ, whether in the course of Executive&#146;s
employment with the use of the Company&#146;s time, material or facilities or that is in any way within or related to the existing or contemplated scope of the Company&#146;s business, shall be solely the property of the Company. Any Inventions
relating to any subject matter with which the Company was concerned during Executive&#146;s employment and made, conceived or suggested by Executive, either solely or jointly with others, within one year following termination of Executive&#146;s
employment under this Agreement or any successor agreements shall be irrebuttably presumed to have been so made, conceived or suggested in the course of such employment with the use of the Company&#146;s time, materials or facilities, and to be
solely the property of the Company. Executive agrees, both during and after employment with the Company, to disclose promptly and in writing to the Company all Inventions that Executive, whether solely or jointly with others, makes, discovers,
develops, conceives, and/or reduces to practice. Executive hereby assigns and agrees to assign to the Company or its designee, without further consideration, Executive&#146;s entire right and interest in and to all such Inventions. Upon request by
the Company with respect to any such Inventions, Executive will execute and deliver to the Company, at any time during or after Executive&#146;s employment, all appropriate documents for use in applying for, obtaining and maintaining such domestic
and foreign patents as the Company may desire, and all proper assignments therefor, when so requested, at the expense of the Company, but without further or additional consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Work Made For Hire.</U> Executive acknowledges that, to the extent permitted by law, all work papers, reports, documentation, drawings,
specifications, photographs, negatives, tapes and masters therefore, prototypes and other materials (hereinafter, &#147;items&#148;), including without limitation, any and all such items generated and maintained on any form of electronic media,
authored or generated by Executive during Executive&#146;s employment with the Company shall be considered a &#147;work made for hire&#148; and that ownership of any and all copyrights in any and all such items shall belong solely to the Company.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Remedies</U>. The parties acknowledge and agree that any breach by Executive of the
terms of this Agreement may cause the Company irreparable harm and injury for which money damages would be inadequate. Accordingly, the Company, in addition to any other remedies available at law or equity, shall be entitled, as a matter of right,
to injunctive relief in any court of competent jurisdiction. The parties agree that such injunctive relief may be granted without the necessity of proving actual damages. Nothing in this Agreement shall limit the Company&#146;s remedies under state
for federal law or elsewhere. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Reasonableness</U>. Executive acknowledges and agrees that Executive&#146;s obligations under this
Section&nbsp;8 are reasonable in the context of the nature of the Company&#146;s Business and the competitive injuries likely to be sustained by the Company if Executive were to violate such obligations. Executive further acknowledges and agrees
that this Agreement is made in consideration of, and is adequately supported by, the agreement of the Company to perform its obligations under this Agreement and by other consideration, which Executive acknowledges constitutes good, valuable and
sufficient consideration. Executive further acknowledges and agrees that Executive&#146;s obligations under this Section&nbsp;8 will not prohibit Executive from engaging in other businesses or employment for the purpose of earning a livelihood
following the termination of his employment with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Modification/Reformation</U>. If any restriction set forth in this
Section&nbsp;8 is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period of time, or over too great a range of activities, or in too broad a geographic territory, it shall be interpreted to extend
only over the maximum period of time, range of activities, or geographic territory as to which it would otherwise be enforceable. If any provision or covenant, or any part thereof, of this Section&nbsp;8 should be held by any court to be invalid,
illegal or unenforceable, either in whole or in part, such invalidity, illegality or unenforceability will not affect the validity, legality or enforceability of the remaining provisions or covenants, or any part thereof, of this Section&nbsp;8 or
this Agreement, all of which will remain in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Additional Acknowledgements</U>. Executive acknowledges and
agrees that, in the event that Executive becomes subject to any other contractual arrangements with the Company regarding competition with the Company, the restrictive covenants set forth in this Agreement were executed first and shall be deemed
supplemented, and in no event diminished or replaced, by such other contractual arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">9. <U>Successors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement is personal to Executive and without the prior written consent of the Company shall not be assignable by Executive
otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of, and be enforceable by, Executive&#146;s legal representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement shall inure to the benefit of and be binding upon the Company and its
successors and assigns. As used in this Agreement, &#147;Company&#148; shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of
law, or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <U>Indemnification</U>. The Company or an affiliate thereof shall indemnify Executive to the maximum extent
permitted under applicable law for acts taken within the scope of Executive&#146;s employment and Executive&#146;s service as an officer or director of the Company or any of its subsidiaries or affiliates. To the extent that the Company or an
affiliate thereof obtains coverage under a director and officer indemnification policy, Executive will be entitled to such coverage on a basis that is no less favorable than the coverage provided to any other officer or director of the Company or
Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">11. <U>Section</U><U></U><U>&nbsp;409A of the Code</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Section&nbsp;409A of the Code
and the regulations and guidance promulgated thereunder (collectively &#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148;) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any provision of this Agreement to the contrary, in the event that Executive is a &#147;specified employee&#148; within
the meaning of Section&nbsp;409A (as determined in accordance with the methodology established by the Company as in effect on the Date of Termination) (a &#147;<U>Specified Employee</U>&#148;), any payments or benefits that are considered <FONT
STYLE="white-space:nowrap">non-qualified</FONT> deferred compensation under Section&nbsp;409A payable under this Agreement on account of a &#147;separation from service&#148; during the <FONT STYLE="white-space:nowrap">six-month</FONT> period
immediately following the Date of Termination shall, to the extent necessary to comply with Section&nbsp;409A, instead be paid, or provided, as the case may be, on the first business day after the date that is six months following Executive&#146;s
&#147;separation from service&#148; within the meaning of Section&nbsp;409A. For purposes of Section&nbsp;409A, Executive&#146;s right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of
separate and distinct payments. In no event may Executive, directly or indirectly, designate the calendar year of any payment to be made under this Agreement that is considered nonqualified deferred compensation, subject to Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) With regard to any provision herein that provides for reimbursement of costs and expenses or
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits that are deferred compensation subject to Section&nbsp;409A, (i)&nbsp;the right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation
or exchange for another benefit, (ii)&nbsp;the amount of expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable year and (iii)&nbsp;such payments shall be made on or before the last day of Executive&#146;s taxable year following the taxable year in which the expense
occurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <U>Compensation Recoupment Policy</U>. Notwithstanding anything in this Agreement to the
contrary, Executive acknowledges and agrees that the terms and conditions set forth in Parent&#146;s compensation recoupment policy as in effect from time to time, including specifically to implement Section&nbsp;10D of the Exchange Act, and any
applicable rules or regulations promulgated thereunder (including applicable rules and regulations of any national securities exchange on which the shares of Parent&#146;s common stock may be traded) (the &#147;<U>Compensation Recovery
Policy</U>&#148;) are incorporated into this Agreement by reference. To the extent the Compensation Recovery Policy is applicable to Executive, it creates additional rights for the Company and Parent with respect to certain compensation, including,
without limitation, incentive-based compensation. Notwithstanding any provisions to the contrary, certain compensation will be subject to potential mandatory cancellation, forfeiture and/or repayment by Executive to the Company or Parent to the
extent Executive is, or in the future becomes, subject to (a)&nbsp;any Parent clawback or recoupment policy, including the Compensation Recovery Policy, and any other policies that are adopted to comply with the requirements of any applicable laws,
rules, regulations, stock exchange listing standards or otherwise, or (b)&nbsp;any applicable laws that impose mandatory clawback or recoupment requirements under the circumstances set forth in such laws, including as required by the Sarbanes-Oxley
Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or other applicable laws, rules, regulations or stock exchange listing standards, as may be in effect from time to time, and which may operate to create additional rights
for the Company or Parent with respect to awards and the recovery of amounts relating thereto. Executive consents to be bound by the terms of the Compensation Recovery Policy, if applicable, and agrees and acknowledges that Executive is obligated to
cooperate with, and provide any and all assistance necessary to, the Company and Parent in their efforts to recover or recoup an award, any gains or earnings related to an award, or any other applicable compensation or amounts, including, without
limitation, annual cash incentive compensation, that is subject to clawback or recoupment pursuant to such laws, rules, regulations, stock exchange listing standards or Company or Parent policy. Such cooperation and assistance shall include, but is
not limited to, executing, completing and submitting any documentation necessary to facilitate the recovery or recoupment by the Company or Parent from Executive of any such amounts, including from Executive&#146;s accounts or from any other
compensation, to the extent permissible under Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <U>Complete Agreement</U>. This Agreement sets forth the entire
agreement of the parties hereto in respect of the subject matter contained herein, and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer,
employee or representative of any party hereto in respect of the subject matter contained herein, including any previous Employment Agreement between Guardian Pharmacy, LLC and Executive. Notwithstanding the foregoing, Executive acknowledges and
agrees that he remains bound by the terms of that certain Restrictive Covenant Agreement entered into between Guardian Pharmacy, LLC and Executive (the &#147;RCA&#148;), and that the terms of the RCA are not superseded by this Agreement but are in
addition to the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">14. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall be governed by and construed in accordance with the laws of the State of Georgia, without reference to principles of
conflict of laws. Executive agrees that the state and federal courts located in the State of Georgia shall have jurisdiction in any action, suit or proceeding against Executive based on or arising out of this Agreement and Executive hereby:
(a)&nbsp;submits to the personal jurisdiction of such courts; (b) consents to service </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of process in connection with any action, suit or proceeding against Executive; and (c)&nbsp;waives any other requirement (whether imposed by statute, rule of court or otherwise) with respect to
personal jurisdiction, venue or service of process. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified otherwise than by a written agreement executed
by the parties hereto or their respective successors and legal representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All notices and other communications hereunder shall
be in writing and shall be given by hand delivery to the other party or by registered or certified mail, return receipt requested, or nationally-recognized overnight courier service, postage prepaid, addressed as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>If to Executive</U>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">At the most recent address<BR>on file at the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>If to the Company</U>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">300 Galleria Parkway SE</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Suite 800</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Atlanta, GA 30339</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as either party shall have furnished to the other in writing in accordance herewith (including via
electronic mail). Notice and communications shall be effective when actually received by the addressee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The invalidity or
unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company, its subsidiaries and affiliates may withhold from any amounts payable under this Agreement such Federal, state, local or
foreign taxes or social security charges as shall be required to be withheld pursuant to any applicable law or regulation. None of the Company, its subsidiaries or affiliates guarantees any tax result with respect to payments or benefits provided
hereunder. Executive is responsible for all taxes owed with respect to all such payments and benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to any limits on
applicability contained therein, Section&nbsp;8 of this Agreement shall survive and continue in full force in accordance with its terms notwithstanding any termination or expiration of the Employment Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will
constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Executive&#146;s or the Company&#146;s failure to insist upon strict compliance with any
provision of this Agreement or the failure to assert any right Executive or the Company may have hereunder shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) With respect to any controversy or claim arising out of or relating to or concerning
injunctive relief for Executive&#146;s breach or purported breach of Section&nbsp;8 of this Agreement, the Company shall have the right, in addition to any other remedies it may have, to seek specific performance and injunctive relief with a court
of competent jurisdiction, without the need to post a bond or other security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15. <U>Other Acknowledgements</U>. Nothing in this
Agreement prevents Executive from providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any
governmental authorities regarding possible legal violations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Remainder of page intentionally left blank] </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Executive and the Company have executed this Agreement on the date first
above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Kendall Forbes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>G. KENDALL FORBES</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUARDIAN PHARMACY SERVICES</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>MANAGEMENT, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fred P. Burke</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>grdn-20240925.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 9/30/2024 9:26:53 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:grdn="http://imetrix.edgar-online.com/20240925"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://imetrix.edgar-online.com/20240925"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="grdn-20240925_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="grdn-20240925_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>grdn-20240925_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 9/30/2024 9:26:53 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>grdn-20240925_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 9/30/2024 9:26:53 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="grdn-20240925.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45366581348752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 25, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001802255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 25,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Guardian Pharmacy Services, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-3627139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Galleria Parkway SE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Atlanta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(404)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">810-0089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class&#160;A Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GRDN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M.#_<" Z-ZBZ [U=*V?<3]\2B?. T_A]02P,$%     @ NH ^69^@&_"Q @
MX@P   T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"
M\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]
MDKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M
M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"D
ML<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#G
MN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/
M\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&
M,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T
M\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]P
MSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=
MD$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL
M?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG
M>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6P
MQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['
MNXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-
M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ N8 ^60=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " "Y@#Y9X+^D_.\    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " "Y@#Y9F5R<(Q &  "<)P  $P
M        @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +F
M/EDNZ8WJJ 0  'P2   8              " @0X(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " "Z@#Y9GZ ;\+$"  #B#   #0
M        @ 'L#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +J /EF7BKL<
MP    !,"   +              "  <@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( +J /ED<.&7J/P$  #P"   /              "  ;$0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "Z@#Y9)!Z;HJT   #X 0  &@
M    @ $=$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "Z@#Y999!YDAD!  #/ P  $P              @ $"$P  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  !,%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d894834d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d894834d8k.htm">d894834d8k.htm</File>
    <File>grdn-20240925.xsd</File>
    <File>grdn-20240925_lab.xml</File>
    <File>grdn-20240925_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d894834d8k.htm": {
   "nsprefix": "grdn",
   "nsuri": "http://imetrix.edgar-online.com/20240925",
   "dts": {
    "inline": {
     "local": [
      "d894834d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "grdn-20240925.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "grdn-20240925_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "grdn-20240925_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "report": {
    "R1": {
     "role": "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-09-25_to_2024-09-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d894834d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-09-25_to_2024-09-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d894834d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imetrix.edgar-online.com//20240925/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-24-228997-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-228997-xbrl.zip
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ML'3U1/,>2>#:EDE^JO)_"A>__*0=5\_.*U[>1+75$^E/GB@Q;!T&(8L;($-
M32FP_LM:VFGT>TC'ECUKW8$U$9!K-B4]=TR=,_YN*M8]<&WS+ ,]7ZZO[KJ7
MI'_7ONOV\Y=3W=-R^MW.E][5W56W3]K7EZ3[1^>W]O7'+NG<?/Y\U>]?W5P_
M:XWZ-M;X'QJ,P) -7:=(+LN=,M&KC7IS;EWQI*=K$&::'E8Q5"9A'C^),,M5
M:):FS3/!I+KV\^+FUV32>#-*1F3AZW1/-/7AIO>9G <>=2(Q-+)"5H(G!@-5
M.?6I5[C(M8(N76."1E#"#'N"$71:+PAS+ZV=SRNXKHLWXMD!\6R%V4$<];K7
M=Z37O;WIW;V\\+F=^,&$.B$)7=)G!I*? )A6(S<]HC4.S:.77Z4[)'<CA@N<
M^%9H0?_NHS&BSCTC;2,D\%IKUNKYZ]P7=M$,PM7TF.?Z(3E4O\$,MV'5(6$/
MT)+X_#4SCUKYSI(2$[?<EGJB$4^$VXHR(VR9,, 8NH],.IO!BIB3E"=@E?:9
M!RT&S!<4H#>*!,=:E#%OPF7;PD6O;X/\<HE)>+8]=F\%&,T(K^'-,W3/<>'B
MXX3ZI@4J\'9$@<2,&3"G_V"!55\D5XY17D$TF\F0ZC: <]A]I" K$"C(DGX$
M#$(#$GC,0-_)))9#K# @(%V 0_UYV?=&[-G$_@RX')R'=& S8C#;1A,*8[J%
M:H'_]JAIJM]R)KE3P[5MZ@6LI?Y83B DO4 !"ZU:_5E"KE65JVQ5E6,(Z_+Y
M?\VTMUFK_XR!@>2+!^:'ED%M"52QT?E&LK>^7F^UQ(76R6'.*W*)OGKKT7M6
M&OB,?L78K66R%GUP@0C6AH[&T9.:D23HA:0(IL5)A<QM - .HBAI'\^SYTI)
M!1+$]4%'<I'4#T%Q==R)$_JSCFL^2PEBO!=C&R'S?/<!ITUKP1/0X<RF4]".
MN:9U:*Z#_8C$YYOO!)Q/]D8$O#]8-H-WH/J?H15.,2JEE>JZ?IIA,TC@?;\P
MO*./5S($9W"@/1N@37#Q3DJU8_U$JS77@.@.Q,'I=J3!4S7_5OSU0RY B.L3
M-QPQG_P?^!"!:7%?9R.S1-O!XL 2L9+"[DBHUY?@CY=%4L<=CZT@> TX06E(
M!/?^L.BXZO5)=^S9[HSY+XZ0M%PEUVXYQ@L7>O ?M"&_48N4^S?/,4D;U:T8
ME?7F=VU4MDW39T$@__<)G"SMZ<JY62U<U*I5\I':-LQ&R2WUOTXIN,'=71F.
M&1#YH;"E/P-;6N&B/P&3CIQ6JV_XB;:R%11UX,\;_\Z=.L] D%ZX:(<V=4(Z
MCYYB?HPTM0QNY=WXM^#76;S89F=>8K-6N/C(7 #OPF)?RL'9*D)O7=B[_;^6
M]R1O.P93'45D;8GK\JI]EA6@/)3 PEBBYP/%61ZU"7MDQB2T'C#$.,1HZ-%K
M=GD/ <<$D7RT@)(,BVJS?,I68K9QQ/J7GTYU[>0L ##8S!NY#B,.M]"+Z#_9
M$S3*" 6J 7(%DLF7&2BMVM#NF;3= .C5J_6CQ?*H)X<1/KF O5O<VG,C!\WC
MPL6I5BU5JZ?YS/>,7-E6<'OMAJ3M>3;0+!#:<_(#V_%X/H#\9[[,#_A<'<!/
M*K@<J&Q(1,81.!+U"[%IH#)Y;UF"7>3;5U%9X:(S8L97$HX8H1YH:A##&.@9
MN(]DP&QWBCC#EXC9U7S)JRDX;Y"A9:,XL0*0+2%S3,!YZ +:QQ,[I YS)X$]
M(P&P8S"<\1ED!W< X!(^JBNF3F29)C .T),S4^^&X">Z4^R'5H:%H8^@E4M)
MC:=ZL5OU4B/7-'97%_WB.;]Y+?5>R'1(?S[+U&IY$O0_OA4"OC"4-'%DM"!X
MMB$X<%U[ &Z>&P)E):7L"<*[>5*OGRT*V36<@R2>21JUY-D2>*X:LG A80/
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M6W0<B6+<RQWP+VRQ3VV$I0,:]%]^N1@Y6]ER# D]&IDSQ[_<D0.._5=@%NJ
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MH='2"VRZGT;<IT6Z2>G\'9*8>[P^6+AM^/F"1R7G&%J'6"$EW#D4D@'I1"V
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M/Q/E_X"#S*,PUC;(1Y\OZ$9QJ2NHT/N9T']W1@1>EL7!,2J)&FR:QB6H,:)
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M2(+0RF(G$;%A3%)0M;\#/I2?B!$1<)-[3F1DQ!  (96<A)AAI?RVNXV29V*
M,L<JE=1GS36F'X1LXP&F@0- 9# :!<!'QEA?+$HXL:#1 :,C.-(A,0>J*.^V
M?=C9?4+<]@DV3D$E!CR9B.,?PV&*>*@:!IF%*&0KJB+%D3:<?D$+4K4]EVQK
MM':SR<\E6Q1+=$NI4&=$4R*W)?#:-=J!<]9AZ+'@]; BJG5<F9X'V3UP1Y6
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M*SMI'I_<E] L-*]';SGUX9.@FNV5>PI&-G$WB@"I> 1_N'&NTJ#3(7F9-@Y
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M+Q$4K8M(M+W2/SII$\)P$,\/5JWS@7N.VU ]JE;D<(21SNMZF'MP8]JD+(A
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MR"L^O%E1TB?@]W I21GAW\)@D91)FD<S^&)0)35^K%[P-]S#ITF5EO1F(..
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MQ@/=1O@%U#I6>A\GG^(DF58DVENC1/PC\&K"#53[R"&UZ0@FQ87 L;7VH)/
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M2S<$7Q%TM$%0>?%98CO">H44&@OU_FG00BVQ[+ ?4LDPI_&(9)H$1;] I-V
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MLB\W(RS;;]H!E[\[_B?\\O?S-Z^?_S]02P,$%     @ NH ^6<GB[H;'3@
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M%]^.CH.-1/4<K],D W$"YSJ;92EOH@ZNQ]^+2;UZ=N^7P6MRX+ZU#U<MN"O
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MV%!!P0*:,$6]$CSPI$P6M5T96LKXUFF&/F1>!)A"0.90DSL\A*T@<I@KLFZ
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MB&!STZ?(:QH<A;Z!"(!GM"UD2'ODR*S2!MZ[2%@[NEBPGLX'PC',_? @.06
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MPBU0/V5KF&O1<+WGRL-CXF\NH93]_6>8]\>E[ZCWF/\TXG")?\ ^A0E?<^&
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MP[2] 3^G[/&5] I&EF3_,-4,8)$S/,EEO+!N08"?8?UPACDZS 4*FG1E/_/
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MBKX]5IT_H_YOL&ORI-M902]5'?J*%=1L2X!,.N[]!1<_GGTZW/L_4$L#!!0
M   ( +J /EF0@XTXC$L  %+/ 0 0    9#@Y-#@S-&1E>#,R+FAT;>U]ZU,;
M69;G=R+X'S+<,1,0(;L,=E7YU8[ @*O8<6$/4%7;N[$?4M(5RBXI4Y.9 JO_
M^CW/^\I,(8P-6,U$QY21E#?OX]SS_)USWOQZ]MN'MV]^/=P[>+NY\>;LZ.S#
MX=O#__WXV9/=-S_P7_#Q#_)]\N;=QX-_).]^V?_XX>/)WQ_]^>O1V>&CY/3L
M'Q\.__YHDN7F\=ADY^/ZU7%13M/)H[?)Y@8\OV_RVI1OWQP<_:$_OLR&]?C5
MBR<_9OFC))UDYSD,8$;U(WK-)_W9-"W/L_QQ7<Q>/9W5KQ/YNU_4=3'ECT9%
M7C^NLG^95SON[U$ZS2:+5V?9U%3)L;E,3HII"F_:^W#TR_'?'Y4XR4=OW[Q[
M>_AYG/6S.H$%)V]^>/?VS0^?WGKO]P;?A<&CZ31F\^CM?^;]:O8:1X%U?VK;
MFITG3U<8Z76_*(>FU$]V9I^3JIADP^1O3^G__#<E[2]Z=O6+=J_W(G])WKBT
M-5_K: 9$*W0VO_R^=W)PM'><?/IU[^2WO?U_)*>')W\<[1^>]I*CX_TG]L!N
M>5Y[OQT>'QP>)'O'!\G)X>G9WAG\\>X?'_;^/+V3*>U5R=ZPF-5FF*3Y,#D<
MC<R@SBY,$A''-[I,.HTBAT7CZM^]E?^<&IC4M&]*)J'='WO)[M/=Y_&\;G#)
M.DC_Z]^QKMO\32[9#\ H80.%;0)#I/^]F255O9B8D*#,M'&0^-$L/3>/^Z5)
M_WK<-Z.B-*_2R66ZJ( EO_EAAB_Y]20Y/?H_L)QGCW1<8NNO_O:2_N]1\N?1
MP=FO?W^T\_3I?]C#WC\\/CL\N;>,W;NE9WOO/APF']\G^Q]ARL=G[7?S)K2'
M I->LG_XX</II[W]H^-?_O[HZ2/Z^]/>P8'^'6SDNX\G!X<G]+G,@3]Y#+O_
M8>_3Z>$K_<?2)<?[T]@"/"":XLE;^<>!3N3Y?\ ._7!VX+[X0Q[FE;H9ZP_#
MYW=O^/R+EU\XP/)_P_\[X0].=&N]:Y#E53:$:W!1P+U;>6M?X)FWS]&2@EO?
M_?[%E;^#JX)T#!_LQN2D&QHQLB=/@?1B7O8)-GW%^=*1.4K]:L=&-R)^/]QJ
M;XD_/GI[>O9Q_[]^_?@!;M]I\MOAX1E<V-,OV<?CCW^>['U:X6#:?QBII3O7
M&[J%[+V-\/;AU\.C7WX]@^L77DKWL7_^7^,GSQ]]NXO9><)O__-O+W9>_OA:
M_O-E%\<-]/+USI,;C.&)O"04+DFKT)./4&+2[4)97IO/->S2$&[BJ\?ZX76D
MXUO\@'3#3Y-T8))BE/QF3)WEYQ4*LG6@^&](3S>GH-WOGX+V\GR>3A[(YC;)
MYMGW3S:G,S/('NCF=NGF^?=/-\=%G86"ZG6R-_QG,2_S*8SZ0$:W0$8_?O]D
M=)17P(#JHKPGC&=WO2GFI^^?8OY[7I3SZ0.UW *U_/S]4\L?!<JFU\FGLOB<
MF0<F<QMD\^+[)YN/Y7F:9_]*ZZR ;=LO\N%\4-\_JWS-">GE]T](3DT^K8O!
M7^-B,C0E<J-94:63>T)&S]:4C':>KA,!'60E:<K)<3'-<F)-]X1^?EQ7^ED#
MQ_+><)@AJ:03Y#H7685DDYR828IR+*F+I!Z;I)U-O9M766ZJBAS32GZ;&_>.
M_EZL*_VM@5OZQ R*$J@GK>^+]KWS=%W)90W<T1^RJH[84)4<YG563\P0N148
M=.:>T-&WCP('L7#_;?<FEAO,\.#HY'#_[./)?8C0/X3H[XP-K4%T8V]>CXLR
MJQ=KPVKN*:VL00CC>(X VEYR.$%0;Y&3MGQFRNE]T7?6EGC6()H!_YPLDGW8
M6@2'JXU5C;,96UU_I(,T']P;S_7ZTM(:Q#I.S+2X2"?WA%+6U3>]LP;AC1-3
M9>?LPGF@EF]++6L0PS@QY_-)6MZSV-?:DLSN&D0M[BFJ<&U)9@T"%?<)U[.^
MA+(&$85/:5EG@VQ&ZDN2Y9;))/U%@CIP;9+]8CJ=Y]G@/D6IUI>HUB#N@ 23
MU;6Y-X;VVA++&GB'@5AF)J_ND_VTKA">W35P$)_,)_>&K:PMG:R!+WA_G&8E
M_ OCWPC*>5>DY?"!;KXMW:R!WW>/PTZ@_?Z>IWDV+>850I8K&-''#7[/+ A^
M_ -5\L#GDC>SCB(EC2U/_*U\T5F9YAO7.MG*MA.I1[*YOK5C[F7UF&\_CZT!
M_#[+YV:X[=4G^RH4*D4W'BK8?,'S#Q5L[N075_[NWZV"S?'',ZR']YW*W7#+
M'A!Q7ZADKD'(^!>3FS*=3.X+(NY>&R1?K<#1[AJ$C_],LPMS;ZR/Y]^8"^[\
M=#5J._C-W<.V/[Y_#R+J7J"VO_7I/,BH+E[Q; U0!_=-1MV<FN\IK:P!W. >
MQG#6EES6 '1P.A\,3%4]$,LW)Y8U !/8["%.G)[7]P>_?_-4_37+6:0*P_\6
M!_.@^79PG'5 I)BRSD:(=ULC3G-/R64-$"EG99I7(U,^D,JW)94U *5\**JZ
MA^48)B9/BC(Y,%5=%@LS3-:2YZR9=G-T?'#XV_'1^Z/]O;.CC\?_%D?TH.=T
M<*,U@#J=(!5A&9@C&&6:,_NY/T;YV@JR-0A@6M+9&UZD^<!,!1YW^!G]@/=&
MA/VTKB2T!I',??BR3 =U0K3T0#'?EF*>KT%$BID.<!F15[4QR(+>E5A[\72>
MW9<^"6M+0VL0J7KS_N/QF07@CH&&'E>S=&!>Y<5EF<ZP1&S^^/#S8#*OL@LJ
M684/O$6JNU=\ZN=UI;$U"&\=Y=6\1*WH@5:^+:VL073KN$@.YK.)6%[(9CZE
M"]2FUX?1K)D7Z)?#X\.3O0__%D?SX/WIX#QK$.5ZGU6#=)+\PZ3W)7*QMG)J
M#8)<)V:2H4J3_#X#,?6N*/ZJ>LF)F15ES;45N33Y^DBM>TI*:Q $VP/U9OB]
MJSB;WWD.[;]%$NTMIM#^WMY='1;_^[(TVIW=CLGXU^SY?USSANT\26!"R[I@
M__[V2;(WF213K?8$WU9^EX#+#+[MFV1L)L,DK9-J/A@GM8XXPQ%[\*-ZG%$@
M&_]5S&NJM'!:IS6^;G/CP$S2R[2$7Z85+'*! PZE6J898HY]::IB,E?3Q]9I
M"#+MDRW\_#__MO/\Y]=OWKU]<_16:CD<O<448?SBQ>MM?.27.7P.8BKY-$[+
M:3I8)*>FO,@&!F3543YX O-(=$X)B"N07FQV-=Z @.8T7T3OZ"6CLICR-F"O
M%_QO4?:P;!8.D/8KDP]XZ:E=J%03L&OKZ5^M%2I:IB(_:ZRWA-4-2E.GY4*'
MD&DW![&_;*P(C[.JZ3QD&;EM7X-_"84\P:XV>,KPVWQ(S6[@2[SHYP7\U<,_
M-S=X"7#2M"<9J 9PO'#FH&K"ZV$G>K M<&&F60X[. :Z2O4%[10(<_&I$-<F
MM-<':D.2 N%<FW1H?P6;.S5I3A1=<OVR05"_#&>6#E!9(7T&UX0;B=\Q*][=
MV=E*MW7]D@8!6^O(Y4-ZJ5\3L6]N(+TJ834V_^"7_0^-?:_F_7_"6Y&.Z&Z=
MST''F&"'(+YA93$PPWF)?U8>>>"2TV$!@J1!BD^2L^!G6.O:3'K)K*AJ4-J0
M5/&^#<8P[H2> MH#[7^2F1*_F\!*RF2(EY?VN30763&O)HM$GX$SX+[H\.N*
MBU)N;G2<WY.D6Z1]&ZZW2UROT;F=6%VN,^^BMFJ<MC \V8RA<#YE8IL;JW&Q
MEB/:JV'+8>3ETZ'KU'(=S(1(9HQ72KDC30\A:!A+HUD7\(,2+HCVF^)I T7-
M3#DA)MPOBSG&4EA4A_?\UJ75,SJW9I%3.CBEL\Z#@P4PN<[A?E9$Y/)/*W+
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M^L!CX6T /LHR=!.J"IP(P0-X6?1;>C#$$[7%P73'[3JZ]EPSW@,D(>?1<52
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M#E^]5^%F8,%,76^&<:_VG]@MJ)P:Q'XF>S9!R*O=T621L'#22XNMQP5.0K1
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MAB-2=D#;^7069>?.<,+@#2S'1)T'V]$LK:))<!@55::*,M@-@[V];7AR!J_
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M&:TC[D/6ZQ-5@H10"C23*;)35$JT'DZ::.XZ(PM21:93U->5(;<6C7*)YO9
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M42Q07] I6)+ODJ.HP[KS6B<O^0'&E5?'@[U.Y' &XQ >*1'A%$\=S68PAPO
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M*^F(EB&:@&61G,M-',VS"N*3YU9&4\5]D"NM!9H([4;41>D\A!5JT\@.5IA
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MY1SSEU)%;8SY#J(YU.)UET=[%R@;3EYAPR_ 6?6HI*>L&%,"-=7J,?@MUHZ
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MV<2[RF GY1Q960A=OL5\[;)*E,>:Y?#@2M#13=R:J3MH;Y&('=YD"<7A)-P
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MX]:5KE)A<;6PAM(Y0V]KSB$![53F$PL[8@%,/@F$%S"/-WZ_%-W_9%D,E0@
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MBT!:!7094'5 %W)?-S3J8&<)<90--]@O>+#2+Q(3Y< 6\-V<EJ V-L[WC[G
MNZ^#!&PN#%K9F5#\-HM46O:*@^$=$92'-2^X)<DM@VFVPBN",% U"&(SFY;
MN\ VV+J18^O^,5;&'\F,ZM\(6?S!7U@3;<YM=5U<8H27Q[BOBDUZN(OBIPJ@
M2R MB9OHV[ BMFX> ^1K%G"QY"*Y+W@?J\$9\Y5:D6_'/*S)]0&I5C&WL\FM
M4]R'P$(>=R9V"D)2$;*2H&LB#<E7\&68F>/-80S1%8W(A]5B2D2]B2GFM3H>
M!@/<?-P=_.=:N)1K=4CED8#&[M= KU73&*!._,UUJ!9+](&F3X*.H;94I%6$
M#UGC%L'N<%<*XY*N2L%N+5SN&[5B&((C_&",Q'D8*@,R^^^&,M*O-PY&@59'
MH<H2/Q#H/@*EHKCX9_JO\PW0E>"68:UC&K-A0/\(+\V@/W!%?_#BT!_8HC]H
M OW!UT-_LN:-H8]DPQK]2B^(Z(_5YJV8\#4["OQB^DO WF#'!/U3&!KRSR4;
M EZ7 2Y %\*%'=M %>IV+A Q3WX?OA5W@C]2%M2\K5.F\1* +S-FHOY9+!KZ
M1MV&^$]O;"AT\FJX0]"(E:I)J.$'<1SNN(S]Z&^ZK'^/TZSP$D;!;,HT"#N1
M:&-@4&UH"-)*H$IAWK=LSD;5 %A[<7SOBS8HB%\'^-V<MM[C8FJ<[Q]S>B_+
MG@X2N,GKO%;&X12_SYUWJ5@VZP:B?@=Z=#?GK.;]\OV\EH L-<#-QUW -&LA
MP9F(0Z*.==^PF7Z+D-9IV@W4/P2-8\+&?+%8L>Q^I+2EM22Y)62KK?"*(!=X
M*P21",XJP&X)9XH;;+R(<MWNW7"^YQ$-:$S9[+U:<0OJ1[8LFS); KG"!"^+
M<$&X3 V)WR=YR/6=X6VJY2*YM?IVP_9.$#T?1&&1O!-2?Q1,W#X\V"\<JA1:
MPMC"%#\4Z8+U(54DO%49*-:!M! DE9Q!;]I$$?@CG:"B?RWEB@CW 3#HO(PQ
M*#=H'H:]>,21*-%N:C#2<HW.1T..*J>DEBW'Y0T)5FH]M>T/IA,:1];W./;S
MVEK:E!G@YN-.RQJC%M:B)A,'I0Z)O/N:II%^=U8T-9IV W4B?/UW%>ZWBRFW
M7H(_2VH)47/KW'#0!4Z#$!*9F3*DTLY4-M!H$4G;;G&NFY>;8*[<DCH?9C#G
MMGS]-!KAY3$8U]%]/>QK:5X!Y\,,S?5MO*9:-H_Q?.]R0<1,3<VO@J_CN5J,
M+'U6\U/K)1*M/N&KML4/AKH_XZN016(]>S"6%X*T$F2ED)[Q-6C#\)"OMA>4
M$=BH5PXFJ;Z;F'XBKB;_AOQVX2\WQ*OC$+ OT41F?@-/9;*/,6(!WY !$^TV
M+HH[;M26_E-:V2Z:_D$IM>=_4$L#!!0    ( +J /EF4S!M3 04  ,\O   5
M    9W)D;BTR,#(T,#DR-5]P<F4N>&ULU9I=<^(V%(;O=V;_@^K>M#,U!I-L
M"Q.R0TG284H^!MA^W>P(ZP":RA(CB0#_OI)!6PQV%K+;CI6+ +;>H_><1Y:1
M\-7[=<K0,TA%!>\$C5H]0, 302B?=8*E"K%** V0TI@3S 2'3K !%;R_?OOF
MZILP1#=W_0<4HKG6"]6.HM5J52-3RI5@2VU"JEHBT@B%H6O?&W] OVV[:Z,A
M,, *4(J5!HE^7E)&VG$];C;JC;@6[\LD8!L/$:RAC5I1LQZ9AA>HU8[?M2^;
MZ.D>W691.!K3%/:E8K&1=#;7Z+OD>Y2);@3GP!ALT!WEF"<4,S1RCG] ?9[4
M4)<Q-+0R96PJD,] :KNHC/*_V_;?Q)I';]\@\V?JR%5VM!/8:NR*L9Y(5A-R
M9MS6FY$3!?N:]9%HU<PDC5:K%65G\^T5+6IM.FA$?]P/1LD<4AP:!H99<M"5
M<4/T)_6^N<MH>]*U5[2MLD@#D62E/R$M5-K"?@I=L] >"AMQV&S4UHH$U[;+
M;56E8#"$*;*O'X;]3WT:I%K2=0W(#,M0<-,8LJ&5C8)Z*[Z,-%X++M)-9+71
MC4B6*7#M7KN<W')-]:;/IT*F648!RHK;GDN8=H*9)#QTT:RO;X<FT,=S NG-
MPEP?BJ8+!@&*]O):2#.&N,Y:#\R!G #6&C@!XL+8!/[CS*^WE'=#622Y2KB+
M.4.H(*G-Q'-$@-H>F_:-+5,S*Y'Y\+$GS/S1G2@M<:+SI6!V[ CI#C(\ =8)
M"D31US34-6D3F_H=P[-3#1V(\H;V\75ED@N)9>+"F;<Y=L?7P:Y%M,#2Q N3
MN9GQG'HJ15I8G%UOHM"HD 1D)XCCFKG^ [205$@#VQP)T%(9+V)A76-FS\$4
MI 0RV*9=ZC*S:.92!5G+KXQG.QI[)@.)6=\,_/6OL#D54XFXNKA*##ML36^P
M]9;2%N&.J@2S/P'+6TYNS-WXY"N^5%]=>.6>';\+;_BY^\'85/)49GE-=3GE
M?3HV[[QC\P3&*SGSPBH15Y_6@6&'[4=OL&WG]B',J$V4ZP><GDRM6%M=:,5^
M';.?/&-FEGA"+H3,2CLR%8:>6)I;]*8GR)D(/Q.JZD0_8]\!;GD&^(XR>%BF
M$Y#GT=S751W=OM<=IV;=,TYCO.X34P8ZI=MMAM= *PU2=8*EQAW.AF<XNX28
M(JO=RX!R:)R'LC! U3$6FG8(?5N8'R<3?RG"V$>$\;\(_5FDYY+IF;>/<BQ6
M_%4 ]^6>X-NW[.#YLT+/I9)]%7N43U(\4[N-_QJ"1S$\P7CDV[&\])/EDU :
ML[_HXOS517$$3S@>N'84_=F7L?-)5P(^AUM>4UU2>9^.C3^;+_9W2?8T%_S,
M==ZQKKJ,CKTZ3OYLN/QN_&G@/9&F2[Y;YJA3896(JTNLQ+##YL\VRD@PFE!-
M^>S>W(PEM=9.8U:DK"ZP(K<[6A?^;*8\2;!##LRWI>QW$/L\@7R<3D^?%E^*
M4%UZ+[EV%/W90SG(IJ_4$N27LRR(XPW1 N^.JS\;*R-(EM9B(YZ,J68G?Y4\
MUE67V[%7Q\F?W9.QQ/;!Q]$FG8B3;W<'HNH2.C#J\/BS/^*&V.TZF6,^@W-^
M;BW65A=6L5_'S+=]D-L4Y,R,O5^D6.FYF=\7F)_YR%=)B.H2?-&V ^G/5L@N
MG;691;BBUMSV\8TS*1;H*X^PP+/C]S]LEUQ%1W49F /V0?3M&?O//E9MCOP#
M4$L! A0#%     @ NH ^69#HD)8L'0  D\L   X              ( !
M &0X.30X,S1D.&LN:'1M4$L! A0#%     @ NH ^69?#1OBC30  QV\! !$
M             ( !6!T  &0X.30X,S1D97@Q,#(N:'1M4$L! A0#%     @
MNH ^6;V,31O730  WV\! !$              ( !*FL  &0X.30X,S1D97@Q
M,#,N:'1M4$L! A0#%     @ NH ^6<GB[H;'3@  *G ! !$
M ( !,+D  &0X.30X,S1D97@Q,#0N:'1M4$L! A0#%     @ NH ^6<P)/!3M
M"@  7B\  !               ( !)@@! &0X.30X,S1D97@R,2YH=&U02P$"
M% ,4    " "Z@#Y9=O8(S; @  !+HP  $               @ %!$P$ 9#@Y
M-#@S-&1E>#,Q+FAT;5!+ 0(4 Q0    ( +J /EF0@XTXC$L  %+/ 0 0
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I9&XM,C R-# Y,C5?<')E+GAM;%!+!08     "P + +8"  ",S $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d894834d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="grdn-20240925.xsd" xlink:type="simple"/>
    <context id="duration_2024-09-25_to_2024-09-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802255</identifier>
        </entity>
        <period>
            <startDate>2024-09-25</startDate>
            <endDate>2024-09-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-472">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-09-25_to_2024-09-25"
      id="Hidden_dei_EntityCentralIndexKey">0001802255</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2024-09-25_to_2024-09-25"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2024-09-25_to_2024-09-25">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-484">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-485">2024-09-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-486">Guardian Pharmacy Services, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-487">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-488">001-42284</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-489">87-3627139</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-490">300 Galleria Parkway SE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-491">Suite 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-492">Atlanta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-493">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-494">30339</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-495">(404)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-496">810-0089</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-497">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-498">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-499">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-500">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-501">Class&#160;A Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-502">GRDN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-503">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-504">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2024-09-25_to_2024-09-25" id="ixv-505">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
